Admission	O
Date	O
:	O
	
2018-10-25	O
	
Discharge	O
Date	O
:	O
	
2018-10-31	O
	
Date	O
of	O
Birth	O
:	O
	
1951-06-15	O
	
Sex	O
:	O
	
M	O
	
Service	O
:	O
	
CARDIOTHORACIC	O
	
Allergies	O
:	O
	
Patient	O
recorded	O
as	O
having	O
No	O
Known	B-Problem
Allergies	I-Problem
to	O
Drugs	B-Treatment
	
Attending	O
:	O
Michael	O
D.	O
Christensen	O
,	O
M.D.	O
	
Chief	O
Complaint	O
:	O
	
Shortness	B-Problem
of	I-Problem
Breath	I-Problem
	
Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O
	
Coronary	B-Treatment
Artery	I-Treatment
Bypass	I-Treatment
Graft	I-Treatment
x3	O
(	O
Left	B-Treatment
internal	I-Treatment
mammary	I-Treatment
->	I-Treatment
left	I-Treatment
anterior	I-Treatment
descending	I-Treatment
,	O
saphaneous	B-Treatment
vein	I-Treatment
graft	I-Treatment
->	I-Treatment
obtuse	I-Treatment
marginal	I-Treatment
,	O
saphaneous	B-Treatment
vein	I-Treatment
graft	I-Treatment
->	I-Treatment
posterior	I-Treatment
descending	I-Treatment
artery	I-Treatment
)	O
2018-10-25	O
	
History	O
of	O
Present	O
Illness	O
:	O
	
67	O
y/o	O
male	O
with	O
worsening	B-Problem
shortness	I-Problem
of	I-Problem
breath.	I-Problem
Had	O
abnormal	B-Problem
ETT	I-Problem
and	O
referred	O
for	O
cath	B-Test
.	O
	
Cath	B-Test
revealed	O
severe	B-Problem
3	I-Problem
vessel	I-Problem
disease	I-Problem
.	O
	
Then	O
referred	O
for	O
surgical	B-Treatment
intervention	I-Treatment
.	O
	
Past	O
Medical	O
History	O
:	O
	
Carpal	B-Problem
tunnel	I-Problem
syndrome	I-Problem
,	O
Hypertension	B-Problem
,	O
Hyperlipidemia	B-Problem
,	O
Arthritis	B-Problem
,	O
h/o	O
Bell's	B-Problem
Palsy	I-Problem
,	O
HOH	B-Problem
,	O
s/p	O
Tonsillectomy	B-Treatment
	
Social	O
History	O
:	O
	
Denies	O
ETOH	O
,	O
rare	O
Tobacco	O
.	O
	
Electrician	O
.	O
	
Family	O
History	O
:	O
	
Father	O
with	O
MI	B-Problem
in	O
50	O
's	O
and	O
underwent	O
CABG	B-Treatment
.	O
	
Physical	O
Exam	O
:	O
	
VS	B-Test
:	O
65	O
20	O
160/100	O
5	O
'	O
7	O
"	O
180	O
#	O
	
General	O
:	O
WD/WN	O
male	O
in	O
NAD	B-Problem
	
HEENT	O
:	O
EOMI	O
,	O
PERRL	O
,	O
NC/AT	B-Problem
	
Neck	O
:	O
Supple	O
,	O
FROM	O
,	O
-	O
JVD	B-Problem
,	O
-	O
carotid	B-Problem
bruits	I-Problem
	
Chest	O
:	O
CTAB	O
-	O
w/r/r	B-Problem
	
Heart	O
:	O
RRR	O
-	O
c/r/m/g	B-Problem
	
Abd	O
:	O
Soft	O
,	O
NT/ND	B-Problem
+BS	O
	
Ext	O
:	O
Warm	O
,	O
well-perfused	O
-	O
edema	B-Problem
,	O
-	O
varicosities	B-Problem
	
Neuro	O
:	O
A&Ox3	O
,	O
MAE	O
,	O
non-focal	O
	
Pertinent	O
Results	O
:	O
	
Echo	B-Test
10-25	O
:	O
PRE-BYPASS	O
:	O
Left	B-Test
ventricular	I-Test
wall	I-Test
thicknesses	I-Test
are	O
normal	O
.	O
	
The	B-Test
left	I-Test
ventricular	I-Test
cavity	I-Test
size	I-Test
is	O
normal	O
.	O
	
There	O
is	O
mild	B-Problem
inferior	I-Problem
wall	I-Problem
hypokinesis	I-Problem
.	O
	
There	O
is	O
akinesis	B-Problem
/	O
dyskinesis	B-Problem
and	O
thinning	B-Problem
of	I-Problem
the	I-Problem
mid	I-Problem
to	I-Problem
distal	I-Problem
inferior	I-Problem
septum	I-Problem
and	O
the	O
apex	O
.	O
	
Overall	B-Test
left	I-Test
ventricular	I-Test
systolic	I-Test
function	I-Test
is	O
mildly	B-Problem
depressed	I-Problem
.	O
	
Right	B-Test
ventricular	I-Test
chamber	I-Test
size	I-Test
and	O
free	B-Test
wall	I-Test
motion	I-Test
are	O
normal	O
.	O
	
The	O
descending	O
thoracic	O
aorta	O
is	O
mildly	B-Problem
dilated	I-Problem
.	O
	
There	O
are	O
simple	B-Problem
atheroma	I-Problem
in	I-Problem
the	I-Problem
descending	I-Problem
thoracic	I-Problem
aorta	I-Problem
.	O
	
There	O
are	O
three	O
aortic	O
valve	O
leaflets	O
.	O
	
There	O
is	O
no	O
aortic	B-Problem
valve	I-Problem
stenosis	I-Problem
.	O
	
No	O
aortic	B-Problem
regurgitation	I-Problem
is	O
seen	O
.	O
	
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	B-Problem
thickened	I-Problem
.	O
	
Trivial	B-Problem
mitral	I-Problem
regurgitation	I-Problem
is	O
seen	O
.	O
	
POST-BYPASS	B-Treatment
:	O
LV	B-Test
and	I-Test
RV	I-Test
function	I-Test
is	O
unchanged	O
.	O
	
Aorta	O
is	O
unchanged	O
.	O
	
Other	O
findings	O
are	O
unchanged	O
.	O
	
CXR	B-Test
10-30	O
:	O
Left	B-Problem
lower	I-Problem
lobe	I-Problem
atelectasis	I-Problem
has	O
partially	O
cleared	O
.	O
	
Upper	O
lungs	O
are	O
clear	O
.	O
	
Mild	B-Problem
postoperative	I-Problem
widening	I-Problem
of	I-Problem
the	I-Problem
cardiomediastinal	I-Problem
silhouette	I-Problem
is	O
stable	O
.	O
	
No	O
pneumothorax	B-Problem
.	O
	
2018-10-25	O
11:15	O
AM	O
BLOOD	B-Test
WBC	B-Test
-	O
18.3	O
*#	O
RBC	B-Test
-	O
3.42	O
*	O
Hgb	B-Test
-	O
10.9	O
*	O
Hct	B-Test
-	O
31.6	O
*	O
MCV	B-Test
-	O
92	O
MCH	B-Test
-	O
31.7	O
MCHC	B-Test
-	O
34.4	O
RDW	B-Test
-	O
13.3	O
Plt	B-Test
Ct	I-Test
-	O
134	O
*	O
	
2018-10-31	O
06:25	O
AM	O
BLOOD	B-Test
WBC	B-Test
-	O
13.6	O
*	O
RBC	B-Test
-	O
2.72	O
*	O
Hgb	B-Test
-	O
8.6	O
*	O
Hct	B-Test
-	O
24.6	O
*	O
MCV	B-Test
-	O
91	O
MCH	B-Test
-	O
31.7	O
MCHC	B-Test
-	O
35.0	O
RDW	B-Test
-	O
14.0	O
Plt	B-Test
Ct	I-Test
-	O
314	O
	
2018-10-25	O
11:15	O
AM	O
BLOOD	B-Test
PT	B-Test
-	O
13.3	O
*	O
PTT	B-Test
-	O
30.0	O
INR(PT)	B-Test
-	O
1.2	O
*	O
	
2018-10-29	O
06:50	O
AM	O
BLOOD	B-Test
PT	B-Test
-	O
11.9	O
INR(PT)	B-Test
-	O
1.0	O
	
2018-10-25	O
12:36	O
PM	O
BLOOD	B-Test
UreaN	B-Test
-	O
17	O
Creat	B-Test
-	O
0.7	O
Cl	B-Test
-	O
111	O
*	O
HCO3	B-Test
-	O
23	O
	
2018-10-31	O
06:25	O
AM	O
BLOOD	B-Test
Glucose	B-Test
-	O
91	O
UreaN	B-Test
-	O
19	O
Creat	B-Test
-	O
0.8	O
Na	B-Test
-	O
134	O
K	B-Test
-	O
4.0	O
Cl	B-Test
-	O
98	O
HCO3	B-Test
-	O
26	O
AnGap	B-Test
-	O
14	O
	
Brief	O
Hospital	O
Course	O
:	O
	
Mr.	O
Kammerer	O
was	O
a	O
same	O
day	O
admit	O
and	O
on	O
10-25	O
was	O
brought	O
to	O
the	O
operating	O
room	O
where	O
he	O
underwent	O
a	B-Treatment
coronary	I-Treatment
artery	I-Treatment
bypass	I-Treatment
graft	I-Treatment
x	O
3	O
.	O
	
Please	O
see	O
operative	O
report	O
for	O
surgical	O
details	O
.	O
	
He	O
tolerated	O
the	B-Treatment
procedure	I-Treatment
well	O
and	O
was	O
transferred	O
to	O
the	O
CSRU	O
for	O
invasive	B-Test
monitoring	I-Test
in	O
stable	O
condition	O
.	O
	
Later	O
on	O
op	O
day	O
he	O
was	O
weaned	O
from	O
sedation	B-Treatment
,	O
awoke	O
neurologically	O
intact	O
,	O
and	O
	
extubated	O
.	O
	
Beta	B-Treatment
blockers	I-Treatment
and	O
diuretics	B-Treatment
were	O
initiated	O
on	O
post-op	O
day	O
one	O
.	O
	
He	O
was	O
diuresed	B-Treatment
towards	O
his	B-Test
pre-op	I-Test
weight	I-Test
.	O
	
He	O
appeared	O
to	O
be	O
doing	O
well	O
and	O
was	O
transferred	O
to	O
the	O
SDU	O
on	O
this	O
day	O
.	O
	
He	O
did	O
have	O
burst	B-Problem
of	I-Problem
atrial	I-Problem
fibrillation	I-Problem
and	O
was	O
started	O
on	O
a	B-Treatment
Amiodarone	I-Treatment
gtt	I-Treatment
.	O
	
His	B-Treatment
beta	I-Treatment
blockers	I-Treatment
were	O
also	O
titrated	O
for	O
maximal	B-Treatment
BP	I-Treatment
and	I-Treatment
HR	I-Treatment
control	I-Treatment
.	O
	
Chest	B-Treatment
tubes	I-Treatment
were	O
removed	O
on	O
post-op	O
day	O
two	O
and	O
epicardial	B-Treatment
pacing	I-Treatment
wires	I-Treatment
on	O
post-op	O
day	O
three	O
.	O
	
Over	O
the	O
next	O
several	O
days	O
he	O
continued	O
to	O
improve	O
his	O
ambulation	O
and	O
mobility	O
with	O
physical	B-Treatment
therapy	I-Treatment
.	O
	
He	O
had	O
no	O
further	B-Problem
episodes	I-Problem
of	I-Problem
AFIB	I-Problem
while	O
on	O
po	B-Treatment
Amiodarone	I-Treatment
.	O
	
On	O
post-op	O
day	O
five	O
he	O
appeared	O
to	O
have	O
left	B-Problem
arm	I-Problem
phlebitis	I-Problem
and	O
was	O
started	O
on	O
antibiotics	B-Treatment
.	O
	
He	O
was	O
discharged	O
home	O
on	O
post-op	O
day	O
six	O
with	O
antibiotics	B-Treatment
and	O
appropriate	B-Treatment
meds	I-Treatment
.	O
	
He	O
will	O
have	O
VNA	B-Treatment
services	I-Treatment
and	O
make	O
the	O
appropriate	O
follow-up	O
appointments	O
.	O
	
Medications	O
on	O
Admission	O
:	O
	
Aspirin	B-Treatment
81	O
mg	O
qd	O
,	O
Toprol	B-Treatment
XL	O
50	O
mg	O
qd	O
,	O
MVI	B-Treatment
,	O
Flexeril	B-Treatment
10	O
mg	O
qhs	O
,	O
Plavix	B-Treatment
75	O
mg	O
qd	O
(	O
last	O
on	O
10-18	O
)	O
	
Discharge	O
Medications	O
:	O
	
1.	O
Docusate	B-Treatment
Sodium	I-Treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O
	
Disp	O
:*	O
60	O
Capsule	O
(s)*	O
Refills	O
:*	O
0	O
*	O
	
2.	O
Aspirin	B-Treatment
81	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
).	O
	
Disp:*	O
30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(s)*	O
Refills	O
:*	O
0	O
*	O
	
3.	O
Ranitidine	B-Treatment
HCl	I-Treatment
150	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O
	
Disp	O
:*	O
60	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O
	
4.	O
Oxycodone	B-Treatment
-	I-Treatment
Acetaminophen	I-Treatment
5-325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4H	O
(	O
every	O
4	O
hours	O
)	O
as	O
needed	O
for	O
pain	B-Problem
.	O
	
Disp	O
:*	O
40	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O
	
5.	O
Atorvastatin	B-Treatment
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O
	
Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O
	
6.	O
Amiodarone	B-Treatment
200	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
):	O
please	O
take	O
400	O
mg	O
twice	O
a	O
day	O
until	O
11-02	O
then	O
decrease	O
to	O
400	O
mg	O
once	O
a	O
day	O
for	O
1	O
week	O
and	O
then	O
decrease	O
to	O
200	O
mg	O
once	O
a	O
day	O
.	O
	
Disp	O
:*	O
40	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O
	
7.	O
Metoprolol	B-Treatment
Succinate	I-Treatment
50	O
mg	O
Tablet	O
Sustained	O
Release	O
24	O
HR	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
Sustained	O
Release	O
24	O
HR	O
PO	O
DAILY	O
(	O
Daily	O
).	O
	
Disp	O
:*	O
30	O
Tablet	O
Sustained	O
Release	O
24	O
HR	O
(s)*	O
Refills	O
:*	O
0	O
*	O
	
8.	O
Ferrous	B-Treatment
Gluconate	I-Treatment
300	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O
	
Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O
	
9.	O
Ascorbic	B-Treatment
Acid	I-Treatment
500	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O
	
Disp	O
:*	O
60	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O
	
10.	O
Cephalexin	B-Treatment
500	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
for	O
6	O
days	O
:	O
please	O
complete	O
full	O
course	O
.	O
	
Disp	O
:*	O
24	O
Capsule	O
(s)*	O
Refills	O
:*	O
0	O
*	O
	
11.	O
Furosemide	B-Treatment
20	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
for	O
2	O
weeks	O
.	O
	
Disp	O
:*	O
14	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O
	
12.	O
Potassium	B-Treatment
Chloride	I-Treatment
10	O
mEq	O
Capsule	O
,	O
Sustained	O
Release	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
,	O
Sustained	O
Release	O
PO	O
DAILY	O
(	O
Daily	O
)	O
for	O
2	O
weeks	O
.	O
	
Disp	O
:*	O
14	O
Capsule	O
,	O
Sustained	O
Release	O
(s)*	O
Refills	O
:*	O
0	O
*	O
	
13.	O
Lisinopril	B-Treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
0.5	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O
	
Disp	O
:*	O
15	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O
	
Discharge	O
Disposition	O
:	O
	
Home	O
with	O
Service	O
	
Discharge	O
Diagnosis	O
:	O
	
Coronary	B-Problem
artery	I-Problem
disease	I-Problem
s/p	O
Coronary	B-Treatment
Artery	I-Treatment
Bypass	I-Treatment
Graft	I-Treatment
x3	O
	
PMH	O
:	O
Carpal	B-Problem
tunnel	I-Problem
syndrome	I-Problem
,	O
Hypertension	B-Problem
,	O
Hyperlipidemia	B-Problem
,	O
Arthritis	B-Problem
	
Discharge	O
Condition	O
:	O
	
good	O
	
Discharge	O
Instructions	O
:	O
	
May	O
shower	O
,	O
no	O
baths	O
or	O
swimming	O
	
Monitor	O
wounds	B-Problem
for	O
infection	B-Problem
-	O
redness	B-Problem
,	O
drainage	B-Problem
,	O
or	O
increased	B-Problem
pain	I-Problem
	
Report	O
any	B-Problem
fever	I-Problem
greater	I-Problem
than	I-Problem
101	I-Problem
	
Report	O
any	B-Problem
weight	I-Problem
gain	I-Problem
of	O
greater	O
than	O
2	O
pounds	O
in	O
24	O
hours	O
or	O
5	O
pounds	O
in	O
a	O
week	O
	
No	O
creams	B-Treatment
,	O
lotions	B-Treatment
,	O
powders	B-Treatment
,	O
or	O
ointments	B-Treatment
to	O
incisions	B-Problem
	
No	O
driving	O
for	O
approximately	O
one	O
month	O
	
No	O
lifting	O
more	O
than	O
10	O
pounds	O
for	O
10	O
weeks	O
	
Please	O
call	O
with	O
any	O
questions	O
or	O
concerns	O
	
Left	O
Arm	O
continue	O
with	O
elevation	B-Treatment
,	O
ice	B-Treatment
,	O
and	O
complete	O
all	B-Treatment
antibiotics	I-Treatment
	
Followup	O
Instructions	O
:	O
	
Dr	O
Day	O
in	O
4	O
weeks	O
((	O
469	O
)	O
587-0462	O
)	O
please	O
call	O
for	O
appointment	O
	
Dr	O
Miller	O
in	O
1	O
week	O
(	O
262-575-0600	O
)	O
please	O
call	O
for	O
appointment	O
	
Dr	O
Scott	O
Raines	O
in	O
2-3	O
weeks	O
please	O
call	O
for	O
appointment	O
	
Wound	O
check	O
appointment	O
4	O
East	O
as	O
instructed	O
by	O
nurse	O
(	O
280-5326	O
)	O
	
For	O
surgical	B-Problem
incision	I-Problem
and	O
left	O
arm	O
	
Craig	O
Douglas	O
MD	O
10-898	O
	
Completed	O
by	O
:	O
Reyes	O
Marengo	O
PA	O
80	O
-	O
BMD	O
2018-11-19	O
@	O
1536	O
	
Signed	O
electronically	O
by	O
:	O
DR.	O
Jeffrey	O
Collins	O
on	O
:	O
WED	O
2018-11-21	O
9:28	O
AM	O
	
(	O
End	O
of	O
Report	O
)	O
	
Admission	O
Date	O
:	O
	
2011-03-10	O
	
Discharge	O
Date	O
:	O
	
2011-03-15	O
	
Date	O
of	O
Birth	O
:	O
	
1927-10-26	O
	
Sex	O
:	O
	
F	O
	
Service	O
:	O
	
Medford	O
	
HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O
	
This	O
is	O
an	O
83	O
year	O
old	O
woman	O
with	O
a	O
history	O
of	O
hypertension	B-Problem
who	O
presents	O
with	O
slurred	B-Problem
speech	I-Problem
when	O
dehydrated	B-Problem
.	O
	
She	O
has	O
paraplegia	B-Problem
secondary	O
to	O
HTLV	B-Problem
exposure	I-Problem
while	O
on	O
vacation	O
in	O
the	O
Bahamas	O
six	O
years	O
ago	O
.	O
	
She	O
presented	O
with	O
three	O
days	O
of	O
general	B-Problem
malaise	I-Problem
,	O
nausea	B-Problem
,	O
vomiting	B-Problem
,	O
shortness	B-Problem
of	I-Problem
breath	I-Problem
,	O
cough	B-Problem
productive	O
of	O
white	B-Problem
sputum	I-Problem
.	O
	
She	O
awoke	O
with	O
nausea	B-Problem
on	O
the	O
day	O
of	O
admission	O
and	O
pleuritic	B-Problem
chest	I-Problem
pain	I-Problem
.	O
	
She	O
reports	O
no	O
sick	O
contacts.	O
	
The	O
patient	O
has	O
some	B-Problem
difficulty	I-Problem
talking	O
and	O
grasping	O
right	O
hand	O
.	O
	
She	O
came	O
to	O
the	O
Emergency	O
Department	O
on	O
the	O
2011-03-10	O
,	O
with	O
temperature	B-Test
of	O
99.0	O
F	O
.;	O
blood	B-Test
pressure	I-Test
of	O
97/50	O
;	O
heart	B-Test
rate	I-Test
100	O
;	O
respirations	B-Test
27	O
;	O
O2	B-Test
saturation	I-Test
84%	O
on	O
room	O
air	O
and	O
94%	O
on	O
two	O
liters	O
.	O
	
The	O
patient	O
had	O
coarse	B-Problem
rhonchi	I-Problem
on	O
examination	B-Test
.	O
	
Chest	B-Test
x-ray	I-Test
revealed	O
mild	B-Problem
pulmonary	I-Problem
edema	I-Problem
.	O
	
Chest	B-Test
CT	I-Test
scan	I-Test
was	O
negative	O
for	O
pulmonary	B-Problem
embolism	I-Problem
but	O
positive	O
for	O
consolidation	B-Problem
.	O
	
She	O
was	O
started	O
on	O
Levofloxacin	B-Treatment
but	O
the	O
patient	O
became	O
hypotensive	B-Problem
at	O
that	O
point	O
with	O
blood	B-Test
pressure	I-Test
of	O
70/45	O
and	O
received	O
a	B-Treatment
normal	I-Treatment
saline	I-Treatment
bolus	I-Treatment
to	O
boost	O
her	B-Test
blood	I-Test
pressure	I-Test
to	O
99/60	O
;	O
however	O
the	O
patient	O
was	O
admitted	O
to	O
the	O
Medical	O
Intensive	O
Care	O
Unit	O
for	O
overnight	B-Test
observation	I-Test
because	O
of	O
her	B-Problem
somnolence	I-Problem
and	O
hypotension	B-Problem
.	O
	
She	O
was	O
transferred	O
to	O
the	O
Everett	O
Firm	O
on	O
the	O
2011-03-11	O
and	O
was	O
mentating	O
well	O
and	O
was	O
stable	O
for	O
transfer	O
.	O
	
PAST	O
MEDICAL	O
HISTORY	O
:	O
	
1.	O
Positive	B-Problem
lupus	I-Problem
anti-coagulant	I-Problem
.	O
	
2.	O
Basilar	B-Problem
stenosis	I-Problem
.	O
	
3.	O
Prior	B-Problem
transient	I-Problem
ischemic	I-Problem
attacks	I-Problem
.	O
	
4.	O
Right	B-Treatment
medial	I-Treatment
malleolus	I-Treatment
repair	I-Treatment
in	O
2004-08-05	O
.	O
	
5.	O
Paraplegia	B-Problem
secondary	O
to	O
HTLV	B-Problem
from	O
a	O
trip	O
to	O
the	O
Bahamas	O
five	O
to	O
six	O
years	O
ago	O
.	O
	
6.	O
Hypertension	B-Problem
.	O
	
7.	O
Chronic	B-Problem
diarrhea	I-Problem
with	O
multiple	O
admissions	O
for	O
dehydration	B-Problem
with	O
most	O
recent	O
one	O
on	O
2011-02-26	O
.	O
	
8.	O
Venous	B-Problem
stasis	I-Problem
.	O
	
9.	O
Depression	B-Problem
.	O
	
10.	O
Seizure	B-Problem
history	I-Problem
on	O
Neurontin	B-Treatment
.	O
	
11.	O
Left	B-Treatment
CMED	I-Treatment
cataract	I-Treatment
surgery	I-Treatment
in	O
2009-10-05	O
.	O
	
12.	O
Chronic	B-Problem
muscle	I-Problem
spasms	I-Problem
.	O
	
ALLERGIES	O
:	O
	
Penicillin	B-Treatment
for	O
which	O
she	O
reports	O
a	B-Problem
rash	I-Problem
and	O
dyspepsia	B-Problem
when	O
taking	O
uncoated	B-Treatment
aspirin	I-Treatment
.	O
	
She	O
has	O
a	O
questionable	O
sensitivity	B-Problem
to	O
iodine	B-Treatment
.	O
	
MEDICATIONS	O
AS	O
OUTPATIENT	O
:	O
	
1.	O
Enteric-coated	B-Treatment
aspirin	I-Treatment
.	O
	
2.	O
Aggrenox	B-Treatment
.	O
	
3.	O
Zanaflex	B-Treatment
.	O
	
4.	O
Neurontin	B-Treatment
300	O
mg	O
three	O
times	O
a	O
day	O
.	O
	
5.	O
Celexa	B-Treatment
10	O
mg	O
daily	O
.	O
	
PHYSICAL	O
EXAMINATION	O
:	O
	
On	O
admission	B-Test
examination	I-Test
she	O
was	O
a	O
well	O
developed	O
,	O
well	O
nourished	O
female	O
in	O
no	O
apparent	B-Problem
distress	I-Problem
.	O
	
She	O
was	O
alert	O
and	O
oriented	O
times	O
three	O
.	O
	
Speech	O
was	O
fluent	O
.	O
	
Her	O
lungs	O
revealed	O
coarse	B-Problem
bilateral	I-Problem
rhonchi	I-Problem
from	O
base	O
to	O
midline	O
.	O
	
Cardiovascular	B-Test
examination	I-Test
is	O
notable	O
for	O
a	O
regular	O
rate	O
and	O
rhythm	O
;	O
no	O
murmurs	B-Problem
,	O
rubs	B-Problem
or	O
gallops	B-Problem
.	O
	
Abdomen	O
is	O
soft	O
and	O
obese	B-Problem
,	O
nontender	B-Problem
.	O
	
Normal	O
bowel	O
sounds	O
present	O
.	O
	
Extremities	O
notable	O
for	O
two	B-Problem
plus	I-Problem
lower	I-Problem
extremity	I-Problem
edema	I-Problem
and	O
the	O
ankles	O
were	O
noted	O
to	O
be	O
in	O
pressure	B-Treatment
stockings	I-Treatment
.	O
	
LABORATORY	O
:	O
	
White	B-Test
blood	I-Test
cell	I-Test
count	I-Test
were	O
11.8	O
,	O
hematocrit	B-Test
31.5	O
,	O
platelets	B-Test
151	O
.	O
	
Chem-7	B-Test
was	O
a	B-Test
sodium	I-Test
of	O
140	O
,	O
potassium	B-Test
of	O
3.0	O
,	O
chloride	B-Test
108	O
,	O
bicarbonate	B-Test
24	O
,	O
BUN	B-Test
22	O
,	O
creatinine	B-Test
1.0	O
and	O
glucose	B-Test
117	O
.	O
	
The	O
patient	O
also	O
had	O
a	B-Test
head	I-Test
CT	I-Test
scan	I-Test
in	O
the	O
Emergency	O
Department	O
before	O
coming	O
to	O
the	O
Unit	O
which	O
reported	O
no	O
recent	B-Problem
bleed	I-Problem
and	O
no	O
change	B-Problem
from	O
a	B-Test
prior	I-Test
CT	I-Test
scan	I-Test
done	O
on	O
2011-03-04	O
.	O
	
EKG	B-Test
is	O
notable	O
for	O
sinus	B-Problem
tachycardia	I-Problem
at	O
100	O
beats	O
per	O
minute	O
,	O
normal	O
axis	O
.	O
	
.....	O
done	O
on	O
02-24	O
,	O
notable	O
for	O
mid-basilar	B-Problem
artery	I-Problem
high-grade	I-Problem
stenosis	I-Problem
.	O
	
HOSPITAL	O
COURSE	O
:	O
	
After	O
transfer	O
to	O
the	O
Floor	O
,	O
the	O
patient	O
was	O
continued	O
on	O
Levofloxacin	B-Treatment
for	O
a	O
ten	O
to	O
14	O
day	O
course	O
for	O
presumptive	O
pneumonia	B-Problem
.	O
	
Due	O
to	O
her	B-Problem
chronic	I-Problem
diarrhea	I-Problem
she	O
was	O
repleted	O
with	O
intravenous	B-Treatment
fluids	I-Treatment
.	O
	
For	O
her	B-Problem
depression	I-Problem
,	O
continued	O
on	O
Citalopram	B-Treatment
10	O
mg	O
daily	O
.	O
	
For	O
her	B-Problem
paraplegia	I-Problem
and	O
associated	O
muscle	B-Problem
spasticity	I-Problem
she	O
was	O
continued	O
on	O
her	B-Treatment
Zanaflex	I-Treatment
.	O
	
For	O
deep	B-Treatment
vein	I-Treatment
thrombosis	I-Treatment
prophylaxis	I-Treatment
she	O
was	O
treated	O
with	O
subcutaneous	B-Treatment
heparin	I-Treatment
and	O
for	O
gastrointestinal	B-Treatment
prophylaxis	I-Treatment
she	O
was	O
treated	O
with	O
Protonix	B-Treatment
.	O
	
She	O
was	O
also	O
evaluated	O
by	O
Physical	B-Treatment
Therapy	I-Treatment
and	O
Speech	B-Treatment
and	O
Swallow	B-Treatment
because	O
of	O
some	O
report	O
of	O
dysphagia	B-Problem
.	O
	
Physical	B-Treatment
Therapy	I-Treatment
felt	O
that	O
the	O
patient	O
was	O
cleared	O
for	O
transfer	O
home	O
with	O
services	O
.	O
	
Occupational	B-Treatment
Therapy	I-Treatment
was	O
also	O
in	O
agreement	O
with	O
the	O
patient	O
's	O
disposition	O
home	O
with	O
services	O
.	O
	
The	O
patient	O
was	O
able	O
to	O
advance	O
her	O
diet	O
well	O
from	O
liquids	O
to	O
solids	O
,	O
however	O
,	O
she	O
was	O
plagued	O
with	O
a	B-Problem
persistent	I-Problem
cough	I-Problem
and	O
some	B-Problem
low	I-Problem
grade	I-Problem
fevers	I-Problem
to	O
99.0	O
F	O
.	O
	
Speech	B-Treatment
and	O
Swallow	B-Treatment
evaluated	O
the	O
patient	O
at	O
bedside	O
and	O
recommended	O
advancing	O
to	O
regular	O
diet	O
with	O
regular	O
consistency	O
and	O
saw	O
no	O
evidence	O
of	O
any	B-Problem
dysphagia	I-Problem
.	O
	
There	O
was	O
some	O
question	O
regarding	O
restarting	O
of	O
the	B-Treatment
patient	I-Treatment
's	I-Treatment
Coumadin	I-Treatment
given	O
her	B-Problem
positive	I-Problem
lupus	I-Problem
anti-coagulant	I-Problem
status	I-Problem
as	O
well	O
as	O
the	O
presence	O
of	O
her	B-Problem
basilar	I-Problem
artery	I-Problem
stenosis	I-Problem
.	O
	
The	O
patient	O
was	O
discharged	O
on	O
the	O
2011-03-15	O
on	O
the	B-Treatment
following	I-Treatment
medications	I-Treatment
.	O
	
DISCHARGE	O
MEDICATIONS	O
:	O
	
1.	O
Levofloxacin	B-Treatment
250	O
mg	O
q.	O
day	O
for	O
ten	O
days	O
.	O
	
2.	O
Aspirin	B-Treatment
/	O
dipyridamole	B-Treatment
25/200	O
mg	O
capsules	O
taken	O
two	O
times	O
a	O
day	O
.	O
	
3.	O
Neurontin	B-Treatment
300	O
mg	O
taken	O
three	O
times	O
a	O
day	O
.	O
	
4.	O
Subcutaneous	B-Treatment
heparin	I-Treatment
taken	O
5000	O
units	O
twice	O
a	O
day	O
.	O
	
5.	O
Albuterol	B-Treatment
multiple	I-Treatment
dose	I-Treatment
inhalers	I-Treatment
,	O
one	O
to	O
two	O
puffs	O
q.	O
six	O
hours	O
as	O
needed	O
.	O
	
6.	O
Atrovent	B-Treatment
multiple	I-Treatment
dose	I-Treatment
inhalers	I-Treatment
,	O
one	O
to	O
two	O
puffs	O
q.	O
six	O
hours	O
as	O
needed	O
.	O
	
7.	O
Citalopram	B-Treatment
10	O
mg	O
q.	O
day	O
.	O
	
8.	O
Lisinopril	B-Treatment
2.5	O
mg	O
once	O
a	O
day	O
.	O
	
9.	O
Trazodone	B-Treatment
25	O
mg	O
q.	O
h.s.	O
p.r.n.	O
	
10.	O
Protonix	B-Treatment
40	O
mg	O
q.	O
day	O
.	O
	
11.	O
Zanaflex	B-Treatment
2	O
mg	O
twice	O
a	O
day	O
.	O
	
12.	O
Tylenol	B-Treatment
325	O
mg	O
,	O
one	O
to	O
two	O
tablets	O
q.	O
four	O
to	O
six	O
hours	O
p.r.n.	O
	
13.	O
The	O
patient	O
was	O
also	O
discharged	O
with	O
the	O
restarting	O
of	O
warfarin	B-Treatment
2	O
mg	O
daily	O
.	O
	
DISCHARGE	O
INSTRUCTIONS	O
:	O
	
1.	O
She	O
was	O
instructed	O
to	O
have	O
blood	B-Test
drawn	O
by	O
the	O
Visiting	O
Nurses	O
Association	O
the	O
day	O
after	O
discharge	O
and	O
then	O
a	O
few	O
days	O
after	O
discharge	O
the	O
same	O
week	O
to	O
have	O
INR	B-Test
.	O
	
Will	O
also	O
have	O
INR	B-Test
checked	O
at	O
once	O
weekly	O
until	O
target	O
of	O
INR	B-Test
of	O
2.0	O
to	O
3.0	O
is	O
reached	O
.	O
	
2.	O
The	O
patient	O
was	O
instructed	O
to	O
contact	O
Dr.	O
Ralph	O
at	O
(	O
428	O
)	O
678-6930	O
,	O
who	O
is	O
covering	O
for	O
her	O
primary	O
care	O
physician	O
,	O
Dr.	O
Erika	O
Witt	O
,	O
to	O
adjust	O
her	B-Treatment
dosages	I-Treatment
based	O
on	O
the	B-Test
INR	I-Test
levels	I-Test
.	O
	
3.	O
The	O
patient	O
also	O
had	O
a	O
Gastrointestinal	O
Clinic	O
follow-up	O
on	O
2011-03-28	O
.	O
	
She	O
is	O
to	O
follow-up	O
with	O
Dr.	O
Geraldo	O
Davis	O
.	O
	
4.	O
She	O
was	O
also	O
instructed	O
to	O
follow-up	O
with	O
Dr.	O
Reid	O
from	O
Neurology	O
within	O
a	O
month	O
at	O
(	O
382	O
)	O
716	O
4151	O
,	O
given	O
her	B-Problem
neurological	I-Problem
deficits	I-Problem
during	O
this	O
presentation	O
.	O
	
Brenda	O
L.	O
Nelson	O
,	O
M.D.	O
	
Dictated	O
By	O
:	O
Rodolfo	O
X	O
Gifford	O
,	O
M.D.	O
	
MEDQUIST36	O
	
D	O
:	O
2011-04-18	O
16:17	O
	
T	O
:	O
2011-04-18	O
22:11	O
	
JOB	O
#:	O
	
46153	O
	
Signed	O
electronically	O
by	O
:	O
DR.	O
Dorothy	O
Donahue	O
on	O
:	O
TUE	O
2011-04-19	O
3:15	O
PM	O
	
(	O
End	O
of	O
Report	O
)	O
	
Admission	O
Date	O
:	O
	
Discharge	O
Date	O
:	O
	
2014-01-24	O
	
Date	O
of	O
Birth	O
:	O
	
1928-11-23	O
	
Sex	O
:	O
	
F	O
	
Service	O
:	O
	
Internal	B-Treatment
Medicine	I-Treatment
	
During	O
the	O
last	O
four	O
hospital	O
days	O
,	O
the	O
continued	O
to	O
do	O
relatively	O
well	O
.	O
	
Her	O
renal	O
function	O
significantly	O
improved	O
,	O
and	O
her	B-Test
discharge	I-Test
creatinine	I-Test
was	O
3.1	O
.	O
	
Of	O
note	O
,	O
her	B-Test
blood	I-Test
pressure	I-Test
significantly	O
improved	O
in	O
the	O
120s-130s	O
which	O
assured	O
better	O
perfusion	O
in	O
her	O
kidneys	O
.	O
	
She	O
received	O
intermittent	O
doses	O
of	O
Lasix	B-Treatment
to	O
assure	O
overall	O
negative	O
intakes	O
and	O
outputs	O
.	O
	
She	O
progressed	O
beautifully	O
with	O
physical	B-Treatment
therapy	I-Treatment
and	O
occupational	B-Treatment
therapy	I-Treatment
and	O
was	O
able	O
to	O
ambulate	O
with	O
assistance	O
.	O
	
She	O
has	O
very	B-Problem
mild	I-Problem
left	I-Problem
lower	I-Problem
extremity	I-Problem
pain	I-Problem
which	O
is	O
largely	O
unchanged	O
.	O
	
DISCHARGE	O
CONDITION	O
:	O
	
Stable	O
.	O
	
DISCHARGE	O
DIAGNOSES	O
:	O
	
1.	O
Coronary	B-Problem
artery	I-Problem
disease	I-Problem
.	O
	
2.	O
Congestive	B-Problem
heart	I-Problem
failure	I-Problem
.	O
	
3.	O
Acute	B-Problem
renal	I-Problem
failure	I-Problem
.	O
	
4.	O
Acute	B-Problem
myocardial	I-Problem
infarction	I-Problem
.	O
	
5.	O
Osteomyelitis	B-Problem
.	O
	
6.	O
Diabetes	B-Problem
mellitus	I-Problem
.	O
	
DISPOSITION	O
:	O
	
Discharged	O
to	O
a	O
rehabilitation	O
facility	O
.	O
	
DISCHARGE	O
MEDICATIONS	O
:	O
	
1.	O
Amiodarone	B-Treatment
200	O
mg	O
p.o.	O
q	O
day	O
.	O
	
2.	O
Warfarin	B-Treatment
3	O
mg	O
p.o.	O
q	O
h.s.	O
	
3.	O
Renagel	B-Treatment
1600	O
mg	O
p.o.	O
t.i.d.	O
	
4.	O
Aspirin	B-Treatment
325	O
mg	O
p.o.	O
q	O
day	O
.	O
	
5.	O
Miconazole	B-Treatment
powder	I-Treatment
2%	O
t.i.d.	O
	
6.	O
Levofloxacin	B-Treatment
250	O
mg	O
p.o.	O
q48	O
hours	O
for	O
the	O
next	O
five	O
weeks	O
for	O
osteomyelitis	B-Problem
.	O
	
7.	O
Flagyl	B-Treatment
500	O
mg	O
p.o.	O
t.i.d.	O
for	O
the	O
next	O
five	O
weeks	O
for	O
osteomyelitis	B-Problem
.	O
	
8.	O
Protonix	B-Treatment
40	O
mg	O
p.o.	O
q	O
day	O
.	O
	
9.	O
Magnesium	B-Treatment
Oxide	I-Treatment
800	O
mg	O
p.o.	O
b.i.d.	O
	
10.	O
Epogen	B-Treatment
5000	O
units	O
two	O
times	O
weekly	O
,	O
on	O
Monday	O
and	O
Thursday	O
.	O
	
11.	O
Colace	B-Treatment
100	O
mg	O
p.o.	O
b.i.d.	O
	
12.	O
Lasix	B-Treatment
80	O
mg	O
p.o.	O
b.i.d.	O
	
13.	O
NPH	B-Treatment
insulin	I-Treatment
7	O
units	O
in	O
the	O
morning	O
and	O
5	O
units	O
at	O
night	O
.	O
	
14.	O
Regular	B-Treatment
insulin	I-Treatment
sliding	I-Treatment
scale	I-Treatment
.	O
	
Richard	O
U.	O
Walker	O
,	O
M.D.	O
	
36-781	O
	
Dictated	O
By	O
:	O
Levi	O
G.	O
Savage	O
,	O
M.D.	O
	
MEDQUIST36	O
	
D	O
:	O
2014-01-24	O
13:13	O
	
T	O
:	O
2014-01-24	O
13:45	O
	
JOB	O
#:	O
	
12151	O
	
Signed	O
electronically	O
by	O
:	O
DR.	O
Kelly	O
Hunter	O
YANG	O
on	O
:	O
FRI	O
2014-01-31	O
2:04	O
PM	O
	
(	O
End	O
of	O
Report	O
)	O
	
Admission	O
Date	O
:	O
	
2015-10-28	O
	
Discharge	O
Date	O
:	O
	
2015-11-13	O
	
Date	O
of	O
Birth	O
:	O
	
1941-08-30	O
	
Sex	O
:	O
	
F	O
	
Service	O
:	O
CARDIOTHORACIC	O
	
Allergies	O
:	O
	
Tape	O
/	O
Benadryl	B-Treatment
	
Attending	O
:Jordan	O
U	O
Kostohryz	O
,	O
M.D.	O
	
Chief	O
Complaint	O
:	O
	
Chest	B-Problem
discomfort	I-Problem
	
Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O
	
2015-10-30	O
Left	B-Treatment
Carotid	I-Treatment
Stenting	I-Treatment
	
2015-11-02	O
Coronary	B-Treatment
Artery	I-Treatment
Bypass	I-Treatment
Graft	I-Treatment
x	O
2	O
(	O
Lima	B-Treatment
to	I-Treatment
LAD	I-Treatment
,	O
SVG	B-Treatment
to	I-Treatment
OM	I-Treatment
)	O
	
History	O
of	O
Present	O
Illness	O
:	O
	
Ms.	O
Bridge	O
is	O
a	O
74	O
y/o	O
female	O
admitted	O
to	O
outside	O
hospital	O
on	O
2015-10-21	O
with	O
chest	B-Problem
discomfort	I-Problem
,	O
vomiting	B-Problem
and	O
shortness	B-Problem
of	I-Problem
breath	I-Problem
.	O
	
Initial	B-Test
EKG	I-Test
showed	O
ST	B-Problem
depressions	I-Problem
,	O
but	O
cardiac	B-Test
enzymes	I-Test
were	O
not	O
elevated	B-Problem
.	O
	
She	O
eventually	O
underwent	O
a	B-Test
cardiac	I-Test
cath	I-Test
to	O
assess	O
coronary	B-Problem
disease	I-Problem
which	O
revealed	O
three	B-Problem
vessel	I-Problem
coronary	I-Problem
artery	I-Problem
disease	I-Problem
.	O
	
She	O
was	O
then	O
transferred	O
to	O
The	O
Hospital	O
for	O
Orthopedics	O
for	O
surgical	B-Treatment
intervention	I-Treatment
.	O
	
Past	O
Medical	O
History	O
:	O
	
Coronary	B-Problem
Artery	I-Problem
Disease	I-Problem
,	O
Hypertension	B-Problem
,	O
Hyperlipidemia	B-Problem
,	O
Diabetes	B-Problem
Mellitus	I-Problem
,	O
Hypothyroid	B-Problem
,	O
h/o	O
Bilateral	B-Problem
DVT	I-Problem
's	I-Problem
(	O
on	O
chronic	B-Treatment
coumadin	I-Treatment
therapy	I-Treatment
),	O
Pleural	B-Problem
disorder	I-Problem
?	O
Sarcoidosis	B-Problem
,	O
Gastritis	B-Problem
,	O
B12	B-Problem
deficiency	I-Problem
,	O
Chronic	B-Problem
renal	I-Problem
insufficiency	I-Problem
,	O
s/p	O
Appendectomy	B-Treatment
,	O
s/p	O
Lap	B-Treatment
cholectomy	I-Treatment
,	O
s/p	O
Total	B-Treatment
abdominal	I-Treatment
hysterectomy	I-Treatment
	
Social	O
History	O
:	O
	
Denies	O
tobacco	O
or	O
ETOH	O
use	O
.	O
	
Lives	O
wth	O
husband	O
.	O
	
Family	O
History	O
:	O
	
Mother	O
died	O
of	O
MI	B-Problem
at	O
age	O
55	O
.	O
	
Brother	O
w/	O
CAD	B-Problem
since	O
age	O
40	O
and	O
died	O
in	O
70	O
's	O
after	O
cardiac	B-Treatment
surgery	I-Treatment
.	O
	
Son	O
died	O
at	O
14	O
d/t	O
ASD	B-Problem
.	O
	
Physical	O
Exam	O
:	O
	
Gen	O
:	O
NAD	B-Problem
	
Neck	O
:	O
Supple	O
,	O
-	O
JVD	B-Problem
,	O
-	O
Bruits	B-Problem
	
Heart	O
:	O
RRR	O
-	O
c/r/m/g	B-Problem
	
Lungs	O
:	O
CTAB	O
,	O
coarse	B-Problem
	
Abd	O
:	O
Soft	O
,	O
NT/NT	B-Problem
+	O
BS	O
	
Ext	O
:	O
Cool	O
,	O
1	O
+	O
pedal	B-Test
pulses	I-Test
,	O
-	O
varicosities	B-Problem
,	O
-	O
edema	B-Problem
	
Neuro	O
:	O
A&O	O
x	O
3	O
,	O
MAE	O
,	O
non-focal	O
	
Some	B-Problem
rashes	I-Problem
on	I-Problem
ACW	I-Problem
around	O
EKG	B-Treatment
leads	I-Treatment
	
Pertinent	O
Results	O
:	O
	
CNIS	B-Test
10-29	O
:	O
	
1.	O
60-69%	B-Problem
stenosis	I-Problem
of	I-Problem
the	I-Problem
right	I-Problem
internal	I-Problem
carotid	I-Problem
artery	I-Problem
.	O
	
2.	O
80-99%	B-Problem
stenosis	I-Problem
of	I-Problem
the	I-Problem
left	I-Problem
internal	I-Problem
carotid	I-Problem
artery	I-Problem
.	O
	
Echo	B-Test
11-02	O
:	O
PRE-BYPASS	O
:	O
Left	O
ventricular	O
wall	O
thickness	O
,	O
cavity	O
size	O
,	O
and	O
systolic	O
function	O
are	O
normal	O
(	O
LVEF>55%	B-Test
).	O
	
Resting	B-Problem
regional	I-Problem
wall	I-Problem
motion	I-Problem
abnormalities	I-Problem
include	O
mild	B-Problem
apical	I-Problem
hypokinesis	I-Problem
.	O
	
The	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
appear	O
structurally	O
normal	O
with	O
good	O
leaflet	O
excursion	O
and	O
no	O
aortic	B-Problem
regurgitation	I-Problem
.	O
	
The	O
mitral	O
valve	O
appears	O
structurally	O
normal	O
with	O
trivial	B-Problem
mitral	I-Problem
regurgitation	I-Problem
.	O
	
There	O
are	O
complex	B-Problem
(>	I-Problem
4	I-Problem
mm	I-Problem
)	I-Problem
atheroma	I-Problem
in	I-Problem
the	I-Problem
descending	I-Problem
thoracic	I-Problem
aorta	I-Problem
.	O
	
Mild	B-Problem
tricuspid	I-Problem
regurgitation	I-Problem
.	O
	
POST-BYPASS	O
:	O
Preserved	O
Kindred	O
/	O
North	O
Shore	O
-	O
ventricular	O
systolic	O
fxn	O
.	O
	
Trivial	B-Problem
MR	I-Problem
.	O
	
Edith	O
AI	O
.	O
	
Aorta	O
intact	O
.	O
	
CT	B-Test
11-04	O
:	O
No	O
acute	B-Problem
intracranial	I-Problem
hemorrhage	I-Problem
.	O
	
Findings	O
consistent	O
with	O
small	B-Problem
vessel	I-Problem
ischemic	I-Problem
changes	I-Problem
.	O
	
MRI	B-Test
would	O
be	O
more	O
sensitive	O
for	O
the	O
detection	O
of	O
acute	B-Problem
infarction	I-Problem
.	O
	
CT	B-Test
angiogram	I-Test
demonstrates	O
no	O
stenosis	B-Problem
or	O
aneurysm	B-Problem
in	I-Problem
the	I-Problem
intracranial	I-Problem
circulation	I-Problem
.	O
	
Slight	B-Problem
irregularity	I-Problem
of	O
the	O
origin	O
of	O
the	O
right	O
vertebral	O
artery	O
may	O
be	O
atherosclerotic	B-Problem
in	O
nature	O
.	O
	
Normal	O
contrast	O
enhancement	O
seen	O
in	O
the	B-Treatment
left	I-Treatment
common/internal	I-Treatment
carotid	I-Treatment
artery	I-Treatment
stent	I-Treatment
.	O
	
Mild	B-Problem
stenosis	I-Problem
of	I-Problem
the	I-Problem
proximal	I-Problem
right	I-Problem
internal	I-Problem
carotid	I-Problem
artery	I-Problem
.	O
	
4	B-Problem
mm	I-Problem
left	I-Problem
upper	I-Problem
lobe	I-Problem
lung	I-Problem
nodule	I-Problem
.	O
	
In	O
the	O
absence	O
of	O
history	O
of	O
malignancy	B-Problem
,	O
this	O
is	O
statistically	O
benign	O
.	O
	
One-year	O
followup	O
may	O
be	O
considered	O
.	O
	
CXR	B-Test
11-06	O
:	O
Allowing	O
for	O
technical	O
changes	O
,	O
no	O
major	B-Problem
adverse	I-Problem
interval	I-Problem
change	I-Problem
has	O
occurred	O
.	O
	
Bibasilar	B-Problem
subsegmental	I-Problem
atelectasis	I-Problem
together	O
with	O
bilateral	B-Problem
pleural	I-Problem
effusions	I-Problem
appear	O
relatively	O
unchanged	O
.	O
	
The	O
mediastinum	O
appears	O
unchanged	O
.	O
	
Left-sided	B-Treatment
subclavian	I-Treatment
line	I-Treatment
is	O
unchanged	O
in	O
position	O
.	O
	
There	O
is	O
evidence	O
of	O
prior	B-Treatment
cardiac	I-Treatment
surgery	I-Treatment
.	O
	
2015-11-13	O
06:15	O
AM	O
BLOOD	O
WBC	B-Test
-	O
8.8	O
RBC	B-Test
-	O
2.79	O
*	O
Hgb	B-Test
-	O
8.6	O
*	O
Hct	B-Test
-	O
25.4	O
*	O
MCV	B-Test
-	O
91	O
MCH	B-Test
-	O
30.9	O
MCHC	B-Test
-	O
33.8	O
RDW	B-Test
-	O
15.6	O
*	O
Plt	B-Test
Ct	I-Test
-	O
583	O
*	O
	
2015-11-12	O
06:00	O
AM	O
BLOOD	O
WBC	B-Test
-	O
7.7	O
RBC	B-Test
-	O
2.73	O
*	O
Hgb	B-Test
-	O
8.3	O
*	O
Hct	B-Test
-	I-Test
25.1	O
*	O
MCV	B-Test
-	O
92	O
MCH	B-Test
-	O
30.4	O
MCHC	B-Test
-	O
33.1	O
RDW	B-Test
-	O
15.5	O
Plt	B-Test
Ct	I-Test
-	O
528	O
*	O
	
2015-11-13	O
06:15	O
AM	O
BLOOD	O
Plt	B-Test
Ct	I-Test
-	O
583	O
*	O
	
2015-11-13	O
06:15	O
AM	O
BLOOD	O
PT	B-Test
-	O
18.0	O
*	O
PTT	B-Test
-	O
62.3	O
*	O
INR(PT)	B-Test
-	O
1.7	O
*	O
	
2015-11-12	O
06:00	O
AM	O
BLOOD	O
PT	B-Test
-	O
15.5	O
*	O
PTT	B-Test
-	O
62.4	O
*	O
INR(PT)	B-Test
-	O
1.4	O
*	O
	
2015-11-11	O
05:45	O
AM	O
BLOOD	O
PT	B-Test
-	O
14.5	O
*	O
PTT	B-Test
-	O
51.4	O
*	O
INR(PT)	B-Test
-	O
1.3	O
*	O
	
2015-11-13	O
06:15	O
AM	O
BLOOD	O
Glucose	B-Test
-	O
96	O
UreaN	B-Test
-	O
20	O
Creat	B-Test
-	O
1.6	O
*	O
Na	B-Test
-	O
141	O
K	B-Test
-	O
4.3	O
Cl	B-Test
-	O
106	O
HCO3	B-Test
-	O
24	O
AnGap	B-Test
-	O
15	O
	
2015-11-12	O
06:00	O
AM	O
BLOOD	O
Glucose	B-Test
-	O
85	O
UreaN	B-Test
-	O
19	O
Creat	B-Test
-	O
1.6	O
*	O
Na	B-Test
-	O
140	O
K	B-Test
-	I-Test
4.4	O
Cl	B-Test
-	O
105	O
HCO3	B-Test
-	O
24	O
AnGap	B-Test
-	I-Test
15	O
	
2015-11-11	O
05:45	O
AM	O
BLOOD	O
Creat	B-Test
-	O
1.6	O
*	O
K	B-Test
-	O
4.7	O
	
2015-10-28	O
03:30	O
PM	O
BLOOD	O
Glucose	B-Test
-	O
98	O
UreaN	B-Test
-	O
26	O
*	O
Creat	B-Test
-	O
1.6	O
*	O
Na	B-Test
-	O
140	O
K	B-Test
-	O
4.6	O
Cl	B-Test
-	O
104	O
HCO3	B-Test
-	O
27	O
AnGap	B-Test
-	O
14	O
	
Brief	O
Hospital	O
Course	O
:	O
	
Ms.	O
Bridge	O
was	O
admitted	O
from	O
OSH	O
for	O
coronary	B-Treatment
artery	I-Treatment
bypass	I-Treatment
surgery	I-Treatment
.	O
	
She	O
underwent	O
usual	B-Test
pre-operative	I-Test
testing	I-Test
along	O
with	O
carotid	B-Test
ultrasound	I-Test
.	O
	
CNIS	B-Test
revealed	O
carotid	B-Problem
stenosis	I-Problem
and	O
she	O
ultimately	O
underwent	O
left	B-Treatment
carotid	I-Treatment
stenting	I-Treatment
by	O
vascular	O
surgery	O
on	O
10-30	O
.	O
	
Please	O
see	O
report	O
for	O
details	O
.	O
	
On	O
11-02	O
she	O
was	O
brought	O
to	O
the	O
operating	O
room	O
where	O
she	O
underwent	O
a	B-Treatment
coronary	I-Treatment
artery	I-Treatment
bypass	I-Treatment
graft	I-Treatment
x	O
2	O
.	O
	
Please	O
see	O
operative	O
report	O
for	O
surgical	O
details	O
.	O
	
She	O
tolerated	O
the	B-Treatment
procedure	I-Treatment
well	O
and	O
was	O
transferred	O
to	O
the	O
CSRU	O
for	O
invasive	B-Test
monitoring	I-Test
in	O
stable	O
condition	O
.	O
	
Later	O
on	O
op	O
day	O
sedation	B-Treatment
was	O
weaned	O
,	O
she	O
awoke	O
neurologically	O
intact	O
and	O
was	O
extubated	B-Treatment
.	O
	
On	O
post-op	O
day	O
one	O
chest	B-Treatment
tubes	I-Treatment
were	O
removed	O
and	O
beta	B-Treatment
blockers	I-Treatment
and	O
diuretics	B-Treatment
were	O
initiated	O
.	O
	
She	O
was	O
gently	O
diuresed	O
towards	O
her	O
pre-op	O
weight	O
.	O
	
Also	O
on	O
this	O
day	O
she	O
was	O
transferred	O
to	O
the	O
SDU	O
.	O
	
Early	O
on	O
post-op	O
day	O
two	O
Ms.	O
Bridge	O
had	O
an	O
episode	O
of	O
aphasia	B-Problem
.	O
	
She	O
underwent	O
an	B-Test
immediate	I-Test
head	I-Test
CT	I-Test
and	O
Neuro	O
consult	O
and	O
was	O
transferred	O
back	O
to	O
the	O
CSRU	O
.	O
	
CT	B-Test
was	O
negative	O
and	O
she	O
returned	O
to	O
baseline	O
neuro	O
status	O
without	O
deficits	B-Problem
by	O
arrival	O
to	O
CSRU	O
.	O
	
Neurology	O
concluded	O
episode	B-Problem
was	O
most	O
concerning	O
for	O
TIA	B-Problem
.	O
	
Epicardial	B-Treatment
pacing	I-Treatment
wires	I-Treatment
were	O
removed	O
on	O
post-op	O
day	O
four	O
.	O
	
After	O
remaining	O
stable	O
in	O
the	O
CSRU	O
for	O
several	O
days	O
without	O
change	B-Problem
in	I-Problem
neuro	I-Problem
status	I-Problem
she	O
was	O
transferred	O
back	O
to	O
the	O
SDU	O
on	O
post-op	O
day	O
four	O
.	O
	
She	O
was	O
then	O
started	O
on	O
Heparin	B-Treatment
with	O
transition	O
to	O
Coumadin	B-Treatment
(	O
goal	O
INR	B-Test
of	O
2-3	O
secondary	O
to	O
h/o	O
bilateral	B-Problem
DVT	I-Problem
's).	O
	
During	O
entire	O
post-op	O
course	O
she	O
was	O
followed	O
by	O
physical	O
therapy	O
for	O
strength	O
and	O
mobility	O
.	O
	
She	O
continued	O
to	O
improve	O
steadily	O
over	O
the	O
next	O
several	O
days	O
without	O
any	O
other	O
post-op	O
	
complications	B-Problem
.	O
	
She	O
was	O
discharged	O
on	O
post-op	O
day	O
11	O
.	O
	
Medications	O
on	O
Admission	O
:	O
	
Meds	B-Treatment
at	O
home	O
:	O
Coumadin	B-Treatment
,	O
Levoxyl	B-Treatment
,	O
Folate	B-Treatment
,	O
Colace	B-Treatment
,	O
Byetta	B-Treatment
,	O
Verapamil	B-Treatment
,	O
Lisinopril	B-Treatment
,	O
Pravachol	B-Treatment
,	O
Nexium	B-Treatment
,	O
Lasix	B-Treatment
,	O
Celexa	B-Treatment
	
Meds	B-Treatment
at	O
transfer	O
:	O
Levoxyl	B-Treatment
,	O
Celexa	B-Treatment
,	O
Folate	B-Treatment
,	O
Lopressor	B-Treatment
,	O
Colace	B-Treatment
,	O
RISS	B-Treatment
,	O
B12	B-Treatment
,	O
Protonix	B-Treatment
,	O
Lasix	B-Treatment
,	O
Zocor	B-Treatment
,	O
Verapamil	B-Treatment
,	O
Lovenox	B-Treatment
,	O
Lisinopril	B-Treatment
	
Discharge	O
Medications	O
:	O
	
1.	O
Aspirin	B-Treatment
81	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
).	O
	
Disp	O
:*	O
30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(s)*	O
Refills	O
:*	O
0	O
*	O
	
2.	O
Pantoprazole	B-Treatment
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
).	O
	
Disp	O
:*	O
30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(s)*	O
Refills	O
:*	O
0	O
*	O
	
3.	O
Levothyroxine	B-Treatment
125	O
mcg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O
	
Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O
	
4.	O
Simvastatin	B-Treatment
40	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O
	
Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O
	
5.	O
Citalopram	B-Treatment
20	O
mg	O
Tablet	O
Sig	O
:	O
0.5	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O
	
Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O
	
6.	O
Clopidogrel	B-Treatment
75	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O
	
Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O
	
7.	O
Ferrous	B-Treatment
Gluconate	I-Treatment
300	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O
	
Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O
	
8.	O
Ascorbic	B-Treatment
Acid	I-Treatment
500	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O
	
Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O
	
9.	O
Folic	B-Treatment
Acid	I-Treatment
1	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O
	
Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O
	
10.	O
Metoprolol	B-Treatment
Tartrate	I-Treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O
	
Disp	O
:*	O
60	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O
	
11.	O
Docusate	B-Treatment
Sodium	I-Treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O
	
Disp	O
:*	O
30	O
Capsule	O
(s)*	O
Refills	O
:*	O
0	O
*	O
	
12.	O
Coumadin	B-Treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
:	O
Check	O
INR	B-Test
11-15	O
with	O
results	O
called	O
to	O
Dr.	O
Lynn	O
.	O
	
Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O
	
13.	O
Tramadol	B-Treatment
50	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O
	
Disp	O
:*	O
50	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O
	
14.	O
Lasix	B-Treatment
40	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
:	O
40	O
mg	O
daily	O
x	O
1	O
week	O
then	O
40	O
mg	O
every	O
other	O
day	O
as	O
prior	O
to	O
surgery	B-Treatment
.	O
	
Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O
	
Discharge	O
Disposition	O
:	O
	
Extended	O
Care	O
	
Discharge	O
Diagnosis	O
:	O
	
Coronary	B-Problem
Artery	I-Problem
Disease	I-Problem
s/p	O
Coronary	B-Treatment
Artery	I-Treatment
Bypass	I-Treatment
Graft	I-Treatment
x	O
2	O
	
Post-operative	B-Problem
Transient	I-Problem
Ischemic	I-Problem
Attack	I-Problem
	
Carotid	B-Problem
Stenosis	I-Problem
s/p	O
Left	B-Treatment
Carotid	I-Treatment
Stenting	I-Treatment
	
PMH	O
:	O
Hypertension	B-Problem
,	O
Hyperlipidemia	B-Problem
,	O
Diabetes	B-Problem
Mellitus	I-Problem
,	O
Hypothyroid	B-Problem
,	O
h/o	O
Bilateral	B-Problem
DVT	I-Problem
's,	I-Problem
Pleural	B-Problem
disorder	I-Problem
?	O
Sarcoidosis	B-Problem
,	O
Gastritis	B-Problem
,	O
B12	B-Problem
deficiency	I-Problem
,	O
Chronic	B-Problem
renal	I-Problem
insufficiency	I-Problem
,	O
s/p	O
Appendectomy	B-Treatment
,	O
s/p	O
Lap	B-Treatment
cholectomy	I-Treatment
,	O
s/p	O
Total	B-Treatment
abdominal	I-Treatment
hysterectomy	I-Treatment
	
Discharge	O
Condition	O
:	O
	
good	O
	
Discharge	O
Instructions	O
:	O
	
Patient	O
may	O
shower	O
,	O
no	O
baths	O
.	O
	
No	O
creams	B-Treatment
,	O
lotions	B-Treatment
or	O
ointments	B-Treatment
to	O
incisions	B-Problem
.	O
	
No	O
driving	O
for	O
at	O
least	O
one	O
month	O
.	O
	
No	O
lifting	O
more	O
than	O
10	O
lbs	O
for	O
at	O
least	O
10	O
weeks	O
from	O
the	O
date	O
of	O
surgery	B-Treatment
.	O
	
Monitor	O
wounds	B-Problem
for	O
signs	B-Problem
of	I-Problem
infection	I-Problem
.	O
Please	O
call	O
with	O
any	O
concerns	O
or	O
questions	O
.	O
	
VVp	O
Instructions	O
:	O
	
Dr.	O
von	O
Sampson	O
in	O
4	O
weeks	O
	
Dr	O
Royer	O
in	O
2-3	O
weeks	O
	
Dr.	O
Lynn	O
in	O
1-2	O
weeks	O
	
Peterson	O
ver	O
Vasquez	O
MD	O
07-506	O
	
Completed	O
by	O
:	O
Theresa	O
Leonore	O
NP	O
80-BXH	O
2015-11-13	O
@	O
1100	O
	
Signed	O
electronically	O
by	O
:	O
DR.	O
Ruby	O
von	O
der	O
Smith	O
on:	O
WED	O
2015-12-09	O
3:34	O
PM	O
	
(	O
End	O
of	O
Report	O
)	O
	
Admission	O
Date:	O
	
2011-02-08	O
	
Discharge	O
Date	O
:	O
	
2011-02-14	O
	
Date	O
of	O
Birth	O
:	O
	
1953-05-15	O
	
Sex	O
:	O
	
M	O
	
Service	O
:	O
	
CMED	O
	
HISTORY	O
OF	O
THE	O
PRESENT	O
ILLNESS	O
:	O
	
Briefly	O
,	O
this	O
is	O
a	O
57-year-old	O
gentleman	O
with	O
a	O
history	O
of	O
COPD	B-Problem
,	O
status	O
post	O
intubation	B-Treatment
six	O
years	O
ago	O
but	O
not	O
on	O
home	B-Treatment
02	I-Treatment
with	O
recent	O
FEV1	B-Test
27%	O
of	O
predicted	O
value	O
,	O
and	O
FEV1/FVC	B-Test
ratio	I-Test
56%	O
of	O
hypercholesterolemia	B-Problem
,	O
who	O
was	O
admitted	O
for	O
COPD	B-Problem
exacerbation	I-Problem
and	O
worsening	O
of	O
upper	B-Problem
respiratory	I-Problem
tract	I-Problem
infection	I-Problem
symptoms	I-Problem
for	O
a	O
week	O
prior	O
to	O
admission	O
.	O
	
He	O
was	O
afebrile	B-Problem
with	O
stable	O
vital	O
signs	O
on	O
presentation	O
to	O
	
HOSPITAL	O
COURSE	O
:	O
	
He	O
was	O
started	O
on	O
p.o.	B-Treatment
steroids	I-Treatment
and	O
to	O
CMED	O
for	O
management	B-Treatment
of	O
COPD	B-Problem
exacerbation	I-Problem
but	O
he	O
appeared	O
in	O
more	B-Problem
respiratory	I-Problem
distress	I-Problem
overnight	O
and	O
was	O
started	O
on	O
IV	B-Treatment
Solu-Medrol	I-Treatment
and	O
more	B-Treatment
frequent	I-Treatment
nebulizers	I-Treatment
for	O
COPD	B-Problem
.	O
	
He	O
was	O
also	O
started	O
on	O
antibiotics	B-Treatment
for	O
possible	O
bronchitis	B-Problem
or	O
community-acquired	B-Problem
pneumonia	I-Problem
.	O
	
Given	O
his	B-Problem
tenuous	I-Problem
respiratory	I-Problem
status	I-Problem
,	O
he	O
was	O
transferred	O
to	O
the	O
FICU	O
with	O
closer	B-Test
observation	I-Test
.	O
	
He	O
did	O
not	O
require	O
intubation	B-Treatment
and	O
improved	O
with	O
q.	O
two	O
hour	O
nebulizers	B-Treatment
and	O
chest	B-Treatment
PT	I-Treatment
.	O
	
He	O
was	O
again	O
transferred	O
to	O
the	O
CMED	O
Service	O
for	O
further	B-Treatment
management	I-Treatment
of	O
his	B-Problem
COPD	I-Problem
exacerbation	I-Problem
.	O
	
He	O
was	O
continued	O
on	O
p.o.	B-Treatment
prednisone	I-Treatment
and	O
frequent	B-Treatment
nebulizers	I-Treatment
for	O
COPD	B-Problem
.	O
	
He	O
was	O
evaluated	O
by	O
the	O
physical	O
therapist	O
in	O
the	O
hospital	O
and	O
was	O
found	O
to	O
desaturate	B-Problem
to	O
84%	O
with	O
ambulating	O
on	O
room	O
air	O
.	O
	
Therefore	O
,	O
home	B-Treatment
02	I-Treatment
was	O
recommended	O
on	O
discharge	O
.	O
	
DISCHARGE	O
CONDITION	O
:	O
	
Stable	O
.	O
	
DISCHARGE	O
STATUS	O
:	O
	
To	O
home	O
.	O
	
DISCHARGE	O
DIAGNOSIS	O
:	O
	
1.	O
Chronic	B-Problem
obstructive	I-Problem
pulmonary	I-Problem
disease	I-Problem
exacerbation	I-Problem
.	O
	
2.	O
Bronchitis	B-Problem
.	O
	
3.	O
Community-acquired	B-Problem
pneumonia	I-Problem
.	O
	
4.	O
Rule	O
out	O
myocardial	B-Problem
infarction	I-Problem
.	O
	
DISCHARGE	O
MEDICATIONS	O
:	O
	
1.	O
Flovent	B-Treatment
two	O
puffs	O
b.i.d.	O
	
2.	O
Levofloxacin	B-Treatment
500	O
mg	O
p.o.	O
q.d.	O
for	O
another	O
11	O
days	O
for	O
a	O
total	O
of	O
a	O
14	O
day	O
course	O
.	O
	
3.	O
Albuterol	B-Treatment
inhaler	I-Treatment
one	O
to	O
two	O
puffs	O
q.	O
four	O
to	O
six	O
hours	O
p.r.n.	O
	
4.	O
Aspirin	B-Treatment
81	O
mg	O
p.o.	O
q.d.	O
	
5.	O
Salmeterol	B-Treatment
one	O
to	O
two	O
puffs	O
b.i.d.	O
	
6.	O
Oxygen	B-Treatment
2	I-Treatment
liters	I-Treatment
nasal	I-Treatment
cannula	I-Treatment
with	O
ambulating	O
as	O
needed	O
.	O
	
7.	O
Prednisone	B-Treatment
taper	I-Treatment
with	O
40	O
mg	O
p.o.	O
q.d.	O
for	O
two	O
days	O
,	O
30	O
mg	O
p.o.	O
q.d.	O
for	O
two	O
days	O
,	O
20	O
mg	O
p.o.	O
q.d.	O
for	O
two	O
days	O
,	O
10	O
mg	O
p.o.	O
q.d.	O
for	O
two	O
days	O
.	O
	
DISCHARGE	O
FOLLOW-UP	O
:	O
	
The	O
patient	O
will	O
see	O
his	O
PCP	O
in	O
one	O
to	O
two	O
weeks	O
.	O
	
The	O
patient	O
will	O
also	O
see	O
his	O
pulmonologist	O
,	O
Dr.	O
Daniel	O
Bell	O
,	O
appointment	O
was	O
made	O
on	O
discharge	O
.	O
	
John	O
C	O
Stalnaker	O
,	O
M.D.	O
	
35-693	O
	
Dictated	O
By	O
:	O
Margaret	O
BT	O
Mahaffey	O
,	O
M.D.	O
	
MEDQUIST36	O
	
D	O
:	O
2011-02-19	O
10:21	O
	
T	O
:	O
2011-02-21	O
18:42	O
	
JOB	O
#:	O
	
74873	O
	
Signed	O
electronically	O
by	O
:	O
DR.	O
Kate	O
Gentry	O
on	O
:	O
MON	O
2011-03-07	O
4:08	O
PM	O
	
(	O
End	O
of	O
Report	O
)	O
	
Admission	O
Date	O
:	O
	
2012-05-21	O
	
Discharge	O
Date	O
:	O
	
2012-05-25	O
	
Date	O
of	O
Birth	O
:	O
	
1957-01-05	O
	
Sex	O
:	O
	
F	O
	
Service	O
:	O
	
CMED	O
CCU	O
	
HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O
	
This	O
is	O
a	O
55-year-old	O
female	O
with	O
multiple	O
prior	O
admissions	O
for	O
pneumonia	B-Problem
,	O
COPD	B-Problem
,	O
asthma	B-Problem
exacerbation	I-Problem
,	O
over	O
3	O
weeks	O
of	O
upper	B-Problem
respiratory	I-Problem
like	I-Problem
infection	I-Problem
unremitting	O
with	O
increased	B-Treatment
nebulizer	I-Treatment
treatments	I-Treatment
at	O
home	O
.	O
	
The	O
patient	O
saw	O
her	O
PCP	O
and	O
was	O
known	O
to	O
have	O
an	B-Test
oxygen	I-Test
saturation	I-Test
of	O
82	O
to	O
85	O
percent	O
on	O
room	O
air	O
.	O
	
She	O
was	O
referred	O
to	O
the	O
Emergency	O
Department	O
.	O
	
In	O
the	O
Emergency	O
Department	O
,	O
the	O
patient	O
received	O
Zithromax	B-Treatment
,	O
ceftriaxone	B-Treatment
,	O
and	O
Flagyl	B-Treatment
.	O
	
Chest	B-Test
x-ray	I-Test
was	O
remarkable	O
for	O
a	O
questionable	O
left	B-Problem
lower	I-Problem
lobe	I-Problem
infiltrate	I-Problem
.	O
	
The	O
patient	O
received	O
nebulizer	B-Treatment
treatment	I-Treatment
with	O
oxygen	B-Test
saturations	I-Test
increasing	O
up	O
to	O
98	O
percent	O
on	O
room	O
air	O
.	O
	
PAST	O
MEDICAL	O
HISTORY	O
:	O
	
Asthma	B-Problem
/	O
COPD	B-Problem
on	O
BiPAP	B-Treatment
,	O
history	O
of	O
intubation	B-Treatment
.	O
	
Restrictive	B-Problem
lung	I-Problem
disease	I-Problem
.	O
	
Chronic	B-Problem
inflammatory	I-Problem
demyelinating	I-Problem
polyradiculopathy	I-Problem
.	O
	
Gastritis	B-Problem
and	O
duodenitis	B-Problem
.	O
	
Question	O
of	O
Tyrone	B-Problem
esophagus	I-Problem
.	O
	
Chronic	B-Problem
abdominal	I-Problem
pain	I-Problem
.	O
	
Neurogenic	B-Problem
bladder	I-Problem
.	O
	
Chronic	B-Problem
muscle	I-Problem
spasms	I-Problem
.	O
	
Coronary	B-Problem
artery	I-Problem
disease	I-Problem
status	O
post	O
negative	O
stress	B-Test
echo	I-Test
on	O
10-12	O
.	O
	
History	O
of	O
syncope	B-Problem
.	O
	
Adrenal	B-Problem
insufficiency	I-Problem
.	O
	
Hypercholesterolemia	B-Problem
.	O
	
Depression	B-Problem
and	O
anxiety	B-Problem
.	O
	
Hyperthyroidism	B-Problem
.	O
	
IgG	B-Problem
deficiency	I-Problem
.	O
	
Status	O
post	O
cholecystectomy	B-Treatment
and	O
appendectomy	B-Treatment
.	O
	
Anemia	B-Problem
of	O
chronic	B-Problem
disease	I-Problem
.	O
	
ALLERGIES	O
:	O
	
AZMACORT	B-Treatment
,	O
CLINDAMYCIN	B-Treatment
,	O
VERSED	B-Treatment
,	O
FENTANYL	B-Treatment
,	O
and	O
MORPHINE	B-Treatment
.	O
	
SOCIAL	O
HISTORY	O
:	O
	
History	O
of	O
20-to-30-pack-year	O
smoking	O
,	O
quit	O
approximately	O
15	O
years	O
ago	O
.	O
	
She	O
denies	O
any	O
alcohol	O
or	O
drug	O
use	O
.	O
	
Married	O
with	O
children	O
,	O
wheelchair	B-Problem
bound	I-Problem
mostly	O
.	O
	
PHYSICAL	O
EXAMINATION	O
:	O
	
From	O
admission	O
,	O
vital	B-Test
signs	I-Test
98.3	O
,	O
blood	B-Test
pressure	I-Test
128/74	O
,	O
68	O
to	O
112	O
is	O
her	B-Test
heart	I-Test
rate	I-Test
,	O
respiratory	B-Test
rate	I-Test
24	O
,	O
100	O
percent	O
on	O
room	O
air	O
.	O
	
General	O
:	O
	
She	O
is	O
a	O
chronically	O
ill-appearing	O
female	O
,	O
in	O
no	O
acute	B-Problem
distress	I-Problem
.	O
	
HEENT	O
:	O
	
Benign	O
.	O
	
Cardiac	B-Test
exam	I-Test
:	O
	
Normal	O
.	O
	
Pulmonary	B-Test
exam	I-Test
:	O
	
Diffuse	B-Problem
bronchial	I-Problem
breath	I-Problem
sounds	I-Problem
,	O
no	O
wheezes	B-Problem
.	O
	
Abdominal	B-Test
exam	I-Test
:	O
	
Benign	O
.	O
	
Extremity	B-Test
exam	I-Test
:	O
	
No	O
edema	B-Problem
.	O
	
Left	B-Problem
lower	I-Problem
extremity	I-Problem
and	I-Problem
left	I-Problem
upper	I-Problem
extremity	I-Problem
weaker	I-Problem
at	O
3/5	O
compared	O
to	O
right	O
upper	O
extremity	O
and	O
right	O
lower	O
extremity	O
,	O
chronic	O
according	O
to	O
the	O
patient	O
.	O
	
MEDICATIONS	O
:	O
	
On	O
admission	O
	
1.	O
Vitamin	B-Treatment
D	I-Treatment
400	O
mg	O
q.d.	O
	
2.	O
Levoxyl	B-Treatment
50	O
mcg	O
q.d.	O
	
3.	O
Baclofen	B-Treatment
20	O
mg	O
p.o.	O
t.i.d.	O
	
4.	O
Florinef	B-Treatment
0.1	O
mg	O
p.o.	O
q.a.m.	O
	
5.	O
Klonopin	B-Treatment
2	O
mg	O
t.i.d.	O
	
6.	O
BuSpar	B-Treatment
10	O
mg	O
t.i.d.	O
	
7.	O
Zanaflex	B-Treatment
8	O
mg	O
q.4	O
h.	O
	
8.	O
Oxazepam	B-Treatment
30	O
mg	O
p.r.n.	O
	
9.	O
Singulair	B-Treatment
10	O
mg	O
q.p.m.	O
	
10.	O
Lipitor	B-Treatment
10	O
mg	O
q.p.m.	O
	
11.	O
Ativan	B-Treatment
2	O
mg	O
p.r.n.	O
	
12.	O
Protonix	B-Treatment
20	O
mg	O
p.o.	O
b.i.d.	O
	
13.	O
Sucralfate	B-Treatment
2	O
mg	O
b.i.d.	O
	
14.	O
Albuterol	B-Treatment
nebulizer	I-Treatment
q.03-14	O
h.	O
p.r.n.	O
	
15.	O
Pamidronate	B-Treatment
30	O
mg	O
IV	O
every	O
month	O
.	O
	
HOSPITAL	O
COURSE	O
:	O
	
Shortness	B-Problem
of	I-Problem
breath	I-Problem
.	O
	
The	O
patient	O
was	O
maintained	O
on	O
albuterol	B-Treatment
nebulizer	I-Treatment
treatments	I-Treatment
and	O
Ipratropium	B-Treatment
nebulizer	I-Treatment
treatments	I-Treatment
,	O
as	O
this	O
was	O
apparently	O
thought	O
to	O
be	O
related	O
to	O
her	B-Problem
chronic	I-Problem
obstructive	I-Problem
pulmonary	I-Problem
disease	I-Problem
.	O
	
Given	O
the	O
presence	O
of	O
consolidation	B-Problem
on	O
chest	B-Test
x-ray	I-Test
,	O
however	O
,	O
and	O
previous	O
history	O
of	O
pneumonia	B-Problem
,	O
the	O
patient	O
was	O
maintained	O
on	O
antibiotics	B-Treatment
of	O
Zithromax	B-Treatment
500	O
mg	O
daily	O
and	O
ceftriaxone	B-Treatment
.	O
	
The	O
patient	O
was	O
also	O
started	O
on	O
Solu-Medrol	B-Treatment
IV	I-Treatment
for	O
active	B-Problem
airway	I-Problem
disease	I-Problem
component	I-Problem
of	O
her	B-Problem
shortness	I-Problem
of	I-Problem
breath	I-Problem
.	O
	
The	O
patient	O
was	O
maintained	O
on	O
supplemental	B-Treatment
oxygen	I-Treatment
and	O
sputum	O
production	O
was	O
maximized	O
with	O
the	O
help	O
of	O
an	B-Treatment
Acapella	I-Treatment
device	I-Treatment
and	O
respiratory	B-Treatment
therapy	I-Treatment
.	O
	
Mucomyst	B-Treatment
was	O
also	O
considered	O
as	O
a	B-Treatment
mucolytic	I-Treatment
component	I-Treatment
towards	O
secretions	B-Problem
.	O
	
Adrenal	B-Problem
insufficiency	I-Problem
.	O
	
The	O
patient	O
was	O
maintained	O
on	O
IV	B-Treatment
Solu	I-Treatment
-	I-Treatment
Medrol	I-Treatment
60	O
mg	O
q.	O
8	O
h.	O
	
Chest	B-Problem
soreness	I-Problem
.	O
	
The	O
patient	O
describes	O
chest	B-Problem
discomfort	I-Problem
without	O
any	B-Problem
significant	I-Problem
EKG	I-Problem
changes	I-Problem
.	O
	
The	O
patient	O
was	O
maintained	O
on	O
Percocet	B-Treatment
p.r.n.	O
for	O
pain	B-Treatment
relief	I-Treatment
.	O
	
This	O
was	O
thought	O
to	O
be	O
related	O
to	O
musculoskeletal	O
.	O
	
There	O
was	O
no	O
evidence	O
of	O
acute	B-Problem
rib	I-Problem
factors	I-Problem
on	O
her	B-Test
chest	I-Test
x-ray	I-Test
.	O
	
GI	O
.	O
	
The	O
patient	O
was	O
maintained	O
on	O
PPI	B-Treatment
for	O
reflux	B-Problem
disease	I-Problem
and	O
known	B-Problem
gastritis	I-Problem
.	O
	
CMED	O
.	O
	
The	O
patient	O
has	O
a	O
history	O
of	O
neurogenic	B-Problem
bladder	I-Problem
and	O
,	O
therefore	O
,	O
she	O
required	O
a	B-Treatment
Foley	I-Treatment
catheterization	I-Treatment
.	O
	
Endocrine	O
.	O
	
The	O
patient	O
was	O
on	O
Levoxyl	B-Treatment
at	O
home	O
as	O
her	O
home	O
dose	O
for	O
hyperthyroidism	B-Problem
.	O
	
CMED	O
CSRU	O
transfer	O
.	O
	
The	O
patient	O
was	O
transferred	O
on	O
the	O
evening	O
of	O
2012-05-22	O
to	O
the	O
ICU	O
given	O
persistent	B-Problem
carbon	I-Problem
dioxide	I-Problem
retention	I-Problem
and	O
respiratory	B-Problem
acidosis	I-Problem
and	O
the	B-Problem
intermittent	I-Problem
mental	I-Problem
status	I-Problem
changes	I-Problem
.	O
	
The	O
patient	O
had	O
had	O
ABG	B-Test
on	O
the	O
floor	O
,	O
which	O
prompted	O
her	O
to	O
transfer	O
to	O
the	O
ICU	O
.	O
	
Her	B-Test
pH	I-Test
was	O
7.23	O
,	O
PCO2	B-Test
73	O
,	O
PO2	B-Test
146	O
on	O
a	B-Treatment
nonrebreather	I-Treatment
.	O
	
The	O
patient	O
had	O
BiPAP	B-Treatment
initiated	O
once	O
she	O
reached	O
the	O
unit	O
,	O
but	O
did	O
not	O
tolerate	O
it	O
,	O
becoming	O
apneic	B-Problem
and	O
obstructing	B-Problem
.	O
	
The	O
patient	O
was	O
switched	O
to	O
2	B-Treatment
liters	I-Treatment
nasal	I-Treatment
cannula	I-Treatment
and	O
oxygen	O
saturating	O
at	O
98	O
to	O
100	O
percent	O
.	O
	
After	O
BiPAP	B-Treatment
was	O
initiated	O
,	O
the	O
patient	O
became	O
hypotensive	B-Problem
down	O
to	O
75/28	O
and	O
bradycardiac	B-Problem
,	O
responding	O
to	O
3	B-Treatment
fluid	I-Treatment
boluses	I-Treatment
over	O
the	O
course	O
of	O
the	O
night	O
.	O
	
The	O
patient	O
was	O
started	O
on	O
Florinef	B-Treatment
for	O
concern	O
of	O
adrenal	B-Problem
insufficiency	I-Problem
;	O
however	O
,	O
she	O
was	O
hemodynamically	O
stable	O
that	O
morning	O
and	O
was	O
transferred	O
back	O
out	O
to	O
the	O
floor	O
.	O
	
It	O
was	O
thought	O
that	O
the	O
patient	O
may	O
have	O
been	O
mucous	B-Problem
plugging	I-Problem
during	O
her	O
stay	O
in	O
the	O
ICU	O
.	O
	
Hematologic	O
.	O
	
The	O
patient	O
has	O
a	O
history	O
of	O
high	B-Problem
MCV	I-Problem
and	O
megaloblastic	B-Problem
cells	I-Problem
on	O
smear	B-Test
in	O
the	O
setting	O
of	O
anemia	B-Problem
;	O
question	O
B12	B-Problem
deficiency	I-Problem
,	O
the	O
patient	O
also	O
has	O
a	O
history	O
of	O
borderline	B-Problem
low	I-Problem
B12	I-Problem
levels	I-Problem
.	O
	
The	O
patient	O
was	O
diagnosed	O
for	O
B12	B-Problem
deficiency	I-Problem
due	O
to	O
her	O
long	O
history	O
of	O
poor	B-Problem
p.o.	I-Problem
intake	I-Problem
.	O
	
Methylmalonic	B-Test
acid	I-Test
levels	I-Test
were	O
sent	O
,	O
the	O
results	O
are	O
pending	O
at	O
the	O
time	O
of	O
discharge	O
.	O
	
DISCHARGE	O
DIAGNOSES	O
:	O
	
Asthma	B-Problem
flare	I-Problem
and	O
bronchitis	B-Problem
.	O
	
Chronic	B-Problem
obstructive	I-Problem
pulmonary	I-Problem
disease	I-Problem
.	O
	
Demyelinating	B-Problem
polyradiculopathy	I-Problem
.	O
	
Anxiety	B-Problem
disorder	I-Problem
.	O
	
Chronic	B-Problem
abdominal	I-Problem
pain	I-Problem
.	O
	
DISCHARGE	O
STATUS	O
:	O
	
The	O
patient	O
will	O
be	O
discharged	O
to	O
home	O
.	O
	
DISCHARGE	O
CONDITION	O
:	O
	
The	O
patient	O
is	O
stable	O
without	O
an	B-Problem
oxygen	I-Problem
requirement	I-Problem
.	O
	
DISCHARGE	O
FOLLOWUP	O
:	O
	
The	O
patient	O
is	O
instructed	O
to	O
followup	O
with	O
her	O
doctor	O
in	O
1	O
to	O
2	O
weeks	O
of	O
discharge	O
.	O
	
DISCHARGE	O
MEDICATIONS	O
:	O
	
1.	O
Cholecalciferol	B-Treatment
.	O
	
2.	O
Vitamin	B-Treatment
D	I-Treatment
.	O
	
3.	O
Levothyroxine	B-Treatment
50	O
mcg	O
p.o.	O
q.d.	O
	
4.	O
Baclofen	B-Treatment
10	O
mg	O
p.o.	O
t.i.d.	O
	
5.	O
Clonazepam	B-Treatment
1	O
mg	O
p.o.	O
t.i.d.	O
	
6.	O
Buspirone	B-Treatment
10	O
mg	O
p.o.	O
t.i.d.	O
	
7.	O
Montelukast	B-Treatment
sodium	I-Treatment
10	O
mg	O
p.o.	O
q.h.s.	O
	
8.	O
Atorvastatin	B-Treatment
10	O
mg	O
p.o.	O
q.h.s.	O
	
9.	O
Protonix	B-Treatment
40	O
mg	O
p.o.	O
q.d.	O
	
10.	O
Albuterol	B-Treatment
sulfate	I-Treatment
solution	I-Treatment
q.05-15	O
h.	O
p.r.n.	O
for	O
shortness	B-Problem
of	I-Problem
breath	I-Problem
.	O
	
11.	O
Tizanidine	B-Treatment
8	O
mg	O
p.o.	O
q.6	O
h.	O
	
12.	O
Acetaminophen	B-Treatment
p.r.n.	O
	
13.	O
Prednisone	B-Treatment
taper	I-Treatment
for	O
3	O
days	O
.	O
	
14.	O
Levofloxacin	B-Treatment
500	O
mg	O
p.o.	O
q.d.	O
for	O
10	O
more	O
days	O
.	O
	
15.	O
Florinef	B-Treatment
Acetate	I-Treatment
0.1	O
mg	O
p.o.	O
q.d.	O
	
James	O
Grunow	O
,	O
M.D.	O
53-506	O
	
Dictated	O
By	O
:	O
Elizabeth	O
A	O
Eaton	O
,	O
M.D.	O
	
MEDQUIST36	O
	
D	O
:	O
2012-08-01	O
12:27:33	O
	
T	O
:	O
2012-08-01	O
20:27:59	O
	
Job	O
#:	O
	
33698	O
	
Signed	O
electronically	O
by	O
:	O
DR.	O
Kenneth	O
Wilford	O
on	O
:	O
Maxine	O
2012-08-16	O
12:22	O
PM	O
	
(	O
End	O
of	O
Report	O
)	O
	
Admission	O
Date	O
:	O
	
2019-06-14	O
	
Discharge	O
Date	O
:	O
	
2019-06-19	O
	
Date	O
of	O
Birth	O
:	O
	
1968-01-21	O
	
Sex	O
:	O
	
M	O
	
Service	O
:	O
	
MEDICINE	B-Treatment
	
Allergies	O
:	O
	
Patient	O
recorded	O
as	O
having	O
No	O
Known	B-Problem
Allergies	I-Problem
to	O
Drugs	B-Treatment
	
Attending	O
:	O
Michael	O
A.E.	O
Adkins	O
,	O
M.D.	O
	
Chief	O
Complaint	O
:	O
	
Shortness	B-Problem
of	I-Problem
breath	I-Problem
,	O
fever	B-Problem
	
Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O
	
None	O
	
History	O
of	O
Present	O
Illness	O
:	O
	
Mr.	O
Mcelveen	O
is	O
a	O
51	O
year-old	O
male	O
with	O
metastatic	B-Problem
RCC	I-Problem
status	O
post	O
left	B-Treatment
radical	I-Treatment
nephrectomy	I-Treatment
in	O
2018-03-21	O
,	O
status	O
post	O
Avastin	B-Treatment
and	O
sorafenib	B-Treatment
,	O
most	O
recently	O
on	O
Sutent	B-Treatment
monotherapy	I-Treatment
since	O
2018-12-21	O
,	O
with	O
mild	B-Problem
renal	I-Problem
insufficiency	I-Problem
,	O
who	O
presented	O
from	O
home	O
on	O
2019-06-14	O
with	O
shortness	B-Problem
of	I-Problem
breath	I-Problem
and	O
fever	B-Problem
.	O
	
Of	O
note	O
,	O
he	O
was	O
hospitalized	O
at	O
Dana-Farber	O
Cancer	O
Institute	O
from	O
9/25-10/6	O
with	O
chest	B-Problem
pain	I-Problem
,	O
at	O
which	O
time	O
he	O
reportedly	O
had	O
cardiac	B-Test
enzymes	I-Test
,	O
an	B-Test
echocardiogram	I-Test
and	O
a	B-Test
pharmacological	I-Test
stress	I-Test
test	I-Test
performed	O
.	O
	
It	O
is	O
unclear	O
from	O
history	O
what	O
these	B-Test
studies	I-Test
revealed	O
.	O
	
He	O
reports	O
that	O
he	O
felt	O
fatigued	B-Problem
during	O
the	O
week	O
prior	O
to	O
the	O
current	O
admission	O
.	O
	
On	O
the	O
day	O
of	O
admission	O
,	O
he	O
felt	O
"	O
congested	B-Problem
"	O
in	O
his	O
chest	O
,	O
and	O
had	O
a	B-Problem
new	I-Problem
fever	I-Problem
.	O
	
He	O
was	O
taken	O
to	O
the	O
Deanna	O
by	O
his	O
wife	O
.	O
	
Patrick	O
reports	O
a	B-Problem
mild	I-Problem
cough	I-Problem
for	O
2	O
days	O
PTA	O
,	O
non-productive	B-Problem
.	O
	
He	O
denies	O
a	O
history	O
of	O
aspiration	B-Problem
events	I-Problem
or	O
choking	B-Problem
with	O
food	O
intake	O
.	O
	
He	O
describes	O
mild	B-Problem
reflux	I-Problem
symptoms	I-Problem
at	O
night	O
.	O
	
Further	B-Test
ROS	I-Test
reveals	O
mild	B-Problem
SOB	I-Problem
in	O
the	O
days	O
preceding	O
admission	O
,	O
but	O
he	O
tells	O
me	O
that	O
he	O
was	O
surprised	O
to	O
find	O
out	O
about	O
his	B-Problem
low	I-Problem
oxygen	I-Problem
saturation	I-Problem
because	O
he	O
did	O
not	O
feel	O
that	O
bad	O
.	O
	
He	O
denies	O
chills	B-Problem
,	O
no	O
chest	B-Problem
pain	I-Problem
,	O
no	O
LE	B-Problem
swelling	I-Problem
.	O
	
In	O
the	O
Deanna	O
,	O
Tmax	B-Test
102.8	O
,	O
BP	B-Test
100	O
-	O
140/60	O
s,	O
HR	B-Test
80	O
s,	O
RR	B-Test
20	O
s,	O
Sat	B-Test
75%	O
on	O
RA	B-Treatment
in	O
triage	O
,	O
up	O
to	O
100%	O
on	O
NRB	B-Treatment
.	O
	
CXR	B-Test
with	O
bibasilar	B-Problem
consolidations	I-Problem
.	O
	
He	O
was	O
given	O
Levo	B-Treatment
750	O
mg	O
PO	O
X1	O
,	O
and	O
Flagyl	B-Treatment
500	O
mg	O
PO	O
X1	O
.	O
	
His	B-Test
BP	I-Test
decreased	O
to	O
100	O
systolic	O
despite	O
hydration	B-Treatment
with	O
2L	O
of	O
NS	B-Treatment
.	O
	
He	O
was	O
subsquently	O
admitted	O
to	O
the	O
ICU	O
for	O
further	B-Treatment
care	I-Treatment
.	O
	
He	O
was	O
placed	O
on	O
Levo	B-Treatment
and	O
Ceftriaxone	B-Treatment
.	O
	
A	B-Test
cosyntropin	I-Test
stimulation	I-Test
test	I-Test
revealed	O
cortisol	B-Test
32.1	O
-->	O
36.4	O
.	O
	
His	B-Problem
oxygen	I-Problem
requirement	I-Problem
decreased	O
,	O
and	O
his	O
overall	O
status	O
improved	O
quickly	O
.	O
	
He	O
is	O
being	O
transferred	O
to	O
the	O
floor	O
for	O
ongoing	B-Treatment
care	I-Treatment
.	O
	
Past	O
Medical	O
History	O
:	O
	
1.	O
Metastatic	B-Problem
renal	I-Problem
cell	I-Problem
carcinoma	I-Problem
,	O
diagnosed	O
in	O
2018-03-21	O
,	O
status	O
post	O
left	B-Treatment
radical	I-Treatment
nephrectomy	I-Treatment
at	O
St.	O
Margaret's	O
Center	O
for	O
Women	O
&	O
Infants	O
in	O
03/2006	O
.	O
	
Path	O
consistent	O
with	O
renal	B-Problem
cell	I-Problem
carcinoma	I-Problem
of	I-Problem
chromophobe	I-Problem
type	I-Problem
with	O
Carter	B-Problem
nuclear	I-Problem
grade	I-Problem
of	O
4/4	O
.	O
	
Lymphovascular	B-Problem
invasion	I-Problem
was	O
present	O
.	O
	
He	O
later	O
presented	O
with	O
increasing	B-Problem
back	I-Problem
pain	I-Problem
,	O
and	O
metastatic	B-Problem
disease	I-Problem
was	O
documented	O
.	O
	
He	O
is	O
status	O
post	O
Avastin	B-Treatment
plus	O
sorafenib	B-Treatment
,	O
protocol	O
#04-393	O
,	O
discontinued	O
in	O
the	O
setting	O
of	O
	
ongoing	B-Problem
grade	I-Problem
III	I-Problem
rash	I-Problem
,	O
involving	O
the	O
hands	O
and	O
feet	O
in	O
addition	O
proteinuria	B-Problem
secondary	O
to	O
the	O
Avastin	B-Treatment
.	O
	
He	O
has	O
been	O
maintained	O
on	O
single	B-Treatment
Timlin	I-Treatment
therapy	I-Treatment
with	O
Sutent	B-Treatment
50	O
mg	O
daily	O
as	O
of	O
2018-12-21	O
and	O
has	O
completed	O
nearly	O
6	O
cycles	O
.	O
	
He	O
has	O
mild	B-Problem
renal	I-Problem
insufficiency	I-Problem
in	O
the	O
setting	O
of	O
Sutent	B-Treatment
.	O
	
2.	O
Seasonal	B-Problem
allergies	I-Problem
	
Social	O
History	O
:	O
	
He	O
lives	O
at	O
home	O
with	O
his	O
wife	O
and	O
son	O
,	O
who	O
is	O
7	O
years	O
old	O
.	O
	
He	O
works	O
in	O
real	O
estate	O
development	O
and	O
invests	O
in	O
stockmarket	O
.	O
	
HE	O
is	O
a	O
lifelong	O
non-smoker	O
.	O
	
Family	O
History	O
:	O
	
Not	O
reviewed	O
with	O
patient	O
.	O
	
Physical	O
Exam	O
:	O
	
VITALS	B-Test
:	O
T	B-Test
96.9	O
,	O
BP	B-Test
110/70	O
,	O
HR	B-Test
84	O
,	O
RR	B-Test
20	O
,	O
Sat	B-Test
97%	O
on	O
4L	O
.	O
	
GEN	O
:	O
In	O
NAD	B-Problem
.	O
	
HEENT	O
:	O
Flushed	B-Problem
cheeks	I-Problem
.	O
	
Slightly	B-Problem
dry	I-Problem
MM	I-Problem
.	O
	
NECK	O
:	O
JVP	B-Test
not	O
elevated	B-Problem
.	O
	
RESP	O
:	O
Decreased	B-Problem
air	I-Problem
entry	I-Problem
and	O
crackles	B-Problem
at	I-Problem
both	I-Problem
lung	I-Problem
bases	I-Problem
.	O
	
+	O
Egophony	B-Problem
.	O
	
CVS	O
:	O
RRR	O
.	O
Normal	O
S1	O
,	O
S2	O
.	O
	
No	O
S3	B-Problem
,	O
S4	B-Problem
.	O
	
No	O
murmur	B-Problem
or	O
rub	B-Problem
.	O
	
GI	O
:	O
BS	O
.	O
	
Abdomen	O
soft	O
and	O
non-tender	B-Problem
.	O
	
EXT	O
:	O
Without	O
edema	B-Problem
.	O
	
Good	O
pedal	O
pulses	O
.	O
	
Pertinent	O
Results	O
:	O
	
Laboratory	O
results	O
:	O
	
2019-06-14	O
10:30	O
AM	O
BLOOD	O
WBC	B-Test
-	O
8.0	O
RBC	B-Test
-	O
4.22	O
*	O
Hgb	B-Test
-	O
12.9	O
*	O
Hct	B-Test
-	O
41.7	O
MCV	B-Test
-	O
99	O
*	O
MCH	B-Test
-	O
30.5	O
MCHC	B-Test
-	O
30.8	O
*	O
RDW	B-Test
-	O
16.8	O
*	O
Plt	B-Test
Ct	I-Test
-	O
797	O
*#	O
	
2019-06-19	O
07:20	O
AM	O
BLOOD	O
WBC	B-Test
-	O
11.1	O
*	O
RBC	B-Test
-	O
3.47	O
*	O
Hgb	B-Test
-	O
10.9	O
*	O
Hct	B-Test
-	O
34.1	O
*	O
MCV	B-Test
-	O
98	O
MCH	B-Test
-	O
31.3	O
MCHC	B-Test
-	O
31.9	O
RDW	B-Test
-	O
16.7	O
*	O
Plt	B-Test
Ct	I-Test
-	O
604	O
*	O
	
2019-06-14	O
10:30	O
AM	O
BLOOD	O
PT	B-Test
-	O
11.2	O
PTT	B-Test
-	O
23.9	O
INR(PT)	B-Test
-	O
0.9	O
	
2019-06-14	O
10:30	O
AM	O
BLOOD	O
Plt	B-Test
Ct	I-Test
-	O
797	O
*#	O
	
2019-06-14	O
10:30	O
AM	O
BLOOD	O
Glucose	B-Test
-	O
134	O
*	O
UreaN	B-Test
-	O
39	O
*	O
Creat	B-Test
-	O
2.1	O
*	O
Na	B-Test
-	O
133	O
K	B-Test
-	O
7.9	O
*	O
Cl	B-Test
-	O
94	O
*	O
HCO3	B-Test
-	O
28	O
AnGap	B-Test
-	O
19	O
	
2019-06-19	O
07:20	O
AM	O
BLOOD	O
Glucose	B-Test
-	O
73	O
UreaN	B-Test
-	O
20	O
Creat	B-Test
-	O
1.1	O
Na	B-Test
-	O
136	O
K	B-Test
-	O
5.0	O
Cl	B-Test
-	O
101	O
HCO3	B-Test
-	O
27	O
AnGap	B-Test
-	O
13	O
	
2019-06-14	O
10:30	O
AM	O
BLOOD	O
ALT	B-Test
-	O
34	O
AST	B-Test
-	O
167	O
*	O
CK(CPK)	B-Test
-	O
313	O
*	O
AlkPhos	B-Test
-	O
383	O
*	O
Amylase	B-Test
-	O
44	O
TotBili	B-Test
-	O
0.7	O
	
2019-06-14	O
06:03	O
PM	O
BLOOD	O
CK(CPK)	B-Test
-	O
194	O
*	O
	
2019-06-14	O
10:30	O
AM	O
BLOOD	O
CK-MB	B-Test
-	O
3	O
cTropnT	B-Test
-	O
0.05	O
*	O
	
2019-06-14	O
06:03	O
PM	O
BLOOD	O
CK-MB	B-Test
-4	O
cTropnT	B-Test
-	O
0.03	O
*	O
	
2019-06-17	O
05:30	O
AM	O
BLOOD	O
proBNP	B-Test
-	O
258	O
*	O
	
2019-06-14	O
06:03	O
PM	O
BLOOD	O
Calcium	B-Test
-	O
8.3	O
*	O
Phos	B-Test
-	O
4.3	O
Mg	B-Test
-	O
1.9	O
	
2019-06-18	O
07:55	O
AM	O
BLOOD	O
calTIBC	B-Test
-	O
229	O
Ferritn	B-Test
-	O
GREATER	O
TH	O
TRF	O
-	O
176	O
*	O
	
2019-06-16	O
07:35	O
AM	O
BLOOD	O
TSH	B-Test
-	O
43	O
*	O
	
2019-06-16	O
07:35	O
AM	O
BLOOD	O
Free	B-Test
T4	I-Test
-	O
0.36	O
*	O
	
2019-06-19	O
07:20	O
AM	O
BLOOD	O
WBC	B-Test
-	O
11.1	O
*	O
RBC	B-Test
-	O
3.47	O
*	O
Hgb	B-Test
-	O
10.9	O
*	O
Hct	B-Test
-	O
34.1	O
*	O
MCV	B-Test
-	O
98	O
MCH	B-Test
-	O
31.3	O
MCHC	B-Test
-	O
31.9	O
RDW	B-Test
-	O
16.7	O
*	O
Plt	B-Test
Ct	I-Test
-	O
604	O
*	O
	
2019-06-19	O
07:20	O
AM	O
BLOOD	O
Neuts	B-Test
-	O
77.0	O
*	O
Bands	B-Test
-	O
5.0	O
Lymphs	B-Test
-	O
11.0	O
*	O
Monos	B-Test
-	O
3.0	O
Eos	B-Test
-	O
0	O
Baso	B-Test
-	O
0	O
Atyps	B-Test
-	O
1.0	O
*	O
Metas	B-Test
-	O
2.0	O
*	O
Myelos	B-Test
-	O
1.0	O
*	O
	
2019-06-18	O
07:55	O
AM	O
BLOOD	O
PT	B-Test
-	O
11.5	O
INR(PT)	B-Test
-	O
1.0	O
	
2019-06-19	O
07:20	O
AM	O
BLOOD	O
Glucose	B-Test
-	O
73	O
UreaN	B-Test
-	O
20	O
Creat	B-Test
-	O
1.1	O
Na	B-Test
-	O
136	O
K	B-Test
-	O
5.0	O
Cl	B-Test
-	O
101	O
HCO3	B-Test
-	O
27	O
AnGap	B-Test
-	O
13	O
	
2019-06-19	O
07:20	O
AM	O
BLOOD	O
Calcium	B-Test
-	O
8.0	O
*	O
Phos	B-Test
-	O
3.3	O
Mg	B-Test
-	O
2.0	O
	
Relevant	O
Imaging	O
:	O
	
1)	O
Bilateral	B-Test
LE	I-Test
doppler	I-Test
(	O
06-14	O
):	O
No	O
evidence	O
of	O
deep	B-Problem
venous	I-Problem
thrombosis	I-Problem
in	I-Problem
the	I-Problem
lower	I-Problem
extremities	I-Problem
bilaterally	I-Problem
.	O
	
2)	O
Cxray	B-Test
(	O
06-14	O
):	O
New	B-Problem
bibasilar	I-Problem
consolidations	I-Problem
are	O
demonstrated	O
accompanied	O
by	O
bilateral	B-Problem
small	I-Problem
pleural	I-Problem
effusion	I-Problem
.	O
	
The	O
lung	O
volumes	O
are	O
slightly	B-Problem
increased	I-Problem
.	O
	
There	O
is	O
no	O
pneumothorax	B-Problem
identified	O
.	O
	
3)	O
CT	B-Test
Torso	I-Test
(	O
06-17	O
):	O
	
1.	O
Marked	B-Problem
interval	I-Problem
enlargement	I-Problem
of	I-Problem
the	I-Problem
cardiac	I-Problem
silhouette	I-Problem
.	O
	
Together	O
with	O
the	O
interval	O
development	O
of	O
bilateral	B-Problem
pleural	I-Problem
effusions	I-Problem
,	O
this	O
indicates	O
cardiac	B-Problem
insufficiency	I-Problem
(	O
or	O
alternatively	O
volume	B-Problem
overload	I-Problem
)	O
and	O
an	B-Test
echocardiogram	I-Test
may	O
be	O
indicated	O
for	O
further	B-Test
evaluation	I-Test
.	O
	
2.	O
Bilateral	B-Problem
basilar	I-Problem
compressive	I-Problem
atelectasis	I-Problem
.	O
	
Superimposed	B-Problem
infectious	I-Problem
consolidation	I-Problem
is	O
likely	O
.	O
	
3.	O
Interval	O
development	O
of	O
tree-in-Eric	B-Problem
nodular	I-Problem
opacities	I-Problem
and	O
scattered	B-Problem
ground	I-Problem
glass	I-Problem
opacities	I-Problem
involving	I-Problem
the	I-Problem
right	I-Problem
lung	I-Problem
,	O
concerning	O
for	O
an	B-Problem
infectious	I-Problem
process	I-Problem
.	O
	
The	O
differential	O
diagnosis	O
of	O
this	O
is	O
wide	O
including	O
viral	B-Problem
,	I-Problem
fungal	I-Problem
and	I-Problem
atypical	I-Problem
mycobacterial	I-Problem
infections	I-Problem
.	O
	
Drug	B-Problem
toxicity	I-Problem
would	O
be	O
a	O
consideration	O
,	O
although	O
somewhat	O
less	O
likely	O
given	O
the	O
unilaterality	O
of	O
the	O
findings	O
.	O
	
4.	O
New	B-Problem
jejunal	I-Problem
wall	I-Problem
thickening	I-Problem
with	O
persistent	B-Problem
distal	I-Problem
ileal	I-Problem
wall	I-Problem
thickening	I-Problem
and	O
diffuse	B-Problem
mesenteric	I-Problem
stranding	I-Problem
,	O
most	O
likely	O
reflecting	O
an	B-Problem
infectious	I-Problem
etiology	I-Problem
.	O
	
5.	O
Overall	O
stability	O
in	O
metastatic	B-Problem
burden	I-Problem
.	O
	
4)	O
ECHO	B-Test
(	O
06-18	O
):	O
Mild	B-Problem
symmetric	I-Problem
left	I-Problem
ventricular	I-Problem
hypertrophy	I-Problem
with	O
preserved	O
biventricular	O
systolic	O
function	O
.	O
	
Mild	B-Problem
posterior	I-Problem
mitral	I-Problem
valve	I-Problem
prolapse	I-Problem
with	O
mild	B-Problem
mitral	I-Problem
regurgitation	I-Problem
.	O
	
Small	B-Problem
(	I-Problem
0.6	I-Problem
cm	I-Problem
)	I-Problem
circumferential	I-Problem
pericardial	I-Problem
effusion	I-Problem
,	O
largest	O
around	O
the	O
left	O
atrium	O
.	O
	
5)	O
L	B-Test
femur	I-Test
xray	I-Test
(	O
06-18	O
):	O
Predominantly	B-Problem
sclerotic	I-Problem
lesion	I-Problem
with	O
interval	B-Problem
periosteal	I-Problem
new	I-Problem
bone	I-Problem
formation	I-Problem
involving	O
the	O
intertrochanteric	O
and	O
subtrochanteric	O
regions	O
.	O
	
No	O
displaced	B-Problem
fracture	I-Problem
is	O
demonstrated	O
.	O
	
Brief	O
Hospital	O
Course	O
:	O
	
Mr.	O
Mcelveen	O
51	O
year-old	O
male	O
with	O
metastatic	B-Problem
RCC	I-Problem
on	O
Sutent	B-Treatment
since	O
2018-12-21	O
,	O
admitted	O
with	O
fever	B-Problem
,	O
hypoxemia	B-Problem
,	O
and	O
bibasilar	B-Problem
pneumonia	I-Problem
.	O
	
1)	O
Bibasilar	B-Problem
pneumonia	I-Problem
:	O
Patient	O
was	O
treated	O
for	O
community-acquired	B-Problem
pneumonia	I-Problem
.	O
	
He	O
was	O
initially	O
placed	O
on	O
Ceftriaxone	B-Treatment
,	O
Levaquin	B-Treatment
,	O
and	O
Flagyl	B-Treatment
in	O
the	O
ICU	O
but	O
then	O
changed	O
to	O
	
Azithromycin	B-Treatment
&	O
CTX	B-Treatment
at	O
time	O
of	O
transfer	O
to	O
the	O
oncology	O
service	O
.	O
	
He	O
continued	O
to	O
have	O
an	B-Problem
oxygen	I-Problem
requirement	I-Problem
and	O
CT	B-Test
scan	I-Test
suggested	O
ground	B-Problem
glass	I-Problem
opacities	I-Problem
,	O
suggestive	O
of	O
an	B-Problem
underlying	I-Problem
infectious	I-Problem
process	I-Problem
.	O
	
ECHO	B-Test
was	O
done	O
and	O
confirmed	O
normal	O
ejection	O
fraction	O
.	O
	
His	O
respiratory	O
status	O
improved	O
slowly	O
,	O
oxygen	B-Treatment
was	O
weaned	O
off	O
,	O
and	O
he	O
was	O
discharged	O
on	O
course	O
of	O
Levaquin	B-Treatment
.	O
	
2)	O
Metastatic	B-Problem
RCC	I-Problem
:	O
Sutent	B-Treatment
was	O
held	O
on	O
admission	O
in	O
light	O
of	O
acute	B-Problem
infection	I-Problem
.	O
	
He	O
underwent	O
a	B-Test
staging	I-Test
CT	I-Test
scan	I-Test
torso	I-Test
which	O
suggested	O
no	O
significant	B-Problem
increase	I-Problem
in	I-Problem
tumor	I-Problem
burden	I-Problem
.	O
	
Patient	O
was	O
also	O
found	O
to	O
have	O
abnormal	B-Problem
TFTs	I-Problem
on	O
Sutent	B-Treatment
and	O
was	O
started	O
on	O
replacement	B-Treatment
	
therapy	B-Treatment
.	O
	
He	O
will	O
need	O
follow-up	B-Test
bloodwork	I-Test
as	O
an	O
outpatient	O
.	O
	
Recent	B-Test
CT	I-Test
scan	I-Test
showed	O
destruction	B-Problem
of	I-Problem
L	I-Problem
femoral	I-Problem
neck	I-Problem
.	O
	
He	O
underwent	O
an	B-Test
xray	I-Test
of	I-Test
the	I-Test
L	I-Test
femur	I-Test
which	O
did	O
not	O
suggest	O
an	B-Problem
acute	I-Problem
fracture	I-Problem
.	O
	
No	O
limitations	O
were	O
placed	O
in	O
regards	O
to	O
weightbearing	O
status	O
.	O
	
Patient	O
was	O
instructed	O
to	O
restart	O
Sutent	B-Treatment
next	O
Monday	O
.	O
	
3)	O
Renal	B-Problem
insufficiency	I-Problem
:	O
Creatinine	B-Test
improved	O
from	O
2.1	O
to	O
1.3	O
at	O
time	O
of	O
discharge	O
.	O
	
Likely	O
related	O
to	O
underlying	B-Problem
malignancy	I-Problem
as	O
well	O
as	O
prerenal	B-Problem
component	I-Problem
given	O
improvement	O
with	O
gentle	B-Treatment
hydration	I-Treatment
.	O
	
Medications	O
on	O
Admission	O
:	O
	
MEDICATIONS	O
ON	O
ADMISSION	O
:	O
He	O
takes	O
Imodium	B-Treatment
and	O
Lomotil	B-Treatment
while	O
on	O
Sutent	B-Treatment
for	O
diarrhea	B-Problem
.	O
	
He	O
has	O
not	O
had	O
a	O
BM	O
in	O
3	O
days	O
now	O
.	O
	
He	O
is	O
also	O
on	O
MS	B-Treatment
Contin	I-Treatment
45	O
mg	O
PO	O
q12	O
hours	O
(	O
confirmed	O
with	O
wife	O
)	O
and	O
MSIR	B-Treatment
15	O
mg	O
every	O
4	O
hours	O
as	O
needed	O
.	O
	
MEDICATIONS	O
ON	O
TRANSFER	O
:	O
	
Heparin	B-Treatment
5000	O
UNIT	O
SC	O
TID	O
	
Albuterol	B-Treatment
0.083%	O
Neb	O
Soln	O
1	O
NEB	O
IH	O
Q6H	O
	
Ipratropium	B-Treatment
Bromide	I-Treatment
Neb	I-Treatment
1	O
NEB	O
IH	O
Q6H	O
	
CeftriaXONE	B-Treatment
1	O
gm	O
IV	O
Q24H	O
	
Levofloxacin	B-Treatment
500	O
mg	O
PO	O
Q24H	O
	
Morphine	B-Treatment
Sulfate	I-Treatment
2-4	O
mg	O
IV	O
Q4H	O
:	O
PRN	O
	
Docusate	B-Treatment
Sodium	I-Treatment
100	O
mg	O
PO	O
BID	O
	
Pantoprazole	B-Treatment
40	O
mg	O
PO	O
Q24H	O
	
Fluticasone	B-Treatment
Propionate	I-Treatment
110mcg	O
2	O
PUFF	O
IH	O
BID	O
	
Discharge	O
Medications	O
:	O
	
1.	O
Levothyroxine	B-Treatment
50	O
mcg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O
	
Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O
	
2.	O
Levofloxacin	B-Treatment
500	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
)	O
for	O
4	O
days	O
:	O
last	O
dose	O
will	O
be	O
Nolen	O
,	O
06-23	O
.	O
	
Disp	O
:*	O
4	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O
	
3.	O
Docusate	B-Treatment
Sodium	I-Treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
):	O
Take	O
as	O
necessary	O
for	O
constipation	B-Problem
.	O
	
4.	O
SUTENT	B-Treatment
50	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
Every	O
other	O
day	O
:	O
Please	O
restart	O
on	O
Wallace	O
,	O
06-24	O
.	O
	
5.	O
Morphine	B-Treatment
15	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
for	O
Pain	B-Problem
.	O
	
Disp	O
:*	O
60	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O
	
6.	O
Morphine	B-Treatment
15	O
mg	O
Tablet	O
Sustained	O
Release	O
Sig	O
:	O
Three	O
(	O
3	O
)	O
Tablet	O
Sustained	O
Release	O
PO	O
Q12H	O
(	O
every	O
12	O
hours	O
).	O
	
Disp	O
:*	O
90	O
Tablet	O
Sustained	O
Release	O
(s)*	O
Refills	O
:*	O
0	O
*	O
	
Discharge	O
Disposition	O
:	O
	
Home	O
	
Discharge	O
Diagnosis	O
:	O
	
Primary	O
diagnoses	O
:	O
	
1)	O
Pneumonia	B-Problem
	
2)	O
Acute	B-Problem
renal	I-Problem
failure	I-Problem
	
3)	O
Metastatic	B-Problem
renal	I-Problem
cell	I-Problem
carcinoma	I-Problem
	
4)	O
Hypoxemia	B-Problem
	
Discharge	O
Condition	O
:	O
	
Stable	O
	
Discharge	O
Instructions	O
:	O
	
1)	O
Please	O
take	O
all	B-Treatment
medications	I-Treatment
as	O
listed	O
in	O
the	O
discharge	O
instructions	O
.	O
	
2)	O
You	O
were	O
admitted	O
to	O
the	O
hospital	O
and	O
started	O
on	O
an	B-Treatment
antibiotic	I-Treatment
called	O
Levaquin	B-Treatment
for	O
a	B-Problem
pneumonia	I-Problem
.	O
	
You	O
should	O
continue	O
taking	O
this	B-Treatment
medication	I-Treatment
and	O
your	O
last	O
day	O
will	O
be	O
Nolen	O
,	O
06-23	O
.	O
	
3)	O
When	O
you	O
were	O
admitted	O
to	O
the	O
hospital	O
your	B-Treatment
Sutent	I-Treatment
was	O
stopped	O
.	O
	
You	O
should	O
resume	O
this	B-Treatment
medication	I-Treatment
starting	O
Wallace	O
,	O
06-24	O
.	O
	
You	O
should	O
take	O
this	B-Treatment
medication	I-Treatment
every	O
other	O
day	O
.	O
	
4)	O
During	O
your	O
hospital	O
stay	O
you	O
were	O
also	O
found	O
to	O
have	O
low	B-Problem
thyroid	I-Problem
hormone	I-Problem
levels	I-Problem
.	O
	
As	O
a	O
result	O
,	O
you	O
were	O
started	O
on	O
thyroid	B-Treatment
supplements	I-Treatment
.	O
	
You	O
should	O
have	O
follow-up	B-Test
blood	I-Test
tests	I-Test
by	O
your	O
primary	O
care	O
physician	O
B	O
3	O
months	O
.	O
	
5)	O
Please	O
attend	O
all	O
appointments	O
as	O
listed	O
below	O
.	O
	
6)	O
If	O
you	O
experience	O
any	O
fevers	B-Problem
,	O
chills	B-Problem
,	O
chest	B-Problem
pain	I-Problem
,	O
shortness	B-Problem
of	I-Problem
breath	I-Problem
,	O
dizziness	B-Problem
or	O
any	B-Problem
other	I-Problem
concerning	I-Problem
symptoms	I-Problem
please	O
return	O
to	O
the	O
emergency	O
department	O
.	O
	
Followup	O
Instructions	O
:	O
	
1)	O
Provider	O
:	O
Yolanda	O
Joyce	O
,	O
MD	O
Phone	O
:	O
337	O
2567	O
	
Date	O
/	O
Time	O
:	O
2019-07-03	O
3:30	O
	
2)	O
Provider	O
:	O
Peter	O
Helen	O
Braddy	O
,	O
MD	O
Phone	O
:	O
337	O
2567	O
	
Date	O
/	O
Time	O
:	O
2019-07-03	O
3:30	O
	
Philip	O
Glenn	O
MD	O
60-385	O
	
Completed	O
by	O
:	O
Eva	O
Susan	O
MD	O
54-940	O
2019-07-27	O
@	O
1700	O
	
Signed	O
electronically	O
by	O
:	O
DR.	O
Patrick	O
B	O
Santiago	O
on	O
:	O
MON	O
2019-07-29	O
9:27	O
AM	O
	
(	O
End	O
of	O
Report	O
)	O
	
Admission	O
Date	O
:	O
	
2013-06-12	O
	
Discharge	O
Date	O
:	O
	
2013-06-25	O
	
Date	O
of	O
Birth	O
:	O
	
1943-03-31	O
	
Sex	O
:	O
	
M	O
	
Service	O
:	O
	
TRA	O
	
ADDENDUM	O
:	O
	
This	O
is	O
a	O
discharge	O
summary	O
addendum	O
for	O
Discharge	O
Summary	O
number	O
554108	O
.	O
	
As	O
follows	O
.	O
	
Patient	O
was	O
discharged	O
to	O
rehabilitation	B-Treatment
on	O
2013-06-25	O
.	O
	
Discharge	O
was	O
delayed	O
by	O
one	O
day	O
to	O
ensure	O
patient	O
could	O
tolerate	O
P.O.	O
which	O
patient	O
did	O
without	O
difficulty	B-Problem
.	O
	
Please	O
see	O
original	O
Discharge	O
Summary	O
for	O
discharge	B-Treatment
medications	I-Treatment
.	O
	
Josh	O
Harry	O
,	O
Missouri	O
43478	O
	
Dictated	O
By	O
:	O
Joe	O
J.	O
T.	O
Gochenour	O
,	O
M.D.	O
	
MEDQUIST36	O
	
D	O
:	O
2013-06-25	O
07:58:05	O
	
T	O
:	O
2013-06-25	O
08:07:03	O
	
Job	O
#:	O
	
79141	O
	
Signed	O
electronically	O
by	O
:	O
DR.	O
Clara	O
M.	O
Odell	O
on	O
:	O
WED	O
2013-06-26	O
9:58	O
AM	O
	
(	O
End	O
of	O
Report	O
)	O
	
01909607	O
	
Admission	O
Date	O
:	O
	
2010-06-28	O
	
Discharge	O
Date	O
:	O
	
2010-07-01	O
	
Date	O
of	O
Birth	O
:	O
	
1990-02-01	O
	
Sex	O
:	O
	
F	O
	
Service	O
:	O
	
ORTHOPEDIC	O
	
HISTORY	O
OF	O
THE	O
PRESENT	O
ILLNESS	O
:	O
	
This	O
is	O
a	O
20-year-old	O
female	O
with	O
no	O
significant	O
past	O
medical	O
history	O
,	O
who	O
was	O
the	O
unrestrained	O
passenger	O
in	O
a	O
high	O
speed	O
rollover	O
motor	O
vehicle	O
accident	O
on	O
2010-06-27	O
.	O
	
By	O
report	O
,	O
the	O
patient	O
was	O
ejected	O
from	O
the	O
vehicle	O
on	O
impact	O
and	O
found	O
curled	O
in	O
the	O
fetal	O
position	O
at	O
the	O
rear	O
of	O
the	O
vehicle	O
at	O
the	O
scene	O
.	O
	
The	O
vehicle	O
was	O
noted	O
to	O
be	O
extensively	O
damaged	O
.	O
	
By	O
report	O
,	O
the	O
patient	O
was	O
noted	O
to	O
be	O
awake	O
,	O
but	O
confused	B-Problem
at	O
the	O
scene	O
of	O
the	O
accident	O
with	O
no	O
memory	O
of	O
the	O
incident	O
.	O
	
She	O
was	O
immobilized	O
in	O
the	B-Treatment
C-spine	I-Treatment
collar	I-Treatment
at	O
the	O
scene	O
of	O
the	O
accident	O
and	O
subsequently	O
transported	O
by	O
EMS	O
to	O
the	O
New	O
England	O
Sinai	O
Hospital	O
&	O
Rehab	O
Center	O
Emergency	O
Department	O
for	O
further	B-Treatment
management	I-Treatment
.	O
	
PHYSICAL	O
EXAMINATION	O
:	O
	
Examination	B-Test
on	O
presentation	O
to	O
the	O
emergency	O
room	O
revealed	O
the	O
following	O
:	O
	
Temperature	B-Test
35.4	O
Celsius	O
,	O
blood	B-Test
pressure	I-Test
116/63	O
,	O
pulse	B-Test
105	O
,	O
respiratory	B-Test
rate	I-Test
18	O
,	O
oxygen	B-Test
saturation	I-Test
98%	O
on	O
room	O
air	O
.	O
	
The	O
patient	O
was	O
alert	O
and	O
oriented	O
times	O
three	O
in	O
no	O
apparent	B-Problem
distress	I-Problem
.	O
	
Boston	B-Test
Coma	I-Test
Scale	I-Test
of	O
15	O
.	O
	
Tympanic	O
membranes	O
were	O
noted	O
to	O
be	O
clear	O
.	O
	
Pupils	O
were	O
equal	O
,	O
round	O
,	O
reactive	O
to	O
light	O
at	O
approximately	O
4	O
mm	O
.	O
	
The	O
patient	O
's	O
trachea	O
was	O
noted	O
to	O
be	O
midline	O
.	O
	
The	B-Test
patient	I-Test
's	I-Test
lung	I-Test
examination	I-Test
revealed	O
the	O
lungs	O
to	O
be	O
clear	O
to	O
auscultation	B-Test
bilaterally	O
,	O
no	O
crepitus	B-Problem
,	O
and	O
a	B-Problem
left	I-Problem
clavicular	I-Problem
deformity	I-Problem
was	O
grossly	O
apparent	O
on	O
examination	B-Test
.	O
	
CARDIAC	O
:	O
	
Cardiac	B-Test
examination	I-Test
demonstrated	O
regular	O
rate	O
and	O
rhythm	O
,	O
no	O
murmurs	B-Problem
,	O
rubs	B-Problem
,	O
or	O
gallops	B-Problem
.	O
	
ABDOMEN	O
:	O
	
Soft	O
,	O
nontender	B-Problem
,	O
nondistended	B-Problem
.	O
	
RECTAL	O
:	O
	
Examination	B-Test
was	O
guaiac	B-Test
negative	O
with	O
good	O
rectal	O
tone	O
.	O
	
The	O
patient	O
's	O
pelvis	O
was	O
stable	O
to	O
AP	B-Test
and	I-Test
lateral	I-Test
compression	I-Test
.	O
	
A	B-Problem
5	I-Problem
cm	I-Problem
laceration	I-Problem
was	O
noted	O
over	O
the	O
patient	O
's	O
occiput	O
on	O
further	B-Test
inspection	I-Test
with	O
no	O
exposed	B-Problem
underlying	I-Problem
bone	I-Problem
.	O
	
Right	B-Test
upper	I-Test
extremity	I-Test
examination	I-Test
demonstrated	O
intact	O
motor	O
,	O
sensory	O
,	O
and	O
vascular	O
function	O
.	O
	
Left	B-Test
upper	I-Test
extremity	I-Test
examination	I-Test
demonstrated	O
no	O
gross	B-Problem
deformities	I-Problem
,	O
tenderness	B-Problem
to	O
palpation	B-Test
in	I-Test
the	I-Test
mid	I-Test
forearm	I-Test
,	O
intact	O
motor	O
function	O
in	O
the	O
median	O
,	O
radial	O
,	O
and	O
ulnar	O
nerve	O
distributions	O
,	O
intact	O
sensation	O
to	O
light	B-Test
touch	I-Test
in	O
the	O
median	O
and	O
radial	O
nerve	O
distributions	O
,	O
decreased	B-Problem
sensation	I-Problem
in	I-Problem
the	I-Problem
ulnar-nerve	I-Problem
distribution	I-Problem
,	O
warm	O
and	O
well	O
perfused	O
limb	O
with	O
2+	O
radial	B-Test
pulses	I-Test
.	O
	
Right	B-Test
lower	I-Test
extremity	I-Test
examination	I-Test
demonstrated	O
mild	B-Problem
swelling	I-Problem
and	O
ecchymosis	B-Problem
of	I-Problem
the	I-Problem
right	I-Problem
posterior	I-Problem
thigh	I-Problem
and	O
approximately	O
a	B-Problem
3	I-Problem
cm	I-Problem
laceration	I-Problem
in	I-Problem
the	I-Problem
lower	I-Problem
leg	I-Problem
,	O
expressive	O
of	O
moderate	O
amounts	O
of	O
standard	O
sterile	O
	
fashion	O
.	O
	
No	O
gross	B-Problem
deformities	I-Problem
.	O
	
Motor	B-Test
,	I-Test
sensory	I-Test
,	I-Test
and	I-Test
vascular	I-Test
examinations	I-Test
were	O
intact	O
in	O
all	O
distributions	O
.	O
	
Left	B-Test
lower	I-Test
extremity	I-Test
examination	I-Test
demonstrated	O
no	O
gross	B-Problem
deformities	I-Problem
and	O
intact	O
motor	O
,	O
sensory	O
,	O
and	O
vascular	O
examinations	O
in	O
all	O
distributions	O
.	O
	
Radiographic	B-Test
studies	I-Test
demonstrated	O
an	B-Problem
inferior	I-Problem
displaced	I-Problem
left	I-Problem
midclavicular	I-Problem
fracture	I-Problem
,	O
no	O
evidence	O
of	O
	
pneumothorax	B-Problem
.	O
	
Trauma	B-Test
series	I-Test
demonstrated	O
no	O
evidence	O
of	O
a	B-Problem
pelvic	I-Problem
fracture	I-Problem
.	O
	
Head	B-Test
CT	I-Test
demonstrated	O
no	O
evidence	O
of	O
intracranial	B-Problem
bleeding	I-Problem
.	O
	
Trauma	B-Test
CT	I-Test
demonstrated	O
mild	B-Problem
pulmonary	I-Problem
contusions	I-Problem
,	O
but	O
no	O
pelvic	B-Problem
fracture	I-Problem
.	O
	
Cervical	B-Test
spine	I-Test
imaging	I-Test
demonstrated	O
no	O
evidence	O
of	O
cervical	B-Problem
spine	I-Problem
injury	I-Problem
.	O
	
Right	B-Test
tibial-fibular	I-Test
film	I-Test
series	I-Test
demonstrated	O
no	O
evidence	O
of	O
fracture	B-Problem
displacement	I-Problem
.	O
	
Left	B-Test
humerus	I-Test
film	I-Test
series	I-Test
demonstrated	O
no	O
evidence	O
of	O
fracture	B-Problem
or	O
displacement	B-Problem
.	O
	
Right	B-Test
foot	I-Test
and	I-Test
femur	I-Test
series	I-Test
demonstrated	O
no	O
evidence	O
of	O
fracture	B-Problem
displacement	I-Problem
.	O
	
Left	B-Test
forearm	I-Test
and	I-Test
wrist	I-Test
series	I-Test
demonstrated	O
transverse	B-Problem
mid	I-Problem
shaft	I-Problem
radial	I-Problem
fracture	I-Problem
with	O
ulnar	B-Problem
displacement	I-Problem
.	O
	
Diagnosis	B-Test
peritoneum	I-Test
lavage	I-Test
times	O
two	O
was	O
negative	O
for	O
any	O
signs	O
of	O
intra-abdominal	B-Problem
bleeding	I-Problem
.	O
	
LABORATORY	O
DATA	O
:	O
	
Studies	B-Test
on	O
admission	O
revealed	O
the	O
following	O
:	O
	
White	B-Test
blood	I-Test
cell	I-Test
12.9	O
,	O
hemoglobin	B-Test
11.5	O
,	O
hematocrit	B-Test
32.8	O
,	O
platelet	B-Test
count	I-Test
197,000	O
,	O
sodium	B-Test
141	O
,	O
potassium	B-Test
3.6	O
,	O
chloride	B-Test
110	O
,	O
bicarbonate	B-Test
21	O
,	O
BUN	B-Test
20	O
,	O
creatinine	B-Test
0.7	O
,	O
glucose	B-Test
189	O
,	O
PT	B-Test
13.3	O
,	O
INR	B-Test
1.2	O
,	O
PTT	B-Test
30.0	O
,	O
amylase	B-Test
57	O
,	O
arterial	B-Test
blood	I-Test
gas	I-Test
7.32	O
,	O
35	O
,	O
159	O
,	O
19	O
,	O
-7	O
.	O
	
Urinalysis	B-Test
was	O
within	O
normal	O
limits	O
with	O
6	O
to	O
10	O
red	B-Test
blood	I-Test
cells	I-Test
.	O
	
Toxicology	B-Test
screen	I-Test
was	O
negative	O
.	O
	
HOSPITAL	O
COURSE	O
:	O
	
The	O
patient	O
was	O
evaluated	O
by	O
the	O
Trauma	O
Service	O
in	O
the	O
emergency	O
room	O
,	O
where	O
she	O
received	O
four	O
liters	O
	
crystalloid	B-Treatment
and	O
four	O
units	O
packed	B-Treatment
red	I-Treatment
blood	I-Treatment
cells	I-Treatment
with	O
good	O
response	O
.	O
	
In	O
addition	O
,	O
the	O
patient	O
received	O
the	O
above-described	O
diagnostic	B-Test
procedures	I-Test
,	O
which	O
demonstrated	O
injuries	B-Problem
limited	O
to	O
a	B-Problem
posterior	I-Problem
scalp	I-Problem
laceration	I-Problem
,	O
left	B-Problem
fractured	I-Problem
clavicle	I-Problem
,	O
left	B-Problem
fractured	I-Problem
radius	I-Problem
,	O
right	B-Problem
thigh	I-Problem
hematoma	I-Problem
,	O
and	O
right	B-Problem
leg	I-Problem
laceration	I-Problem
.	O
	
The	O
patient	O
was	O
subsequently	O
admitted	O
to	O
the	O
Trauma	O
Service	O
on	O
2010-06-28	O
under	O
the	O
direction	O
of	O
Dr.	O
Lowery	O
.	O
	
Given	O
the	B-Problem
patient	I-Problem
's	I-Problem
right	I-Problem
thigh	I-Problem
hematoma	I-Problem
,	O
a	B-Test
duplex	I-Test
evaluation	I-Test
of	I-Test
the	I-Test
right	I-Test
lower	I-Test
extremity	I-Test
was	O
performed	O
on	O
2010-06-28	O
and	O
demonstrated	O
no	O
evidence	O
of	O
major	B-Problem
arterial	I-Problem
or	I-Problem
venous	I-Problem
injury	I-Problem
in	O
the	O
level	O
of	O
	
the	O
right	O
inguinal	O
region	O
.	O
	
On	O
06-28	O
,	O
the	O
patient	O
was	O
also	O
cleared	O
for	O
removal	O
of	O
her	B-Treatment
C-spine	I-Treatment
collar	I-Treatment
and	O
deemed	O
stable	O
for	O
transfer	O
to	O
the	O
Orthopedic	O
Service	O
under	O
the	O
direction	O
of	O
Dr.	O
Ronda	O
Lopez	O
.	O
	
The	O
patient	O
remained	O
stable	O
through	O
2010-06-29	O
at	O
which	O
point	O
she	O
was	O
sent	O
to	O
the	O
operating	O
room	O
to	O
undergo	O
a	B-Treatment
left	I-Treatment
radial	I-Treatment
fracture	I-Treatment
open	I-Treatment
reduction	I-Treatment
and	O
internal	B-Treatment
fixation	I-Treatment
procedure	I-Treatment
.	O
	
The	O
patient	O
tolerated	O
the	B-Treatment
procedure	I-Treatment
well	O
and	O
demonstrated	O
a	B-Test
postoperative	I-Test
hematocrit	I-Test
of	O
40.9	O
.	O
	
Of	O
note	O
,	O
the	B-Problem
scalp	I-Problem
and	I-Problem
right	I-Problem
lower	I-Problem
leg	I-Problem
lacerations	I-Problem
were	O
closed	O
primarily	O
by	O
the	O
trauma	O
team	O
on	O
admission	O
and	O
on	O
hospital	O
day	O
#1	O
were	O
noted	O
to	O
be	O
clean	O
,	O
dry	O
,	O
and	O
intact	O
.	O
	
Nonoperative	B-Treatment
treatment	I-Treatment
was	O
elected	O
for	O
the	B-Problem
patient	I-Problem
's	I-Problem
left	I-Problem
clavicular	I-Problem
fracture	I-Problem
.	O
	
On	O
postoperative	O
day	O
#1	O
,	O
2010-06-30	O
,	O
the	O
patient	O
was	O
noted	O
to	O
be	O
clinically	O
stable	O
,	O
tolerating	O
oral	O
intake	O
,	O
and	O
expressive	O
of	O
adequate	O
amounts	O
of	O
urine	O
independent	O
of	O
a	B-Treatment
Foley	I-Treatment
catheter	I-Treatment
.	O
	
The	B-Problem
patient	I-Problem
's	I-Problem
head	I-Problem
wound	I-Problem
laceration	I-Problem
was	O
noted	O
to	O
be	O
clean	O
and	O
dry	O
with	O
intact	B-Treatment
staples	I-Treatment
.	O
	
There	O
was	O
no	O
erythema	B-Problem
or	O
purulence	B-Problem
.	O
	
The	O
left	O
clavicle	O
was	O
noted	O
to	O
have	O
continued	B-Problem
ecchymosis	I-Problem
decreased	O
from	O
prior	B-Test
examination	I-Test
with	O
a	B-Problem
minor	I-Problem
stepoff	I-Problem
and	O
mild	B-Problem
tenderness	I-Problem
to	O
palpation	B-Test
decreased	O
from	O
prior	B-Test
examinations	I-Test
.	O
	
The	B-Treatment
left	I-Treatment
forearm	I-Treatment
dressing	I-Treatment
was	O
noted	O
to	O
be	O
in	O
place	O
,	O
clean	O
,	O
dry	O
,	O
and	O
intact	O
with	O
no	O
saturation	B-Problem
.	O
	
The	O
patient	O
was	O
noted	O
to	O
be	O
able	O
to	O
wiggle	O
her	O
fingers	O
with	O
intact	O
flexor	O
,	O
extensor	O
,	O
abductor	O
,	O
and	O
adductor	O
function	O
.	O
	
Mild	B-Problem
swelling	I-Problem
was	O
noted	O
in	O
the	O
left	O
hand	O
.	O
	
Sensation	O
was	O
intact	O
in	O
the	O
median	O
,	O
radius	O
,	O
and	O
ulnar-nerve	O
distributions	O
.	O
	
Fingers	O
were	O
warm	O
and	O
well	O
perfused	O
with	O
capillary	B-Test
refill	I-Test
less	O
than	O
3	O
seconds	O
.	O
	
The	B-Problem
patient	I-Problem
's	I-Problem
right	I-Problem
anterior	I-Problem
tibial	I-Problem
wound	I-Problem
was	O
noted	O
to	O
be	O
clean	O
,	O
dry	O
,	O
and	O
intact	O
with	O
sutures	B-Treatment
intact	O
and	O
no	O
erythema	B-Problem
or	O
purulence	B-Problem
noted	O
.	O
	
On	O
06-30	O
,	O
the	O
patient	O
was	O
evaluated	O
by	O
Occupational	O
Therapy	O
and	O
fitted	O
for	O
a	B-Treatment
left	I-Treatment
upper	I-Treatment
extremity	I-Treatment
splint	I-Treatment
.	O
	
The	O
patient	O
was	O
also	O
administered	O
adaptive	B-Treatment
training	I-Treatment
for	O
activities	B-Treatment
of	I-Treatment
daily	I-Treatment
life	I-Treatment
and	O
advised	O
regarding	O
wound	B-Treatment
care	I-Treatment
.	O
	
In	O
addition	O
,	O
the	O
patient	O
was	O
also	O
fitted	O
with	O
a	B-Treatment
figure-of-eight	I-Treatment
clavicular	I-Treatment
splint	I-Treatment
and	O
instructed	O
in	O
its	O
	
proper	O
use	O
.	O
	
On	O
2010-07-01	O
,	O
the	O
patient	O
was	O
discharged	O
from	O
the	O
hospital	O
with	O
instructions	O
for	O
follow	O
up	O
care	O
on	O
return	O
to	O
the	O
United	O
Kingdom	O
.	O
	
CONDITION	O
ON	O
DISCHARGE	O
:	O
	
The	O
patient	O
is	O
to	O
be	O
discharged	O
to	O
home	O
.	O
	
DISCHARGE	O
STATUS	O
:	O
	
Stable	O
.	O
	
DIAGNOSIS	O
:	O
	
1.	O
Left	B-Problem
transverse	I-Problem
mid	I-Problem
shaft	I-Problem
radial	I-Problem
fracture	I-Problem
with	O
ulnar	B-Problem
displacement	I-Problem
status	O
post	O
left	B-Treatment
radial	I-Treatment
open	I-Treatment
reduction	I-Treatment
and	O
internal	B-Treatment
fixation	I-Treatment
.	O
	
2.	O
Left	B-Problem
midclavicular	I-Problem
fracture	I-Problem
managed	O
nonoperatively	O
.	O
	
3.	O
Occipital	B-Problem
scalp	I-Problem
laceration	I-Problem
.	O
	
4.	O
Right	B-Problem
anterior	I-Problem
tibial	I-Problem
laceration	I-Problem
.	O
	
DISCHARGE	O
MEDICATIONS	O
:	O
	
Percocet	B-Treatment
one	O
to	O
two	O
tablets	O
PO	O
q.4h.	O
to	O
6h.p.r.n.	O
pain	B-Problem
.	O
	
FOLLOW-UP	O
CARE	O
:	O
	
The	O
patient	O
is	O
medically	O
cleared	O
for	O
a	O
flight	O
to	O
return	O
to	O
her	O
home	O
in	O
the	O
United	O
Kingdom	O
.	O
	
The	O
patient	O
is	O
to	O
maintain	O
her	B-Treatment
figure-of-eight	I-Treatment
clavicular	I-Treatment
splint	I-Treatment
and	O
left	B-Treatment
posterior	I-Treatment
forearm	I-Treatment
splint	I-Treatment
in	O
place	O
for	O
fourteen	O
days	O
following	O
discharge	O
.	O
	
The	B-Problem
left	I-Problem
forearm	I-Problem
and	I-Problem
right	I-Problem
lower	I-Problem
leg	I-Problem
wound	I-Problem
should	O
be	O
kept	O
clean	O
and	O
dry	O
with	O
regular	B-Treatment
dressing	I-Treatment
changes	I-Treatment
with	O
dry	B-Treatment
gauze	I-Treatment
once	O
per	O
day	O
.	O
	
Scalp	B-Problem
laceration	I-Problem
should	O
be	O
kept	O
clean	O
and	O
dry	O
for	O
five	O
days	O
following	O
discharge	O
after	O
which	O
point	O
the	O
patient	O
may	O
once	O
wash	O
her	O
hair	O
.	O
	
Percocet	B-Treatment
for	O
pain	B-Problem
as	O
needed	O
.	O
	
The	O
patient	O
is	O
to	O
followup	O
with	O
an	O
orthopedist	O
in	O
the	O
United	O
Kingdom	O
fourteen	O
days	O
following	O
discharge	O
at	O
which	O
point	O
repeat	B-Test
x-rays	I-Test
of	I-Test
her	I-Test
left	I-Test
forearm	I-Test
should	O
be	O
obtained	O
and	O
her	B-Treatment
left	I-Treatment
forearm	I-Treatment
scalp	I-Treatment
and	I-Treatment
right	I-Treatment
lower	I-Treatment
leg	I-Treatment
sutures	I-Treatment
and	O
staples	B-Treatment
may	O
be	O
removed	O
.	O
	
Questions	O
regarding	O
follow	O
up	O
may	O
be	O
referred	O
to	O
Dr.	O
Ronda	O
Lopez	O
at	O
the	O
Ayer	O
Orthopedic	O
Group	O
.	O
	
Telephone	O
#:	O
	
(	O
658	O
)	O
842-8661	O
.	O
	
Ortiz	O
V	O
Baugher	O
,	O
M.D.	O
	
75-285	O
	
Dictated	O
By	O
:	O
Catherine	O
K	O
Thomas	O
,	O
M.D.	O
	
MEDQUIST36	O
	
D	O
:	O
2010-06-30	O
17:18	O
	
T	O
:	O
2010-06-30	O
17:39	O
	
JOB	O
#:	O
	
03326	O
	
Signed	O
electronically	O
by	O
:	O
DR.	O
Kisha	O
Jones	O
on	O
:	O
Jose	O
2010-07-01	O
8:27	O
AM	O
	
(	O
End	O
of	O
Report	O
)	O
	
Admission	O
Date	O
:	O
	
2018-10-25	O
	
Discharge	O
Date	O
:	O
	
2018-11-01	O
	
Date	O
of	O
Birth	O
:	O
	
1943-11-06	O
	
Sex	O
:	O
	
M	O
	
Service	O
:	O
	
MEDICINE	O
	
Allergies	O
:	O
	
Patient	O
recorded	O
as	O
having	O
No	O
Known	B-Problem
Allergies	I-Problem
to	I-Problem
Drugs	I-Problem
	
Attending	O
:	O
Kelly	O
L.	O
Bradley	O
,	O
M.D.	O
	
Addendum	O
:	O
	
Explained	O
to	O
pt	O
which	O
of	O
the	B-Treatment
meds	I-Treatment
he	O
should	O
no	O
longer	O
take	O
that	O
he	O
was	O
taking	O
pre-admission	O
.	O
	
Also	O
,	O
explained	O
which	O
meds	B-Treatment
are	O
new	O
.	O
	
Wife	O
verbally	O
agrees	O
to	O
understanding	O
.	O
	
Discharge	O
Medications	O
:	O
	
1.	O
Diltiazem	B-Treatment
HCl	O
240	O
mg	O
Capsule	O
,	O
Sustained	O
Release	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
,	O
Sustained	O
Release	O
PO	O
DAILY	O
(	O
Daily	O
).	O
	
2.	O
Simvastatin	B-Treatment
40	O
mg	O
Tablet	O
Sig:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O
	
3.	O
Albuterol-Ipratropium	B-Treatment
103-18	O
mcg	O
/	O
Actuation	O
Aerosol	O
Sig	O
:	O
02-26	O
Puffs	O
Inhalation	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
.	O
	
4.	O
Fluticasone-Salmeterol	B-Treatment
250-50	O
mcg	O
/	O
Dose	O
Disk	O
with	O
Device	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Disk	O
with	O
Device	O
Inhalation	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O
	
5.	O
Terazosin	B-Treatment
1	O
mg	O
Capsule	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Capsule	O
PO	O
HS	O
(	O
at	O
bedtime	O
).	O
	
6.	O
Acetaminophen	B-Treatment
325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O
	
7.	O
Nimodipine	B-Treatment
30	O
mg	O
Capsule	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Capsule	O
PO	O
Q4H	O
(	O
every	O
4	O
hours	O
)	O
for	O
2	O
weeks	O
.	O
	
Disp	O
:*	O
168	O
Capsule	O
(s)*	O
Refills	O
:*	O
0	O
*	O
	
8.	O
Ferrous	B-Treatment
Sulfate	I-Treatment
325	O
(	O
65	O
)	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O
	
Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O
	
9.	O
Aspirin	B-Treatment
81	O
mg	O
Tablet	O
,	O
Chewable	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Chewable	O
PO	O
DAILY	O
(	O
Daily	O
).	O
	
10.	O
Ipratropium	B-Treatment
Bromide	I-Treatment
0.02	O
%	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Inhalation	O
Q6H	O
(	O
every	O
6	O
hours	O
).	O
	
11.	O
Simvastatin	B-Treatment
40	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O
	
12.	O
Hydralazine	B-Treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
1.5	O
Tablets	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
).	O
	
Disp	O
:*	O
135	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O
	
13.	O
Metoprolol	B-Treatment
Tartrate	I-Treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
1.5	O
Tablets	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O
	
Disp	O
:*	O
90	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O
	
14.	O
Isosorbide	B-Treatment
Dinitrate	I-Treatment
20	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
).	O
	
Disp	O
:*	O
90	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O
	
15.	O
Clopidogrel	B-Treatment
75	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O
	
16.	O
Glipizide	B-Treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
.	O
	
Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O
	
Discharge	O
Disposition	O
:	O
	
Home	O
with	O
Service	O
	
Jacob	O
Montegut	O
MD	O
71-786	O
	
Completed	O
by	O
:	O
Oscar	O
Jerome	O
Julian	O
MD	O
39-824	O
2018-11-01	O
@	O
1610	O
	
Signed	O
electronically	O
by	O
:	O
DR.	O
Joyce	O
Arney	O
on	O
:	O
MON	O
2018-12-03	O
10:55	O
PM	O
	
(	O
End	O
of	O
Report	O
)	O
	
Admission	O
Date	O
:	O
	
2012-01-07	O
	
Discharge	O
Date	O
:	O
	
2012-03-10	O
	
Date	O
of	O
Birth	O
:	O
	
Sex	O
:	O
	
M	O
	
Service	O
:	O
	
Since	O
2012-02-26	O
,	O
the	O
patient	O
has	O
been	O
stable	O
.	O
	
The	O
Whidden	O
Memorial	O
Hospital	O
hospital	O
course	O
has	O
been	O
smooth	O
with	O
the	O
patient	O
progressively	O
improving	O
.	O
	
The	O
patient	O
was	O
initially	O
on	O
several	B-Treatment
antibiotics	I-Treatment
included	O
Cefepime	B-Treatment
,	O
Vancomycin	B-Treatment
,	O
Ciprofloxacin	B-Treatment
,	O
Ambazone	B-Treatment
and	O
Flagyl	B-Treatment
.	O
	
The	B-Test
patient	I-Test
's	I-Test
HSV	I-Test
antibody	I-Test
titer	I-Test
was	O
found	O
to	O
be	O
negative	O
and	O
the	O
patient	O
's	O
Acyclovir	B-Treatment
was	O
not	O
restarted	O
.	O
	
Infectious	O
disease	O
continued	O
to	O
follow	O
and	O
on	O
2012-02-29	O
,	O
the	O
patient	O
spiked	O
again	O
which	O
at	O
that	O
time	O
was	O
felt	O
to	O
be	O
due	O
to	O
his	B-Treatment
central	I-Treatment
line	I-Treatment
and	O
the	B-Treatment
central	I-Treatment
line	I-Treatment
was	O
resited	O
on	O
the	O
left	O
side	O
and	O
the	O
patient	O
was	O
started	O
on	O
intravenous	B-Treatment
Vancomycin	I-Treatment
.	O
	
Over	O
the	O
following	O
days	O
until	O
discharge	O
,	O
the	O
patient	O
remained	O
afebrile	B-Problem
and	O
on	O
2012-03-09	O
,	O
in	O
fact	O
all	O
the	B-Treatment
patient	I-Treatment
's	I-Treatment
antibiotics	I-Treatment
were	O
discontinued	O
.	O
	
As	O
for	O
the	O
patient	O
's	O
ALL	B-Problem
and	O
AML	B-Problem
,	O
the	O
patient	O
was	O
started	O
on	O
a	B-Treatment
new	I-Treatment
chemotherapy	I-Treatment
protocol	I-Treatment
called	O
hyper-CVAD	B-Treatment
on	O
2012-03-06	O
.	O
	
After	O
the	O
patient	O
began	O
on	O
this	B-Treatment
protocol	I-Treatment
,	O
his	B-Test
white	I-Test
blood	I-Test
cell	I-Test
count	I-Test
steadily	O
began	O
to	O
climb	O
.	O
	
The	O
patient	O
became	O
no	O
longer	O
neutropenic	B-Problem
.	O
	
The	O
patient	O
's	O
also	O
began	O
to	O
climb	O
and	O
the	B-Test
percent	I-Test
blasts	I-Test
in	O
his	B-Test
differential	I-Test
decreased	O
significantly	O
.	O
	
The	O
patient	O
had	O
no	O
further	B-Problem
complaints	I-Problem
and	O
on	O
2012-03-10	O
,	O
his	B-Test
white	I-Test
blood	I-Test
cell	I-Test
count	I-Test
was	O
2.3	O
,	O
neutrophils	B-Test
50%	O
,	O
bands	B-Test
2%	O
,	O
lymphocytes	B-Test
5%	O
,	O
monocytes	B-Test
40%	O
,	O
and	O
blasts	B-Test
1%	O
.	O
	
Platelet	B-Test
count	I-Test
was	O
759,000	O
.	O
	
The	O
patient	O
was	O
discharged	O
to	O
home	O
with	O
instructions	O
to	O
return	O
to	O
the	O
hospital	O
on	O
Monday	O
,	O
2012-03-12	O
,	O
for	O
follow-up	O
and	O
laboratory	B-Test
checks	I-Test
.	O
	
The	O
patient	O
was	O
also	O
given	O
instructions	O
to	O
be	O
prudent	O
and	O
stay	O
away	O
from	O
public	O
places	O
as	O
well	O
as	O
small	O
children	O
.	O
	
The	O
patient	O
was	O
also	O
told	O
to	O
continue	O
on	O
a	B-Treatment
neutropenic	I-Treatment
diet	I-Treatment
.	O
	
The	O
patient	O
was	O
also	O
told	O
that	O
he	O
would	O
have	O
to	O
be	O
admitted	O
for	O
several	O
days	O
during	O
his	B-Treatment
next	I-Treatment
cycle	I-Treatment
of	I-Treatment
CVAD	I-Treatment
.	O
	
The	O
patient	O
was	O
discharged	O
to	O
home	O
in	O
good	O
condition	O
.	O
	
MEDICATIONS	O
ON	O
DISCHARGE	O
:	O
	
1.	O
Bactrim	B-Treatment
double	I-Treatment
strength	I-Treatment
one	O
tablet	O
q.	O
Monday	O
,	O
Wednesday	O
and	O
Friday	O
.	O
	
2.	O
Compazine	B-Treatment
10	O
mg	O
p.o.	O
q	O
6hours	O
p.r.n.	O
nausea	B-Problem
.	O
	
3.	O
Anzemet	B-Treatment
100	O
mg	O
p.o.	O
once	O
daily	O
p.r.n.	O
nausea	B-Problem
.	O
	
The	O
patient	O
is	O
to	O
return	O
to	O
the	O
hospital	O
on	O
Monday	O
for	O
follow-up	O
.	O
	
DR.	O
Esparza	O
,	O
Gail	O
18-714	O
	
Dictated	O
By	O
:	O
Cristobal	O
C.	O
Reid	O
,	O
M.D.	O
	
MEDQUIST36	O
	
D	O
:	O
2012-03-10	O
22:44	O
	
T	O
:	O
2012-03-11	O
10:08	O
	
JOB	O
#:	O
	
24313	O
	
1	O
	
1	O
	
1	O
	
OMR	O
	
Signed	O
electronically	O
by	O
:	O
DR.	O
Brenda	O
C.	O
Massey	O
on	O
:	O
MON	O
2012-04-23	O
1:02	O
PM	O
	
(	O
End	O
of	O
Report	O
)	O
	
Admission	O
Date	O
:	O
	
2010-08-26	O
	
Discharge	O
Date	O
:	O
	
2010-09-02	O
	
Date	O
of	O
Birth	O
:	O
	
1961-06-26	O
	
Sex	O
:	O
	
M	O
	
Service	O
:	O
	
HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O
	
Mr.	O
Robert	O
Mackey	O
is	O
a	O
49	O
year	O
old	O
gentleman	O
with	O
a	O
22	O
year	O
history	O
of	O
diabetes	B-Problem
mellitus	I-Problem
.	O
	
He	O
has	O
a	O
history	O
of	O
peripheral	B-Problem
neuropathy	I-Problem
,	O
kidney	B-Treatment
transplantation	I-Treatment
in	O
2003	O
secondary	O
to	O
diabetic	B-Problem
nephropathy	I-Problem
,	O
as	O
well	O
as	O
throat	B-Problem
cancer	I-Problem
in	O
2004	O
treated	O
with	O
local	B-Treatment
resection	I-Treatment
and	O
radical	B-Treatment
neck	I-Treatment
dissection	I-Treatment
on	I-Treatment
the	I-Treatment
left	I-Treatment
as	O
well	O
as	O
postoperative	B-Treatment
radiation	I-Treatment
.	O
	
Mr.	O
Mackey	O
also	O
had	B-Problem
signs	I-Problem
and	I-Problem
symptoms	O
consistent	O
with	B-Problem
cervical	I-Problem
myelopathy	O
;	B-Test
a	I-Test
cervical	I-Test
MRI	I-Test
scan	O
showed	O
very	B-Problem
impressive	I-Problem
disc	I-Problem
herniations	I-Problem
at	I-Problem
C5-C6	O
,	O
less	O
so	O
at	O
C4-C5	O
,	O
with	B-Problem
clear	I-Problem
cut	I-Problem
cord	I-Problem
compression	O
,	O
particularly	O
on	O
the	O
right	O
side	O
C5-C6	O
.	O
	
Therefore	O
,	O
he	O
was	O
admitted	O
for	O
C4-C5	B-Treatment
and	I-Treatment
C5-C6	I-Treatment
anterior	I-Treatment
diskectomy	I-Treatment
with	O
autologous	B-Treatment
bone	I-Treatment
graft	I-Treatment
and	O
instrumented	B-Treatment
fusion	I-Treatment
.	O
	
PHYSICAL	O
EXAMINATION	O
:	O
	
Postoperative	B-Test
physical	I-Test
examination	I-Test
demonstrated	O
that	O
he	O
was	O
afebrile	B-Problem
at	O
97	O
degrees	O
;	O
blood	B-Test
pressure	I-Test
145/80	O
;	O
pulse	B-Test
60	O
;	O
respiratory	B-Test
rate	I-Test
10	O
;	O
100%	O
on	O
a	B-Treatment
non-rebreather	I-Treatment
.	O
	
He	O
was	O
awake	O
,	O
alert	O
,	O
uncomfortable	B-Problem
secondary	O
to	O
incisional	B-Problem
tenderness	I-Problem
at	O
neck	B-Problem
site	I-Problem
as	O
well	O
as	O
right	B-Problem
iliac	I-Problem
graft	I-Problem
site	I-Problem
.	O
	
The	B-Problem
wounds	I-Problem
were	O
clean	O
,	O
dry	O
and	O
intact	O
,	O
and	O
flat	O
.	O
	
HOSPITAL	O
COURSE	O
:	O
	
While	O
in	O
the	O
PACU	O
,	O
Anesthesia	O
was	O
called	O
because	O
the	O
patient	O
became	O
dyspneic	B-Problem
and	O
tachypneic	B-Problem
and	O
his	B-Test
SAO2	I-Test
dropped	O
to	O
89%	O
.	O
	
His	B-Test
respiratory	I-Test
rate	I-Test
was	O
30	O
on	O
face	B-Treatment
mask	I-Treatment
.	O
	
Interoperatively	O
,	O
he	O
was	O
positive	O
two	O
liters	O
with	O
a	O
stable	O
blood	O
pressure	O
and	O
heart	B-Test
rate	I-Test
,	O
although	O
requiring	O
some	B-Treatment
neo-synephrine	I-Treatment
interoperatively	O
.	O
	
He	O
responded	O
to	O
intravenous	B-Treatment
Lasix	I-Treatment
with	O
3.2	O
liters	O
of	O
urine	B-Test
output	I-Test
as	O
well	O
as	O
marked	O
clinical	O
improvement	O
.	O
	
The	O
etiology	O
for	O
his	B-Problem
congestive	I-Problem
heart	I-Problem
failure	I-Problem
was	O
determined	O
likely	O
to	O
be	O
diastolic	B-Problem
dysfunction	I-Problem
from	O
increased	B-Problem
heart	I-Problem
rate	I-Problem
as	O
well	O
as	O
excess	B-Problem
volume	I-Problem
.	O
	
No	O
definite	O
evidence	O
for	O
significant	B-Problem
myocardial	I-Problem
ischemia	I-Problem
,	O
although	O
cardiac	B-Test
enzymes	I-Test
were	O
sent	O
and	O
he	O
ruled	O
out	O
for	O
myocardial	B-Problem
infarction	I-Problem
.	O
	
He	O
was	O
admitted	O
to	O
the	O
Surgical	O
Intensive	O
Care	O
Unit	O
where	O
his	O
respiratory	O
and	O
cardiac	O
status	O
was	O
monitored	O
carefully	O
.	O
	
He	O
was	O
given	O
Lasix	B-Treatment
to	O
continue	O
to	O
diurese	O
the	B-Problem
excess	I-Problem
volume	I-Problem
.	O
	
He	O
was	O
also	O
put	O
on	O
Lopressor	B-Treatment
150	O
mg	O
twice	O
a	O
day	O
.	O
	
Also	O
in	O
the	O
Intensive	O
Care	O
Unit	O
,	O
O2	B-Test
saturation	I-Test
was	O
closely	O
monitored	O
.	O
	
The	O
patient	O
became	O
agitated	B-Problem
with	O
both	O
tent	B-Treatment
and	O
Bi-PAP	B-Treatment
machine	I-Treatment
,	O
although	O
continued	O
to	O
saturate	O
well	O
.	O
	
He	O
was	O
transferred	O
to	O
Medicine	O
the	O
morning	O
of	O
2010-08-30	O
,	O
for	O
continued	B-Treatment
medical	I-Treatment
management	I-Treatment
post	O
surgery	O
.	O
	
On	O
the	O
day	O
of	O
transfer	O
,	O
the	O
patient	O
was	O
noted	O
to	O
be	O
confused	B-Problem
with	O
waxing	B-Problem
and	I-Problem
waning	I-Problem
sensorium	I-Problem
;	O
thus	O
,	O
a	B-Test
delirium	I-Test
work-up	I-Test
was	O
initiated	O
looking	O
for	O
precipitants	O
.	O
	
1.	O
When	O
his	B-Test
O2	I-Test
saturation	I-Test
was	O
monitored	O
,	O
his	B-Test
pulse	I-Test
oximetry	I-Test
remained	O
in	O
the	O
90s	O
during	O
his	O
stay	O
.	O
	
2.	O
His	B-Treatment
non-essential	I-Treatment
medications	I-Treatment
that	O
may	O
have	O
been	O
contributing	O
to	O
his	B-Problem
change	I-Problem
in	I-Problem
mental	I-Problem
status	I-Problem
were	O
discontinued	O
;	O
those	O
included	O
Temocillin	B-Treatment
,	O
Nortriptyline	B-Treatment
,	O
Haldol	B-Treatment
,	O
Lorazepam	B-Treatment
,	O
Venlafaxine	B-Treatment
,	O
Bupropion	B-Treatment
,	O
and	O
Gabapentin	B-Treatment
.	O
	
In	O
addition	O
,	O
his	B-Test
cyclosporin	I-Test
levels	I-Test
were	O
checked	O
.	O
	
3.	O
Hypo	B-Problem
or	I-Problem
hyperglycemia	I-Problem
:	O
	
Mahoney	O
had	O
been	O
following	O
with	O
their	O
appreciated	O
recommendations	O
on	O
glucose	B-Treatment
control	I-Treatment
.	O
	
Finger	B-Test
sticks	I-Test
were	O
in	O
the	O
150	O
s	O
when	O
acutely	B-Problem
agitated	I-Problem
,	O
therefore	O
,	O
it	O
was	O
not	O
determined	O
that	O
glucose	B-Test
levels	I-Test
were	O
contributory	O
.	O
	
4.	O
Infectious	B-Problem
causes	I-Problem
were	O
evaluated	O
.	O
	
He	O
was	O
febrile	B-Problem
in	O
the	O
Intensive	O
Care	O
Unit	O
to	O
101.0	O
F.	O
;	O
yet	O
,	O
chest	B-Test
x-ray	I-Test
,	O
blood	B-Test
cultures	I-Test
,	O
urinalysis	B-Test
and	O
urine	B-Test
cultures	I-Test
were	O
all	O
negative	O
for	O
sources	O
.	O
	
A	B-Test
lumbar	I-Test
puncture	I-Test
was	O
considered	O
,	O
although	O
not	O
performed	O
due	O
to	O
the	O
fact	O
that	O
the	O
cerebrospinal	O
fluid	O
was	O
not	O
breached	O
during	O
the	B-Treatment
procedure	I-Treatment
.	O
	
5.	O
Mass	B-Problem
effect	I-Problem
was	O
considered	O
,	O
although	O
no	O
focal	B-Problem
deficits	I-Problem
were	O
ever	O
noted	O
on	O
examination	B-Test
and	O
due	O
to	O
the	B-Problem
fluctuating	I-Problem
sensorium	I-Problem
,	O
it	O
was	O
determined	O
that	O
there	O
was	O
no	O
severe	B-Problem
underlying	I-Problem
structural	I-Problem
abnormality	I-Problem
.	O
	
A	B-Test
head	I-Test
and	I-Test
neck	I-Test
CT	I-Test
scan	I-Test
,	I-Test
non-contrast	I-Test
,	O
were	O
ordered	O
though	O
to	O
evaluate	O
for	O
such	B-Problem
processes	I-Problem
.	O
	
No	O
acute	B-Problem
intracranial	I-Problem
hemorrhages	I-Problem
or	O
midline	B-Problem
shifts	I-Problem
were	O
noted	O
,	O
although	O
a	B-Problem
soft	I-Problem
tissue	I-Problem
mass	I-Problem
was	O
noted	O
at	O
the	O
level	O
of	O
C2	O
.	O
	
This	O
was	O
determined	O
to	O
be	O
within	O
the	O
normal	O
expected	O
changes	O
post	O
surgery	O
.	O
	
6.	O
Trauma	B-Problem
was	O
also	O
considered	O
.	O
	
The	O
patient	O
was	O
found	O
out	O
of	O
bed	O
but	O
no	O
signs	O
of	O
head	B-Problem
trauma	I-Problem
,	O
no	O
loss	B-Problem
of	I-Problem
consciousness	I-Problem
.	O
	
Throughout	O
his	O
stay	O
,	O
Chem-10	B-Test
was	O
monitored	O
.	O
	
There	O
were	O
no	O
electrolytes	B-Problem
or	I-Problem
mineral	I-Problem
abnormalities	I-Problem
that	O
could	O
explain	O
his	B-Problem
delirium	I-Problem
.	O
	
Liver	B-Test
function	I-Test
tests	I-Test
were	O
checked	O
,	O
only	O
total	B-Test
bilirubin	I-Test
was	O
slightly	B-Problem
elevated	I-Problem
at	O
1.6	O
.	O
	
TSH	B-Test
was	O
within	O
normal	O
limits	O
as	O
was	O
B12	B-Test
and	O
folate	B-Test
.	O
	
RPR	B-Test
evaluating	I-Test
for	O
possible	O
neurologic	B-Problem
syphilis	I-Problem
was	O
also	O
checked	O
.	O
	
The	B-Test
assay	I-Test
was	O
nonreactive	O
.	O
	
An	B-Test
EEG	I-Test
was	O
also	O
considered	O
to	O
rule	O
out	O
non-convulsive	B-Problem
status	I-Problem
epilepticus	I-Problem
,	O
although	O
again	O
this	O
did	O
not	O
seem	O
to	O
be	O
a	O
likely	O
cause	O
.	O
	
On	O
the	O
evening	O
of	O
the	O
22nd	O
,	O
the	O
patient	O
became	O
acutely	B-Problem
agitated	I-Problem
,	O
threatening	O
to	O
leave	O
,	O
and	O
also	O
threatening	O
to	O
harm	O
those	O
nurses	O
and	O
physicians	O
that	O
were	O
attempting	O
to	O
prevent	O
him	O
from	O
leaving	O
.	O
	
Security	O
was	O
notified	O
who	O
then	O
arrived	O
to	O
the	O
room	O
and	O
helped	O
to	O
place	O
the	O
patient	O
in	O
four-point	O
	
restraints	B-Treatment
,	O
for	O
the	O
safety	O
of	O
both	O
the	O
patient	O
and	O
the	O
staff	O
of	O
the	O
hospital	O
.	O
	
The	B-Treatment
restraints	I-Treatment
were	O
weaned	O
off	O
overnight	O
although	O
he	O
became	O
acutely	B-Problem
agitated	I-Problem
and	O
they	O
were	O
replaced	O
early	O
on	O
08-31	O
.	O
	
Later	O
in	O
the	O
morning	O
on	O
08-31	O
,	O
the	O
patient	O
was	O
more	O
oriented	O
and	O
alert	O
,	O
and	O
asked	O
to	O
have	O
the	B-Treatment
restraints	I-Treatment
removed	O
.	O
	
They	O
were	O
taken	O
off	O
two	O
at	O
a	O
time	O
.	O
	
The	O
patient	O
continued	O
to	O
do	O
well	O
and	O
did	O
not	O
require	O
restraints	B-Treatment
after	O
that	B-Problem
event	I-Problem
.	O
	
Intramuscular	B-Treatment
as	O
well	O
as	O
intravenous	B-Treatment
Haldol	I-Treatment
were	O
ordered	O
p.r.n.	O
for	O
emergency	O
use	O
should	O
he	O
become	O
acutely	B-Problem
agitated	I-Problem
.	O
	
haldol	B-Treatment
as	O
well	O
as	O
the	B-Treatment
restraints	I-Treatment
were	O
not	O
required	O
after	O
the	O
morning	O
of	O
the	O
23rd	O
.	O
	
Each	O
progressive	O
day,	O
Mr.	O
Donald	B-Problem
delirium	O
abated	O
with	O
return	O
to	O
baseline	O
mental	O
status	O
early	O
on	O
09-01	O
.	O
	
The	O
likely	O
cause	O
of	O
the	B-Problem
delirium	I-Problem
was	O
a	O
combination	O
of	O
surgery	B-Treatment
and	O
Intensive	O
Care	O
Unit	O
stay	O
in	O
addition	O
to	O
poly-pharmacy	B-Treatment
.	O
	
Other	O
concerns	O
during	O
his	O
stay	O
was	O
his	B-Test
kidney	I-Test
function	I-Test
,	O
due	O
to	O
his	B-Treatment
renal	I-Treatment
transplant	I-Treatment
in	O
2003	O
.	O
	
His	B-Treatment
immunosuppressive	I-Treatment
therapy	I-Treatment
was	O
continued	O
throughout	O
his	O
stay	O
;	O
his	B-Test
creatinine	I-Test
remained	O
approximately	O
2.3	O
to	O
2.4	O
;	O
he	O
has	O
a	B-Problem
baseline	I-Problem
renal	I-Problem
insufficiency	I-Problem
.	O
	
With	O
this	O
in	O
mind	O
,	O
when	O
obtaining	O
a	B-Test
CT	I-Test
scan	I-Test
it	O
was	O
determined	O
that	O
contrast	B-Treatment
would	O
not	O
be	O
the	O
best	O
option	O
.	O
	
While	O
the	O
patient	O
was	O
in	O
restraints	B-Treatment
,	O
gentle	B-Treatment
hydration	I-Treatment
was	O
initiated	O
since	O
p.o.	B-Test
intake	I-Test
was	O
not	B-Problem
adequate	I-Problem
.	O
	
As	O
for	O
his	B-Problem
diabetes	I-Problem
mellitus	I-Problem
,	O
the	O
Mahoney	O
Team	O
provided	O
updated	O
recommendations	O
each	O
day	O
,	O
adjusting	O
for	O
the	O
changing	O
p.o.	O
intake	O
.	O
	
The	O
only	O
other	B-Problem
complaints	I-Problem
from	O
Mr.	O
Mackey	O
during	O
his	O
stay	O
were	O
:	O
	
Soreness	B-Problem
at	O
his	B-Problem
operative	I-Problem
sites	I-Problem
,	O
for	O
which	O
he	O
was	O
given	O
p.r.n.	B-Treatment
Tylenol	I-Treatment
once	O
his	B-Problem
delirium	I-Problem
had	O
resolved	O
.	O
	
In	O
addition	O
,	O
he	O
also	O
complained	O
of	O
difficulty	B-Problem
with	I-Problem
swallowing	I-Problem
,	O
necessitating	O
only	O
soft	B-Treatment
and	I-Treatment
liquid	I-Treatment
diet	I-Treatment
.	O
	
This	O
was	O
attributed	O
to	O
postoperative	B-Problem
swelling	I-Problem
and	O
changes	O
from	O
his	B-Treatment
diskectomy	I-Treatment
performed	O
2010-08-27	O
.	O
	
DISPOSITION	O
:	O
	
The	O
patient	O
was	O
discharged	O
on	O
09-02	O
.	O
	
DISCHARGE	O
INSTRUCTIONS	O
:	O
	
1.	O
Follow-up	O
with	O
Dr.	O
Williams	O
on	O
Tuesday	O
,	O
09-07	O
,	O
at	O
noon	O
.	O
	
2.	O
Follow-up	O
with	O
Dr.	O
Michael	O
,	O
his	O
psychiatrist	O
,	O
on	O
Wednesday	O
,	O
09-08	O
.	O
	
3.	O
He	O
was	O
also	O
discharged	O
home	O
with	O
Visiting	O
Nurse	O
Association	O
for	O
Physical	B-Test
Therapy	I-Test
evaluation	I-Test
of	O
home	O
safety	O
.	O
	
DISCHARGE	O
MEDICATIONS	O
:	O
	
1.	O
Venlafaxine	B-Treatment
XR	I-Treatment
75	O
mg	O
q.	O
a.m.	O
	
2.	O
Furosemide	B-Treatment
20	O
mg	O
q.o.d.	O
	
3.	O
Metoprolol	B-Treatment
100	O
mg	O
twice	O
a	O
day	O
.	O
	
4.	O
Nitroglycerin	B-Treatment
sublingual	I-Treatment
0.3	O
mg	O
p.r.n.	O
	
5.	O
Cyclosporin	B-Treatment
microemulsion	I-Treatment
.	O
	
6.	O
Neoral	B-Treatment
100	O
mg	O
twice	O
a	O
day	O
.	O
	
7.	O
Zithropren	B-Treatment
50	O
mg	O
q.	O
day	O
.	O
	
8.	O
Prednisone	B-Treatment
10	O
mg	O
q.	O
day	O
.	O
	
9.	O
Minoxidil	B-Treatment
10	O
mg	O
twice	O
a	O
day	O
.	O
	
10.	O
Prilosec	B-Treatment
20	O
mg	O
q.	O
day	O
.	O
	
11.	O
NPH	B-Treatment
30	O
units	O
q.	O
a.m.	O
,	O
5	O
to	O
6	O
units	O
q.	O
p.m.	O
	
12.	O
Regular	B-Treatment
insulin	I-Treatment
5	O
units	O
q.	O
a.m.	O
and	O
3	O
to	O
5	O
units	O
q.	O
p.m.	O
	
13.	O
Wellbutrin	B-Treatment
100	O
mg	O
q.	O
day	O
.	O
	
14.	O
Zocor	B-Treatment
60	O
mg	O
q.	O
day	O
.	O
	
15.	O
Nitroglycerin	B-Treatment
SR	I-Treatment
2.5	O
mg	O
twice	O
a	O
day	O
.	O
	
He	O
was	O
instructed	O
to	O
hold	O
the	O
following	O
three	O
medications	B-Treatment
that	O
he	O
took	O
prior	O
to	O
admission	O
:	O
	
Nortriptyline	B-Treatment
10	O
mg	O
q.	O
h.s.	O
;	O
Flomax	B-Treatment
0.4	O
mg	O
q.	O
h.s.	O
;	O
Neurontin	B-Treatment
600	O
mg	O
three	O
times	O
a	O
day	O
.	O
	
He	O
was	O
instructed	O
not	O
to	O
restart	O
these	O
until	O
seen	O
by	O
Dr.	O
Ercek	O
.	O
	
DISCHARGE	O
DIAGNOSES	O
:	O
	
1.	O
C4-C5	B-Treatment
,	I-Treatment
C5-C6	I-Treatment
,	I-Treatment
anterior	I-Treatment
microdiscectomy	I-Treatment
and	I-Treatment
fusion	I-Treatment
with	O
right	B-Treatment
iliac	I-Treatment
bone	I-Treatment
graft	I-Treatment
.	O
	
For	O
completeness	O
,	O
the	O
patient	O
's	O
complete	O
past	O
medical	O
history	O
:	O
	
1.	O
End-stage	B-Problem
renal	I-Problem
disease	I-Problem
secondary	O
to	O
type	B-Problem
1	I-Problem
diabetes	I-Problem
mellitus	I-Problem
;	O
status	O
post	O
renal	B-Treatment
transplant	I-Treatment
in	O
2003	O
.	O
	
2.	O
History	O
of	O
multiple	B-Problem
urinary	I-Problem
tract	I-Problem
infections	I-Problem
.	O
	
3.	O
Pyelonephritis	B-Problem
.	O
	
4.	O
Creatinine	B-Test
2.2	O
to	O
2.5	O
.	O
	
5.	O
Right	B-Treatment
coronary	I-Treatment
artery	I-Treatment
stent	I-Treatment
in	O
2008	O
;	O
ejection	B-Test
fraction	I-Test
60	O
to	O
65%	O
.	O
	
6.	O
Type	B-Problem
1	I-Problem
diabetes	I-Problem
mellitus	I-Problem
with	O
triopathy	B-Problem
,	O
retinopathy	B-Problem
,	O
neuropathy	B-Problem
,	O
nephropathy	B-Problem
.	O
	
7.	O
Benign	B-Problem
prostatic	I-Problem
hypertrophy	I-Problem
status	O
post	O
transurethral	B-Treatment
resection	I-Treatment
of	I-Treatment
the	I-Treatment
prostate	I-Treatment
;	O
self	B-Treatment
catheterization	I-Treatment
.	O
	
8.	O
Hypertension	B-Problem
.	O
	
9.	O
Hypercholesterolemia	B-Problem
.	O
	
10.	O
Hepatitis	B-Problem
B	I-Problem
.	O
	
11.	O
Throat	B-Problem
cancer	I-Problem
status	O
post	O
right	B-Treatment
neck	I-Treatment
dissection	I-Treatment
and	O
XRT	B-Treatment
in	O
2004	O
.	O
	
12.	O
Cerebral	B-Problem
aneurysm	I-Problem
.	O
	
13.	O
Left	B-Treatment
prosthetic	I-Treatment
CMED	O
CCU	O
.	O
	
ALLERGIES	O
:	O
	
Gentamicin	B-Treatment
,	O
and	O
ibuprofen	B-Treatment
.	O
	
Kenneth	O
Jeffrey	O
,	O
MD	O
89-808	O
	
Dictated	O
By	O
:	O
Michael	O
S	O
Bonham	O
,	O
M.D.	O
	
MEDQUIST36	O
	
D	O
:	O
2010-09-02	O
18:23	O
	
T	O
:	O
2010-09-07	O
16:04	O
	
JOB	O
#:	O
	
36814	O
	
Signed	O
electronically	O
by	O
:	O
DR.	O
Victoria	O
Williams	O
on	O
:	O
MON	O
2010-11-08	O
3:18	O
PM	O
	
(	O
End	O
of	O
Report	O
)	O
	
Admission	O
Date	O
:	O
	
2009-08-17	O
	
Discharge	O
Date	O
:	O
	
2009-09-10	O
	
Date	O
of	O
Birth	O
:	O
	
1951-04-02	O
	
Sex	O
:	O
	
M	O
	
Service	O
:	O
	
BLUE	O
GENERAL	O
SURGERY	O
	
Attending	O
:	O
Terry	O
U	O
Cheatom	O
,	O
M.D.	O
	
HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O
	
Mr.	O
Cordano	O
is	O
a	O
58-year-old	O
gentlemen	O
with	O
a	O
past	O
medical	O
history	O
significant	O
for	O
primary	B-Problem
sclerosing	I-Problem
cholangitis	I-Problem
who	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
endoscopic	B-Test
retrograde	I-Test
cholangiopancreatography	I-Test
endoscopic	B-Test
retrograde	I-Test
cholangiopancreatography	I-Test
and	O
percutaneous	B-Test
transhepatic	I-Test
cholangiogram	I-Test
.	O
	
The	B-Treatment
most	I-Treatment
recent	I-Treatment
percutaneous	I-Treatment
transluminal	I-Treatment
coronary	I-Treatment
angioplasty	I-Treatment
was	O
done	O
in	O
2009-07-25	O
.	O
	
At	O
the	O
time	O
an	B-Treatment
8	I-Treatment
Caucasian	I-Treatment
catheter	I-Treatment
was	O
placed	O
in	O
the	O
common	O
hepatic/bioduct	O
for	O
external	B-Treatment
drainage	I-Treatment
.	O
	
The	B-Test
endoscopic	I-Test
retrograde	I-Test
cholangiopancreatography	I-Test
also	O
showed	O
the	O
presence	O
proximal	O
common	O
bile	O
duct	O
.	O
	
Nodularities	B-Problem
in	I-Problem
the	I-Problem
common	I-Problem
bile	I-Problem
duct	I-Problem
visualized	O
by	O
endoscopic	B-Test
retrograde	I-Test
cholangiopancreatography	I-Test
was	O
also	O
worrisome	O
for	O
cholangiocarcinoma	B-Problem
and	O
the	O
patient	O
was	O
admitted	O
to	O
the	O
Blue	O
General	O
Surgery	O
Service	O
for	O
possible	O
surgical	B-Treatment
interventions	I-Treatment
.	O
	
PAST	O
MEDICAL	O
HISTORY	O
:	O
	
Ulcerative	B-Problem
colitis	I-Problem
,	O
primary	B-Problem
sclerosing	I-Problem
cholangitis	I-Problem
.	O
	
PAST	O
SURGICAL	O
HISTORY	O
:	O
	
Status	O
post	O
placement	B-Treatment
of	I-Treatment
percutaneous	I-Treatment
transhepatic	I-Treatment
biliary	I-Treatment
drainage	I-Treatment
with	O
placement	B-Treatment
of	I-Treatment
8	I-Treatment
Caucasian	I-Treatment
nephrostomy	I-Treatment
catheter	I-Treatment
in	O
the	O
common	O
bile	O
duct	O
.	O
	
ALLERGIES	O
:	O
	
No	O
known	B-Problem
drug	I-Problem
allergies	I-Problem
.	O
	
MEDICATIONS	O
ON	O
ADMISSION	O
:	O
	
1.	O
Ursodiol	B-Treatment
600	O
mg	O
t.i.d.	O
	
2.	O
Ambien	B-Treatment
5	O
mg	O
q.h.s.	O
	
PHYSICAL	O
EXAMINATION	O
ON	O
ADMISSION	O
:	O
	
The	O
patient	O
is	O
a	O
jaundiced	O
looking	O
gentlemen	O
in	O
no	O
acute	B-Problem
distress	I-Problem
.	O
	
The	O
head	O
is	O
normocephalic	O
,	O
atraumatic	B-Problem
and	O
eyes	O
are	O
icteric	B-Problem
.	O
	
The	O
neck	O
is	O
supple	O
with	O
no	O
lymphadenopathy	B-Problem
.	O
	
The	O
chest	O
is	O
clear	O
to	O
auscultation	B-Test
bilaterally	O
.	O
	
The	O
heart	O
has	O
a	O
regular	O
rate	O
and	O
rhythm	O
with	O
normal	O
S1	O
,	O
S2	O
.	O
	
There	O
is	O
no	O
murmurs	B-Problem
.	O
	
The	O
abdomen	O
was	O
soft	O
,	O
nontender	B-Problem
,	O
no	O
masses	B-Problem
and	O
nondistended	B-Problem
.	O
	
There	O
is	O
no	O
hepatosplenomegaly	B-Problem
.	O
	
Rectal	B-Test
exam	I-Test
showed	O
no	O
masses	B-Problem
and	O
is	O
guaiac	B-Test
negative	O
.	O
	
The	O
extremities	O
have	O
distal	O
pulses	O
and	O
were	O
warm	O
and	O
well	O
perfused	O
.	O
	
Neurological	B-Test
exam	I-Test
was	O
grossly	O
intact	O
.	O
	
LABORATORY	O
STUDIES	O
AT	O
ADMISSION	O
:	O
	
A	B-Test
white	I-Test
blood	I-Test
cell	I-Test
count	I-Test
of	O
14.2	O
,	O
hematocrit	B-Test
of	O
35.3	O
,	O
platelet	B-Test
count	I-Test
of	O
449,000	O
.	O
	
Sodium	B-Test
of	O
130	O
,	O
potassium	B-Test
3.5	O
,	O
chloride	B-Test
93	O
,	O
bicarbonate	B-Test
28	O
,	O
BUN	B-Test
15	O
,	O
creatinine	B-Test
1.1,	O
prothrombin	B-Test
time	I-Test
14.1	O
,	O
partial	B-Test
thrombin	I-Test
time	I-Test
29.7	O
.	O
	
INR	B-Test
1.4	O
.	O
	
ALT	B-Test
106	O
,	O
AST	B-Test
149	O
,	O
alkaline	B-Test
phosphatase	I-Test
242	O
.	O
	
Total	B-Test
bilirubin	I-Test
10.1	O
,	O
amylase	B-Test
90	O
and	O
lipase	B-Test
112	O
.	O
	
RADIOLOGICAL	O
STUDIES	O
AT	O
TIME	O
OF	O
ADMISSION	O
:	O
	
Chest	B-Test
x-ray	I-Test
revealed	O
minimal	B-Problem
left	I-Problem
base	I-Problem
atelectasis	I-Problem
and	O
elevation	B-Problem
of	I-Problem
left	I-Problem
hemidiaphragm	I-Problem
.	O
	
A	B-Test
CT	I-Test
scan	I-Test
with	I-Test
po	I-Test
contrast	I-Test
showed	O
dilation	B-Problem
of	I-Problem
intrahepatic	I-Problem
common	I-Problem
bile	I-Problem
duct	I-Problem
which	O
is	O
improved	O
from	O
previous	B-Test
studies	I-Test
.	O
	
It	O
is	O
also	O
noted	O
that	O
there	O
was	O
splenomegaly	B-Problem
.	O
	
HOSPITAL	O
COURSE	O
:	O
	
Mr.	O
Cordano	O
was	O
admitted	O
on	O
2009-08-17	O
for	O
a	B-Treatment
replacement	I-Treatment
of	I-Treatment
transhepatic	I-Treatment
biliary	I-Treatment
drainage	I-Treatment
catheter	I-Treatment
.	O
	
At	O
that	O
time	O
,	O
cholangiogram	B-Test
confirmed	O
that	O
there	O
was	O
a	B-Problem
distal	I-Problem
stricture	I-Problem
of	I-Problem
the	I-Problem
common	I-Problem
bile	I-Problem
duct	I-Problem
.	O
	
An	B-Test
endoscopic	I-Test
retrograde	I-Test
cholangiopancreatography	I-Test
also	O
demonstrated	O
similar	O
findings	O
	
and	O
it	O
is	O
noted	O
there	O
was	O
nodularity	B-Problem
in	I-Problem
the	I-Problem
common	I-Problem
bile	I-Problem
duct	I-Problem
which	O
is	O
worrisome	O
for	O
cholangiocarcinoma	B-Problem
.	O
	
Therefore	O
,	O
the	O
patient	O
was	O
taken	O
to	O
the	O
Operating	O
Room	O
on	O
2009-08-24	O
for	O
a	B-Treatment
Whipple	I-Treatment
procedure	I-Treatment
versus	O
hepaticojejunostomy	B-Treatment
.	O
	
On	O
exploration	B-Test
of	I-Test
the	I-Test
abdomen	I-Test
revealed	O
significant	B-Problem
nodularity	I-Problem
of	I-Problem
the	I-Problem
liver	I-Problem
indicating	O
of	O
advanced	B-Problem
cirrhosis	I-Problem
.	O
	
Intraoperative	O
frozen	O
section	O
of	O
the	O
distal	O
and	O
proximal	O
common	O
bile	O
duct	O
in	O
the	O
	
region	B-Problem
nodularity	I-Problem
,	O
which	O
is	O
identified	O
previously	O
by	O
endoscopic	B-Test
retrograde	I-Test
cholangiopancreatography	I-Test
,	O
and	O
regional	O
lymph	O
nodes	O
were	O
all	O
sent	O
to	O
pathology	B-Test
.	O
	
They	O
were	O
all	O
negative	O
for	O
malignancy	B-Problem
and	O
therefore	O
a	B-Treatment
hepaticojejunostomy	I-Treatment
	
was	O
performed	O
.	O
	
Cholangiogram	B-Test
on	O
postoperative	O
day	O
number	O
two	O
showed	O
no	O
evidence	O
of	O
leakage	B-Problem
at	I-Problem
the	I-Problem
anastomosis	I-Problem
site	I-Problem
.	O
	
The	O
patient	O
tolerated	O
the	B-Treatment
procedure	I-Treatment
well	O
and	O
he	O
was	O
sent	O
to	O
the	O
floor	O
in	O
stable	O
condition	O
.	O
	
The	O
patient	O
's	O
postoperative	O
course	O
was	O
notable	O
for	O
an	B-Problem
elevation	I-Problem
in	O
white	B-Test
blood	I-Test
cell	I-Test
count	O
peaking	O
at	O
30.0	O
on	O
postoperative	O
day	O
number	O
two	O
.	O
	
He	O
was	O
given	O
Unasyn	B-Treatment
for	O
empiric	B-Treatment
antibiotic	I-Treatment
treatment	I-Treatment
.	O
	
At	O
the	O
time	O
,	O
blood	O
,	O
urine	O
and	O
bile	O
was	O
sent	O
for	O
culture	B-Test
,	O
which	O
were	O
all	O
negative	O
.	O
	
A	B-Test
chest	I-Test
x-ray	I-Test
was	O
also	O
negative	O
for	O
any	B-Problem
pneumonia	I-Problem
.	O
	
Postoperatively	O
,	O
Mr.	O
Cordano	O
also	O
suffered	O
from	O
low	B-Problem
urine	I-Problem
output	I-Problem
ranges	O
between	O
25	O
to	O
30	O
cc	O
per	O
hour	O
.	O
	
Fractional	B-Test
excretion	I-Test
of	I-Test
sodium	I-Test
was	O
less	O
than	O
1%	O
suggesting	O
a	B-Problem
prerenal	I-Problem
etiology	I-Problem
.	O
	
The	B-Test
sodium	I-Test
creatinine	I-Test
peaked	O
at	O
2.0	O
and	O
the	O
patient	O
was	O
treated	O
with	O
boluses	B-Treatment
of	I-Treatment
intravenous	I-Treatment
fluid	I-Treatment
and	O
intravenous	B-Treatment
albumin	I-Treatment
infusion	I-Treatment
was	O
also	O
administered	O
.	O
	
He	O
responded	O
well	O
to	O
this	B-Treatment
regimen	I-Treatment
and	O
made	O
adequate	O
urine	O
output	O
.	O
	
At	O
the	O
same	O
time	O
,	O
the	O
patient	O
also	O
developed	O
distentions	B-Problem
of	I-Problem
the	I-Problem
abdomen	I-Problem
consistent	O
with	O
accumulation	B-Problem
of	I-Problem
ascitic	I-Problem
fluid	I-Problem
.	O
	
He	O
also	O
had	O
significant	B-Problem
lower	I-Problem
extremity	I-Problem
and	I-Problem
scrotum	I-Problem
edema	I-Problem
.	O
	
On	O
postoperative	O
day	O
number	O
eight	O
,	O
the	B-Test
patient	I-Test
's	I-Test
oxygen	I-Test
saturation	I-Test
dropped	O
to	O
85%	O
on	O
room	O
air	O
and	O
he	O
was	O
transferred	O
to	O
the	O
Surgical	O
Intensive	O
Care	O
Unit	O
for	O
fluid	B-Treatment
management	I-Treatment
.	O
	
Chest	B-Test
x-ray	I-Test
and	O
sputum	B-Test
culture	I-Test
obtained	O
at	O
the	O
time	O
were	O
negative	O
and	O
the	O
patient	O
was	O
treated	O
with	O
100%	B-Treatment
nonrebreather	I-Treatment
which	O
improved	O
his	B-Test
oxygenation	I-Test
.	O
	
While	O
he	O
is	O
in	O
the	O
Surgical	O
Intensive	O
Care	O
Unit	O
,	O
paracentesis	B-Test
was	O
performed	O
and	O
it	O
	
revealed	O
greater	O
than	O
24,000	O
white	B-Test
blood	I-Test
cell	I-Test
count	I-Test
in	O
the	B-Problem
ascites	I-Problem
which	O
is	O
consistent	O
with	O
SVT	B-Problem
.	O
	
He	O
was	O
given	O
Zosyn	B-Treatment
for	O
empiric	B-Treatment
treatment	I-Treatment
.	O
	
Gram	B-Test
stain	I-Test
and	O
culture	B-Test
of	O
the	B-Problem
ascites	I-Problem
failed	O
to	O
identify	O
any	B-Problem
organism	I-Problem
.	O
	
He	O
was	O
weaned	O
from	O
oxygen	B-Problem
requirement	I-Problem
and	O
was	O
continued	O
on	O
normal	B-Treatment
saline	I-Treatment
boluses	I-Treatment
and	O
	
intravenous	B-Treatment
albumin	I-Treatment
for	O
treatment	O
of	O
prerenal	B-Problem
azotemia	I-Problem
.	O
	
Somatostatin	B-Treatment
and	O
midodrine	B-Treatment
were	O
also	O
given	O
for	O
this	B-Problem
condition	I-Problem
and	O
he	O
also	O
received	O
packed	B-Treatment
red	I-Treatment
blood	I-Treatment
cells	I-Treatment
.	O
	
On	O
postoperative	O
day	O
number	O
ten	O
,	O
the	O
patient	O
returned	O
to	O
the	O
floor	O
with	O
improved	O
renal	O
function	O
and	O
without	O
oxygen	B-Problem
requirement	I-Problem
.	O
	
The	B-Treatment
somatostatin	I-Treatment
and	O
the	B-Treatment
midodrine	I-Treatment
were	O
discontinued	O
and	O
the	O
regimen	O
of	O
Lasix	B-Treatment
and	O
spironolactone	B-Treatment
was	O
started	O
for	O
diuresis	B-Treatment
.	O
	
His	B-Test
creatinine	I-Test
levels	I-Test
trended	O
toward	O
normal	O
and	O
the	B-Test
fractional	I-Test
excretion	I-Test
of	I-Test
sodium	I-Test
also	O
increased	O
indicating	O
a	O
resolution	O
of	O
the	B-Problem
prerenal	I-Problem
kidney	I-Problem
failure	I-Problem
.	O
	
On	O
postoperative	O
day	O
number	O
17	O
,	O
the	O
patient	O
was	O
discharged	O
.	O
	
At	O
the	O
time	O
he	O
took	O
good	O
po	O
.	O
	
He	O
has	O
a	B-Treatment
PICC	I-Treatment
line	I-Treatment
in	O
place	O
for	O
continued	O
treatment	O
with	O
Rocephin	B-Treatment
and	O
he	O
will	O
have	O
a	O
visiting	O
nurse	O
to	O
help	O
him	O
to	O
administer	O
these	B-Treatment
medications	I-Treatment
.	O
	
While	O
in	O
the	O
hospital	O
,	O
the	O
patient	O
received	O
initial	B-Test
work-up	I-Test
including	O
echocardiogram	B-Test
,	O
electrocardiogram	B-Test
and	O
serology	B-Test
studies	I-Test
to	O
be	O
listed	O
for	O
liver	B-Treatment
transplant	I-Treatment
.	O
	
MEDICATIONS	O
ON	O
DISCHARGE	O
:	O
	
1.	O
Rocephin	B-Treatment
1	O
gram	O
q.d.	O
	
2.	O
Furosemide	B-Treatment
10	O
mg	O
q.d.	O
	
3.	O
Spironolactone	B-Treatment
100	O
mg	O
q.d.	O
	
4.	O
Ursodiol	B-Treatment
600	O
mg	O
po	O
t.i.d.	O
	
CONDITION	O
ON	O
DISCHARGE	O
:	O
	
Stable	O
.	O
	
DISCHARGE	O
STATUS	O
:	O
	
To	O
home	O
with	O
services	O
.	O
	
DISCHARGE	O
DIAGNOSIS	O
:	O
	
PSC	B-Problem
,	O
status	O
post	O
hepaticojejunostomy	B-Treatment
.	O
	
Hope	O
Raymond	O
,	O
M.D.	O
,	O
Ph.D.	O
	
02-366	O
	
Dictated	O
By	O
:	O
Alden	O
B.	O
Edwards	O
,	O
M.D.	O
	
MEDQUIST36	O
	
D	O
:	O
2009-10-02	O
09:08	O
	
T	O
:	O
2009-10-02	O
09:08	O
	
JOB	O
#:	O
	
86749	O
	
Signed	O
electronically	O
by	O
:	O
DR.	O
Mary	O
Jones	O
on	O
:	O
SUN	O
2009-10-04	O
1:08	O
PM	O
	
(	O
End	O
of	O
Report	O
)	O
	
Admission	O
Date	O
:	O
	
2016-12-30	O
	
Discharge	O
Date	O
:	O
	
2017-01-13	O
	
Date	O
of	O
Birth	O
:	O
	
1960-09-05	O
	
Sex	O
:	O
	
M	O
	
Service	O
:	O
	
HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O
	
This	O
is	O
a	O
56	O
year	O
old	O
man	O
with	O
history	O
of	O
hypercholesterolemia	B-Problem
and	O
type	B-Problem
II	I-Problem
diabetes	I-Problem
mellitus	I-Problem
.	O
	
He	O
has	O
a	O
recent	O
history	O
of	O
dyspnea	B-Problem
on	O
exertion	O
on	O
exertional	B-Problem
chest	I-Problem
pain	I-Problem
which	O
has	O
increased	O
over	O
the	O
last	O
several	O
weeks	O
and	O
is	O
relieved	O
by	O
sublingual	B-Treatment
nitroglycerin	I-Treatment
.	O
	
On	O
2016-06-26	O
,	O
he	O
had	O
a	B-Problem
positive	I-Problem
exercise	I-Problem
tolerance	I-Problem
test	I-Problem
.	O
	
Cardiac	B-Test
catheterization	I-Test
at	O
the	O
end	O
of	O
October	O
revealed	O
a	B-Problem
dilated	I-Problem
aortic	I-Problem
root	I-Problem
to	O
4.4	O
cm	O
and	O
80%	B-Problem
stenosis	I-Problem
of	I-Problem
the	I-Problem
mid	I-Problem
left	I-Problem
anterior	I-Problem
descending	I-Problem
at	O
the	O
bifurcation	O
involving	O
the	O
diagonal	O
branch	O
,	O
70%	B-Problem
stenoses	I-Problem
of	I-Problem
the	I-Problem
left	I-Problem
circumflex	I-Problem
and	I-Problem
oblique	I-Problem
marginal	I-Problem
artery	I-Problem
and	O
90%	B-Problem
stenosis	I-Problem
of	I-Problem
the	I-Problem
posterior	I-Problem
descending	I-Problem
artery	I-Problem
.	O
	
His	B-Test
atrioventricular	I-Test
valve	I-Test
gradient	I-Test
was	O
27	O
with	O
an	B-Test
AV	I-Test
surface	I-Test
area	I-Test
of	O
.91	O
.	O
	
REVIEW	O
OF	O
SYSTEMS	O
:	O
	
Review	B-Test
of	I-Test
systems	I-Test
shows	O
that	O
the	O
patient	O
denies	O
any	B-Problem
orthopnea	I-Problem
,	O
paroxysmal	B-Problem
nocturnal	I-Problem
dyspnea	I-Problem
.	O
	
He	O
has	O
no	O
bleeding	B-Problem
or	O
clotting	B-Problem
problems	I-Problem
.	O
	
Juanita	O
does	O
not	O
feel	O
any	B-Problem
palpitations	I-Problem
.	O
	
He	O
does	O
not	O
have	O
wheezing	B-Problem
,	O
claudication	B-Problem
or	O
gastrointestinal	B-Problem
bleeding	I-Problem
.	O
	
Nor	O
does	O
he	O
have	O
any	O
history	O
of	O
stroke	B-Problem
like	I-Problem
symptoms	I-Problem
.	O
	
PAST	O
MEDICAL	O
HISTORY	O
:	O
	
Hypercholesterolemia	B-Problem
.	O
	
Type	B-Problem
II	I-Problem
diabetes	I-Problem
.	O
	
Recent	B-Problem
pneumonia	I-Problem
.	O
	
Remote	O
tobacco	O
use	O
.	O
	
Recent	B-Problem
weight	I-Problem
loss	I-Problem
associated	O
with	O
the	B-Problem
pneumonia	I-Problem
.	O
	
Gastroesophageal	B-Problem
reflux	I-Problem
disease	I-Problem
.	O
	
ALLERGIES	O
:	O
	
No	O
known	B-Problem
drug	I-Problem
allergies	I-Problem
.	O
	
MEDICATIONS	O
ON	O
ADMISSION	O
:	O
	
One	O
aspirin	B-Treatment
a	O
day	O
.	O
	
Nexium	B-Treatment
40	O
mg	O
a	O
day	O
.	O
	
Carvedilol	B-Treatment
6.125	O
mg	O
a	O
day	O
.	O
	
Glucophage	B-Treatment
25	O
mg	O
once	O
a	O
day	O
.	O
	
Lipitor	B-Treatment
10	O
mg	O
once	O
a	O
day	O
.	O
	
SOCIAL	O
HISTORY	O
:	O
	
He	O
lives	O
with	O
his	O
wife	O
and	O
works	O
as	O
a	O
drug	O
representative	O
for	O
Carvedilol	O
.	O
	
PHYSICAL	O
EXAMINATION	O
:	O
	
On	O
physical	B-Test
examination	I-Test
,	O
the	O
patient	O
is	O
afebrile	B-Problem
.	O
	
Weight	B-Test
is	O
82	O
kilograms	O
.	O
	
Blood	B-Test
pressure	I-Test
126/66	O
.	O
	
General	O
:	O
	
Active	O
,	O
well-developed	O
,	O
well-nourished	O
male	O
.	O
	
Head	B-Test
and	I-Test
neck	I-Test
examination	I-Test
:	O
	
No	O
bruits	B-Problem
appreciated	O
.	O
	
Lungs	O
are	O
clear	O
to	O
auscultation	B-Test
bilaterally	O
.	O
	
Heart	O
was	O
regular	O
rate	O
and	O
rhythm	O
.	O
	
S1	O
and	O
S2	O
.	O
	
3/6	B-Problem
systolic	I-Problem
ejection	I-Problem
murmur	I-Problem
throughout	O
his	O
precordium	O
.	O
	
His	O
abdomen	O
is	O
soft	O
,	O
nontender	B-Problem
,	O
nondistended	B-Problem
.	O
	
No	O
hepatosplenomegaly	B-Problem
and	O
no	O
CVA	B-Problem
tenderness	I-Problem
.	O
	
Extremities	O
are	O
warm	O
,	O
well	O
perfused	O
,	O
no	O
cyanosis	B-Problem
,	O
clubbing	B-Problem
or	O
	
edema	B-Problem
.	O
	
Palpable	O
dorsalis	O
pedis	O
pulses	O
.	O
	
No	O
varicosities	B-Problem
noted	O
.	O
	
The	O
patient	O
was	O
also	O
noted	O
to	O
be	O
right	O
handed	O
.	O
	
HOSPITAL	O
COURSE	O
:	O
	
He	O
was	O
admitted	O
to	O
the	O
cardiac	O
surgery	O
service	O
for	O
an	B-Treatment
elected	I-Treatment
Bental	I-Treatment
procedure	I-Treatment
with	O
homograft	B-Treatment
and	O
coronary	B-Treatment
artery	I-Treatment
bypass	I-Treatment
graft	I-Treatment
.	O
	
Once	O
consent	O
and	O
preoperative	B-Test
evaluation	I-Test
was	O
complete	O
,	O
he	O
was	O
taken	O
to	O
the	O
operating	O
room	O
.	O
	
Please	O
refer	O
to	O
the	O
previously	O
dictated	O
operative	O
note	O
of	O
2016-12-30	O
by	O
Dr.	O
Lawrence	O
.	O
	
Briefly	O
,	O
the	O
patient	O
was	O
taken	O
to	O
the	O
operating	O
room	O
to	O
repair	B-Treatment
his	B-Problem
critical	I-Problem
aortic	I-Problem
stenosis	I-Problem
,	O
his	B-Problem
coronary	I-Problem
artery	I-Problem
disease	I-Problem
and	O
his	B-Problem
significantly	I-Problem
dilated	I-Problem
ascending	I-Problem
aortic	I-Problem
aneurysm	I-Problem
.	O
	
The	B-Treatment
procedure	I-Treatment
was	O
an	B-Treatment
aortic	I-Treatment
valve	I-Treatment
replacement	I-Treatment
with	O
a	B-Treatment
tissue	I-Treatment
valve	I-Treatment
,	O
a	B-Treatment
coronary	I-Treatment
artery	I-Treatment
bypass	I-Treatment
graft	I-Treatment
procedure	I-Treatment
where	O
five	B-Treatment
grafts	I-Treatment
were	O
performed	O
.	O
	
The	O
left	O
internal	O
mammary	O
artery	O
was	O
connected	O
to	O
the	O
proximal	O
left	O
anterior	O
descending	O
and	O
saphenous	B-Treatment
vein	I-Treatment
grafts	I-Treatment
were	O
connected	O
to	O
the	O
posterior	O
descending	O
artery	O
,	O
diagonal	O
branch	O
,	O
obtuse	O
marginal	O
and	O
distal	O
left	O
anterior	O
descending	O
.	O
	
Finally	O
,	O
a	B-Treatment
super	I-Treatment
coronary	I-Treatment
arch	I-Treatment
graft	I-Treatment
was	O
implanted	O
.	O
	
This	O
was	O
a	B-Treatment
....................	I-Treatment
graft	I-Treatment
.	O
	
Cardiopulmonary	B-Treatment
bypass	I-Treatment
time	O
was	O
234	O
minutes	O
.	O
	
His	O
aorta	O
was	O
cross	B-Treatment
clamped	I-Treatment
for	O
168	O
minutes	O
.	O
	
He	O
had	O
pharmacologic	B-Treatment
circulatory	I-Treatment
arrest	I-Treatment
for	O
18	O
minutes	O
.	O
	
The	O
patient	O
tolerated	O
the	B-Treatment
procedure	I-Treatment
well	O
and	O
was	O
transferred	O
to	O
the	O
unit	O
,	O
intubated	B-Treatment
on	O
Milrinone	B-Treatment
,	O
Levophed	B-Treatment
and	O
Propofol	B-Treatment
drips	I-Treatment
.	O
	
The	O
rest	O
of	O
the	O
hospital	O
stay	O
can	O
be	O
discussed	O
in	O
terms	O
of	O
system	O
based	O
approach	O
.	O
	
Pulmonary	O
:	O
	
The	O
patient	O
remained	O
intubated	B-Treatment
until	O
postoperative	O
day	O
number	O
five	O
.	O
	
After	O
that	O
,	O
the	O
patient	O
had	O
no	O
major	B-Problem
problems	I-Problem
with	I-Problem
his	I-Problem
lungs	I-Problem
.	O
	
His	B-Test
oxygen	I-Test
saturations	I-Test
remained	O
good	O
and	O
he	O
did	O
not	O
require	O
supplemental	B-Treatment
oxygen	I-Treatment
more	O
than	O
a	O
couple	O
of	O
days	O
after	O
his	O
extubation	O
.	O
	
He	O
was	O
sent	O
to	O
the	O
floor	O
from	O
the	O
cardiac	O
surgery	O
recovery	O
unit	O
on	O
postoperative	O
day	O
number	O
seven	O
.	O
	
After	O
an	O
extended	O
stay	O
for	O
hemodynamic	B-Test
monitoring	I-Test
and	O
pressor	B-Treatment
support	I-Treatment
to	O
maintain	O
his	O
perfusion	O
.	O
	
Neurologic	O
:	O
	
The	B-Problem
major	I-Problem
neurologic	I-Problem
event	I-Problem
of	O
this	O
hospital	O
course	O
was	O
that	O
the	O
patient	O
was	O
slow	B-Problem
to	I-Problem
awake	I-Problem
after	O
his	B-Treatment
Propofol	I-Treatment
drip	I-Treatment
was	O
discontinued	O
.	O
	
Because	O
of	O
his	B-Problem
confusion	I-Problem
,	O
a	O
neurology	O
consult	O
was	O
obtained	O
and	O
subsequent	B-Test
radiographic	I-Test
imaging	I-Test
revealed	O
chronic	B-Problem
appearing	I-Problem
infarcts	I-Problem
in	I-Problem
the	I-Problem
right	I-Problem
occipital	I-Problem
lobe	I-Problem
as	O
well	O
as	O
both	O
cerebellar	O
hemispheres	O
,	O
suggestive	O
of	O
more	B-Problem
chronic	I-Problem
infarcts	I-Problem
,	O
as	O
well	O
as	O
an	O
area	O
in	O
the	O
left	O
corona	O
radiata	O
,	O
adjacent	O
to	O
the	O
left	O
lateral	O
ventricle	O
which	O
may	O
or	O
may	O
not	O
be	O
an	B-Problem
acute	I-Problem
infarct	I-Problem
.	O
	
This	O
was	O
seen	O
on	O
the	B-Test
CAT	I-Test
scan	I-Test
on	O
postoperative	O
day	O
number	O
one	O
,	O
12-31	O
.	O
	
As	O
the	O
patient	O
became	O
more	O
awake	O
,	O
he	O
still	O
remained	O
somewhat	B-Problem
confused	I-Problem
and	O
a	B-Problem
little	I-Problem
bit	I-Problem
out	I-Problem
of	I-Problem
it	I-Problem
.	O
	
In	O
addition	O
,	O
he	O
was	O
noted	O
to	O
have	O
a	B-Problem
right	I-Problem
sided	I-Problem
hemiplegia	I-Problem
.	O
	
Over	O
his	O
postoperative	O
course	O
,	O
Mr.	O
Douglass	O
has	O
gradually	O
been	O
able	O
to	O
utilize	O
more	O
and	O
more	O
of	O
his	O
right	O
side	O
and	O
with	O
the	O
assistance	O
of	O
physical	B-Treatment
therapy	I-Treatment
and	O
occupational	B-Treatment
therapy	I-Treatment
,	O
he	O
has	O
4	O
to	O
5	O
+	O
strength	O
in	O
his	O
right	O
hand	O
and	O
arm	O
and	O
about	O
4	O
+	O
strength	O
in	O
his	O
right	O
leg	O
.	O
	
He	O
is	O
able	O
to	O
walk	O
about	O
the	O
floor	O
on	O
the	O
days	O
prior	O
to	O
discharge	O
,	O
with	O
the	O
assistance	O
of	O
the	O
physical	O
therapist	O
and	O
nurses	O
.	O
	
In	O
addition	O
,	O
Mr.	O
Douglass	O
is	O
given	O
Trazodone	B-Treatment
to	O
help	O
him	O
sleep	O
at	O
night	O
.	O
	
A	O
psychiatric	O
consult	O
was	O
also	O
obtained	O
due	O
to	O
his	O
mental	O
status	O
and	O
confusion	B-Problem
postoperatively	O
but	O
his	B-Problem
psychiatric	I-Problem
issues	I-Problem
are	O
mostly	O
related	O
to	O
his	B-Problem
neurologic	I-Problem
insults	I-Problem
and	O
he	O
has	O
no	O
distinctive	B-Problem
psychiatric	I-Problem
disorder	I-Problem
,	O
except	O
for	O
perhaps	O
postoperative	B-Problem
delirium	I-Problem
.	O
	
Cardiovascularly	O
,	O
the	O
patient	O
did	O
extremely	O
well	O
following	O
the	B-Treatment
surgery	I-Treatment
.	O
	
The	B-Treatment
Levophed	I-Treatment
drip	I-Treatment
was	O
continued	O
until	O
postoperative	O
day	O
number	O
one	O
.	O
	
Milrinone	B-Treatment
was	O
continued	O
until	O
postoperative	O
day	O
number	O
three	O
,	O
at	O
which	O
point	O
he	O
was	O
having	O
good	O
enough	O
cardiac	O
output	O
that	O
he	O
did	O
not	O
need	O
these	B-Treatment
drips	I-Treatment
to	O
help	O
maintain	O
his	B-Test
blood	I-Test
pressure	I-Test
anymore	O
.	O
	
He	O
has	O
remained	O
without	O
any	B-Problem
chest	I-Problem
pain	I-Problem
following	O
this	B-Treatment
procedure	I-Treatment
and	O
his	B-Problem
sternal	I-Problem
wound	I-Problem
is	O
clean	O
,	O
dry	O
and	O
intact	O
at	O
the	O
end	O
of	O
the	B-Treatment
procedure	I-Treatment
.	O
	
In	O
addition	O
,	O
he	O
has	O
hypertension	B-Problem
,	O
for	O
which	O
he	O
receives	O
Metoprolol	B-Treatment
and	O
he	O
has	O
hypercholesterolemia	B-Problem
,	O
for	O
which	O
he	O
receives	O
nothing	O
at	O
this	O
time	O
.	O
	
Pulmonary	O
:	O
	
The	O
patient	O
remained	O
intubated	B-Treatment
until	O
postoperative	O
day	O
number	O
five	O
.	O
	
He	O
was	O
diuresed	O
and	O
was	O
soon	O
saturating	O
very	O
well	O
on	O
room	O
air	O
.	O
	
Gastrointestinal	O
:	O
	
The	O
patient	O
has	O
gastroesophageal	B-Problem
reflux	I-Problem
disease	I-Problem
,	O
for	O
which	O
he	O
has	O
been	O
receiving	O
Zantac	B-Treatment
as	O
an	O
inpatient	O
.	O
	
We	O
will	O
put	O
him	O
back	O
on	O
his	B-Treatment
Nexium	I-Treatment
.	O
	
In	O
addition	O
,	O
over	O
the	O
last	O
couple	O
of	O
days	O
prior	O
to	O
discharge	O
,	O
the	O
patient	O
did	O
appear	O
a	B-Problem
little	I-Problem
bit	I-Problem
icteric	I-Problem
.	O
	
Liver	B-Test
function	I-Test
tests	I-Test
were	O
obtained	O
and	O
they	O
were	O
slightly	B-Problem
elevated	I-Problem
liver	I-Problem
function	I-Problem
tests	I-Problem
and	O
ALT	B-Test
was	O
44	O
,	O
AST	B-Test
was	O
34	O
;	O
alkaline	B-Test
phosphatase	I-Test
was	O
199	O
,	O
within	O
normal	O
limits	O
.	O
	
Total	B-Test
bilirubin	I-Test
was	O
2.8	O
.	O
	
Amylase	B-Test
was	O
108	O
and	O
lipase	B-Test
was	O
213	O
.	O
	
A	B-Test
right	I-Test
upper	I-Test
quadrant	I-Test
ultrasound	I-Test
did	O
not	O
reveal	O
any	B-Problem
gallstones	I-Problem
or	O
common	B-Problem
bile	I-Problem
duct	I-Problem
dilatation	I-Problem
indicative	O
of	O
cholecystitis	B-Problem
or	O
cholelithiasis	B-Problem
.	O
	
In	O
addition	O
,	O
the	O
patient	O
did	O
have	O
slightly	B-Problem
elevated	I-Problem
blood	I-Problem
sugars	I-Problem
over	O
the	O
last	O
couple	O
of	O
days	O
and	O
has	O
required	O
an	B-Treatment
insulin	I-Treatment
sliding	I-Treatment
scale	I-Treatment
and	O
basal	B-Treatment
insulin	I-Treatment
to	O
maintain	O
his	B-Test
blood	I-Test
sugars	I-Test
at	O
a	O
more	O
appropriate	O
level	O
.	O
	
The	O
ideal	O
blood	O
sugar	O
levels	O
for	O
Mr.	O
Douglass	O
in	O
this	O
postoperative	O
period	O
should	O
be	O
less	O
than	O
140	O
.	O
	
Please	O
stay	O
on	O
top	O
of	O
the	B-Treatment
sliding	I-Treatment
scale	I-Treatment
so	O
that	O
the	O
patient	O
can	O
keep	O
a	O
euglycemic	O
level	O
.	O
	
Hematologic	O
:	O
	
The	O
patient	O
,	O
during	O
this	O
admission	O
,	O
required	O
transfusion	O
of	O
three	O
units	O
of	O
packed	B-Treatment
red	I-Treatment
blood	I-Treatment
cells	I-Treatment
to	O
maintain	O
adequate	O
hematocrit	O
.	O
	
At	O
the	O
time	O
of	O
discharge	O
,	O
Mr.	O
Norman	O
hematocrit	B-Test
is	O
at	O
40.7	O
.	O
	
Fluids	O
,	O
electrolytes	O
and	O
nutrition	O
:	O
	
The	O
patient	O
did	O
receive	O
a	O
significant	O
amount	O
of	O
diuresis	B-Treatment
postoperatively	O
and	O
is	O
well	O
below	O
his	O
baseline	O
with	O
weight	B-Test
,	O
most	O
likely	O
because	O
of	O
his	B-Problem
inability	I-Problem
to	I-Problem
eat	I-Problem
because	O
of	O
his	B-Problem
stroke	I-Problem
.	O
	
Once	O
he	O
was	O
coherent	O
enough	O
,	O
the	O
patient	O
was	O
evaluated	O
by	O
the	O
swallow	O
team	O
who	O
	
declared	O
him	O
at	O
first	O
an	B-Problem
aspiration	I-Problem
risk	I-Problem
.	O
	
As	O
Mr.	O
Douglass	O
has	O
improved	O
from	O
his	B-Problem
initial	I-Problem
stroke	I-Problem
,	O
he	O
has	O
become	O
more	O
lucid	O
	
and	O
is	O
less	O
of	O
an	B-Problem
aspiration	I-Problem
risk	I-Problem
.	O
	
On	O
01-12	O
,	O
one	O
day	O
prior	O
to	O
discharge	O
,	O
he	O
was	O
cleared	O
by	O
the	O
swallow	O
team	O
to	O
eat	O
	
a	O
diet	O
as	O
he	O
wishes	O
.	O
	
He	O
is	O
going	O
out	O
on	O
a	B-Treatment
cardiac	I-Treatment
healthy	I-Treatment
,	I-Treatment
diabetic	I-Treatment
diet	I-Treatment
,	O
as	O
tolerated	O
with	O
Boost	B-Treatment
supplements	I-Treatment
.	O
	
Infectious	O
disease	O
:	O
	
The	O
patient	O
had	O
positive	B-Problem
blood	I-Problem
and	I-Problem
urine	I-Problem
cultures	I-Problem
on	O
01-05	O
for	O
history	O
of	O
Methicillin	B-Problem
resistant	I-Problem
Staphylococcus	I-Problem
aureus	I-Problem
,	O
which	O
was	O
pan	B-Test
sensitive	I-Test
.	O
	
He	O
was	O
started	O
on	O
Oct.	O
25	O
for	O
this	B-Problem
bug	I-Problem
.	O
	
On	O
01-08	O
,	O
the	B-Treatment
patient	I-Treatment
's	I-Treatment
central	I-Treatment
venous	I-Treatment
line	I-Treatment
was	O
discontinued	O
.	O
	
The	B-Test
catheterization	I-Test
tip	I-Test
also	O
grew	O
out	O
Serratia	B-Problem
.	O
	
On	O
the	O
16th	O
,	O
a	B-Test
urine	I-Test
culture	I-Test
was	O
obtained	O
and	O
did	O
grow	O
out	O
greater	O
than	O
100,000	O
colonies	O
of	O
E.	B-Problem
coli	I-Problem
which	O
was	O
intermittently	B-Problem
resistant	I-Problem
to	O
Ciprofloxacin	B-Treatment
.	O
	
He	O
was	O
started	O
on	O
Bactrim	B-Treatment
for	O
that	O
.	O
	
Please	O
continue	O
Mr.	O
David	O
Montero	O
for	O
one	O
month	O
to	O
fight	O
his	B-Problem
blood	I-Problem
borne	I-Problem
infection	I-Problem
,	O
to	O
prevent	O
seeding	O
of	O
his	B-Treatment
aortic	I-Treatment
graft	I-Treatment
and	O
continue	O
Bactrim	B-Treatment
for	O
ten	O
days	O
after	O
discharge	O
to	O
treat	O
the	B-Problem
E.	I-Problem
coli	I-Problem
in	I-Problem
his	I-Problem
urine	I-Problem
.	O
	
DISPOSITION	O
:	O
	
Mr.	O
Douglass	O
is	O
being	O
discharged	O
on	O
2017-01-13	O
to	O
a	O
rehabilitation	O
facility	O
in	O
good	O
condition	O
.	O
	
FOLLOW-UP	O
:	O
	
One	O
to	O
two	O
weeks	O
with	O
his	O
primary	O
care	O
physician	O
and	O
two	O
to	O
three	O
weeks	O
with	O
his	O
cardiologist	O
and	O
at	O
one	O
month	O
with	O
Dr.	O
Costello	O
.	O
	
DISCHARGE	O
DIAGNOSES	O
:	O
	
Coronary	B-Problem
artery	I-Problem
disease	I-Problem
,	O
status	O
post	O
coronary	B-Treatment
artery	I-Treatment
bypass	I-Treatment
graft	I-Treatment
.	O
	
Critical	B-Problem
aortic	I-Problem
stenosis	I-Problem
,	O
status	O
post	O
aortic	B-Treatment
valve	I-Treatment
replacement	I-Treatment
.	O
	
Aortic	B-Problem
arch	I-Problem
aneurysm	I-Problem
,	O
status	O
post	O
aortic	B-Treatment
arch	I-Treatment
graft	I-Treatment
.	O
	
Acute	B-Problem
postoperative	I-Problem
delirium	I-Problem
.	O
	
Perioperative	B-Problem
stroke	I-Problem
.	O
	
Chronic	B-Problem
blood	I-Problem
loss	I-Problem
anemia	I-Problem
and	O
chronic	B-Treatment
RBC	I-Treatment
transfusion	I-Treatment
.	O
	
Urinary	B-Problem
tract	I-Problem
infection	I-Problem
.	O
	
Hypercholesterolemia	B-Problem
.	O
	
Type	B-Problem
II	I-Problem
diabetes	I-Problem
.	O
	
Gastroesophageal	B-Problem
reflux	I-Problem
disease	I-Problem
.	O
	
DISCHARGE	O
MEDICATIONS	O
:	O
	
Metoprolol	B-Treatment
75	O
mg	O
p.o.	O
twice	O
a	O
day	O
.	O
	
Captopril	B-Treatment
12.5	O
mg	O
p.o.	O
three	O
times	O
a	O
day	O
.	O
	
Aspirin	B-Treatment
81	O
mg	O
p.o.	O
q.	O
day	O
.	O
	
Plavix	B-Treatment
75	O
mg	O
p.o.	O
q.	O
day	O
.	O
	
Heparin	B-Treatment
5000	O
units	O
subcutaneous	O
twice	O
a	O
day	O
.	O
	
Metformin	B-Treatment
1000	O
mg	O
extended	O
release	O
p.o.	O
q.	O
day	O
.	O
	
Humalog	B-Treatment
Max	I-Treatment
75/25	O
,	O
20	O
units	O
subcutaneous	O
once	O
a	O
day	O
in	O
the	O
morning	O
.	O
	
Levofloxacin	B-Treatment
500	O
mg	O
p.o.	O
q.	O
day	O
.	O
	
Bactrim	B-Treatment
DS	I-Treatment
tabs	I-Treatment
,	O
one	O
tablet	O
p.o.	O
q.	O
day	O
for	O
ten	O
days	O
.	O
	
Colace	B-Treatment
100	O
mg	O
p.o.	O
twice	O
a	O
day	O
.	O
	
Hold	O
for	O
loose	B-Problem
stools	I-Problem
.	O
	
Nexium	B-Treatment
40	O
mg	O
p.o.	O
q.	O
day	O
.	O
	
Trazodone	B-Treatment
25	O
mg	O
p.o.	O
q	O
h.s.	O
as	O
needed	O
for	O
sleep	O
.	O
	
Lasix	B-Treatment
20	O
mg	O
p.o.	O
q.	O
day	O
for	O
one	O
week	O
.	O
	
KCl	B-Treatment
20	O
mg	O
p.o.	O
q.	O
day	O
for	O
one	O
week	O
.	O
	
Dolly	O
V	O
Blevins	O
,	O
M.D.	O
	
04-100	O
	
Dictated	O
By	O
:	O
Kenneth	O
O.	O
Hogan	O
,	O
M.D.	O
	
MEDQUIST36	O
	
D	O
:	O
2017-01-12	O
11:35	O
	
T	O
:	O
2017-01-13	O
05:30	O
	
JOB	O
#:	O
	
92344	O
	
Signed	O
electronically	O
by	O
:	O
DR.	O
Dolly	O
D.F.	O
Sipes	O
on:	O
Roxane	O
2017-02-21	O
11:52	O
AM	O
	
(	O
End	O
of	O
Report	O
)	O
	
Admission	O
Date	O
:	O
	
2014-02-21	O
	
Discharge	O
Date	O
:	O
	
2014-03-25	O
	
Date	O
of	O
Birth	O
:	O
	
1928-07-25	O
	
Sex	O
:	O
	
F	O
	
Service	O
:	O
	
SURGERY	O
	
Allergies	O
:	O
	
Sulfa	B-Treatment
(	I-Treatment
Sulfonamides	I-Treatment
)	I-Treatment
	
Attending	O
:	O
Mattie	O
R.	O
A.	O
Hamilton	O
,	O
M.D.	O
	
Chief	O
Complaint	O
:	O
	
Nausea	B-Problem
,	O
vomiting	B-Problem
,	O
Abdominal	B-Problem
pain	I-Problem
,	O
distention	B-Problem
.	O
	
Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O
	
1.	O
Subtotal	B-Treatment
colectomy	I-Treatment
,	O
end	B-Treatment
ileostomy	I-Treatment
,	O
Hartmann's	B-Treatment
pouch	I-Treatment
,	O
G-tube	B-Treatment
	
2.	O
Completion	B-Treatment
sigmoid	I-Treatment
colectomy	I-Treatment
,	O
repair	B-Treatment
of	O
colovesicular	B-Problem
fistula	I-Problem
,	O
small	B-Treatment
bowel	I-Treatment
repair	I-Treatment
	
History	O
of	O
Present	O
Illness	O
:	O
	
Ms	O
Crossman	O
is	O
an	O
84	O
year	O
old	O
female	O
with	O
complaints	O
of	O
abdominal	B-Problem
pain	I-Problem
,	O
diarrhea	B-Problem
,	O
nausea	B-Problem
and	O
vomiting	B-Problem
x	O
1	O
week	O
,	O
who	O
presented	O
to	O
an	O
outside	O
hospital	O
.	O
	
She	O
was	O
transferred	O
to	O
Arbour	O
Hospital	O
on	O
2015-02-21	O
for	O
bowel	B-Problem
obstruction	I-Problem
,	O
ischemia	B-Problem
and	O
worsening	B-Problem
abdominal	I-Problem
distention	I-Problem
and	O
pain	B-Problem
.	O
	
Past	O
Medical	O
History	O
:	O
	
CAD	B-Problem
s/p	O
MI	B-Problem
,	O
HTN	B-Problem
,	O
DMII	B-Problem
	
Social	O
History	O
:	O
	
Lives	O
independently	O
,	O
but	O
in	O
the	O
same	O
building	O
with	O
daughter	O
.	O
	
Amy	O
3	O
children	O
,	O
2	O
daughters	O
and	O
1	O
son	O
.	O
	
Daughter	O
Lurline	O
is	O
Durable	O
Power	O
of	O
Attorney	O
.	O
	
The	O
other	O
daughter	O
was	O
recently	O
in	O
a	O
car	O
accident	O
and	O
underwent	O
surgery	B-Treatment
at	O
Saint	O
Vincent	O
Hospital	O
.	O
	
Family	O
History	O
:	O
	
NC	O
	
Physical	O
Exam	O
:	O
	
At	O
time	O
of	O
discharge	O
:	O
	
Afebrile	B-Problem
,	O
VSS	O
	
A&O	O
X	O
3	O
,	O
NAD	B-Problem
	
RRR	O
	
CTAB	O
,	O
mildly	B-Problem
decreased	I-Problem
breath	I-Problem
sounds	I-Problem
b/l	I-Problem
	
Abd	O
soft	O
,	O
NT/ND	B-Problem
,	O
+	O
bs	O
,	O
no	O
masses	B-Problem
,	O
ostomy	B-Treatment
in	I-Treatment
RLQ	I-Treatment
pink	O
,	O
with	O
stool	O
	
G-tube	B-Treatment
in	O
place	O
	
LE	B-Problem
trace	I-Problem
edema	I-Problem
	
Pertinent	O
Results	O
:	O
	
2014-02-21	O
12:20	O
PM	O
BLOOD	B-Test
WBC	B-Test
-	O
10.2	O
RBC	B-Test
-	O
5.32	O
Hgb	B-Test
-	O
14.9	O
Hct	B-Test
-	O
43.4	O
MCV	B-Test
-	O
82	O
MCH	B-Test
-	O
28.0	O
MCHC	B-Test
-	O
34.4	O
RDW	B-Test
-	O
16.0	O
*	O
Plt	B-Test
Ct	I-Test
-	O
204	O
	
2014-02-21	O
12:20	O
PM	O
BLOOD	B-Test
PT	B-Test
-	O
12.9	O
PTT	B-Test
-	O
32.5	O
INR(PT)	B-Test
-	O
1.1	O
	
2014-02-21	O
12:20	O
PM	O
BLOOD	B-Test
Glucose	B-Test
-	O
345	O
*	O
UreaN	B-Test
-	O
34	O
*	O
Creat	B-Test
-	O
1.0	O
Na	B-Test
-	O
137	O
K	B-Test
-	O
4.3	O
Cl	B-Test
-	O
99	O
HCO3	B-Test
-	O
24	O
AnGap	B-Test
-	O
18	O
	
2014-02-21	O
12:20	O
PM	O
BLOOD	B-Test
ALT	B-Test
-	O
17	O
AST	B-Test
-	O
27	O
AlkPhos	B-Test
-	O
119	O
*	O
Amylase	B-Test
-	O
27	O
TotBili	B-Test
-	O
0.9	O
	
2014-02-21	O
12:20	O
PM	O
BLOOD	B-Test
Lipase	B-Test
-	O
11	O
	
2014-02-21	O
12:20	O
PM	O
BLOOD	B-Test
CK-MB	B-Test
-	O
7	O
cTropnT	B-Test
-<	O
0.01	O
	
2014-03-09	O
02:59	O
AM	O
BLOOD	B-Test
cTropnT	B-Test
-	O
0.21	O
*	O
	
2014-03-09	O
11:29	O
AM	O
BLOOD	B-Test
CK-MB	B-Test
-	O
35	O
*	O
MB	B-Test
Indx	I-Test
-	O
25.5	O
*	O
cTropnT	B-Test
-	O
0.45	O
*	O
	
2014-03-09	O
07:52	O
PM	O
BLOOD	B-Test
CK-MB	B-Test
-	O
NotDone	O
cTropnT	B-Test
-	O
0.55	O
*	O
	
2014-03-10	O
05:25	O
PM	O
BLOOD	B-Test
cTropnT	B-Test
-	O
0.42	O
*	O
	
2014-03-11	O
02:00	O
AM	O
BLOOD	B-Test
cTropnT	B-Test
-	O
0.45	O
*	O
	
2014-03-19	O
07:13	O
AM	O
BLOOD	B-Test
CK-MB	B-Test
-	O
3	O
cTropnT	B-Test
-	O
0.19	O
*	O
	
2014-03-19	O
01:33	O
PM	O
BLOOD	B-Test
CK-MB	B-Test
-	O
NotDone	O
cTropnT	B-Test
-	O
0.17	O
*	O
	
2014-03-21	O
09:58	O
AM	O
BLOOD	B-Test
CK-MB	B-Test
-	O
NotDone	O
cTropnT	B-Test
-	O
0.06	O
*	O
	
03-07	O
wound	B-Test
swab	I-Test
:	O
VRE	B-Problem
	
CT	B-Test
Abd	I-Test
02-21	O
:	O
	
1.	O
Markedly	B-Problem
dilated	I-Problem
colon	I-Problem
throughout	O
ascending	O
,	O
transverse	O
,	O
and	O
descending	O
colon	O
with	O
air-fluid	B-Problem
levels	I-Problem
,	O
overall	O
unchanged	O
since	O
prior	B-Test
study	I-Test
performed	O
on	O
the	O
same	O
day	O
with	O
pneumatosis	B-Problem
in	I-Problem
the	I-Problem
ascending	I-Problem
colon	I-Problem
.	O
	
Sigmoid	B-Problem
diverticulosis	I-Problem
with	O
focal	B-Problem
narrowing	I-Problem
of	I-Problem
the	I-Problem
sigmoid	I-Problem
colon	I-Problem
just	O
distal	O
to	O
the	B-Problem
dilatation	I-Problem
with	O
wall	B-Problem
thickening	I-Problem
,	O
due	O
to	O
diverticulitis	B-Problem
.	O
	
This	O
area	O
can	O
be	O
a	O
leading	O
point	O
of	O
obstruction	B-Problem
.	O
	
An	B-Problem
underlying	I-Problem
mass	I-Problem
lesion	I-Problem
or	O
cancer	B-Problem
cannot	O
be	O
excluded	O
in	O
this	O
area	O
,	O
and	O
further	B-Test
clinical	I-Test
investigation	I-Test
is	O
recommended	O
.	O
	
2.	O
Limited	B-Test
evaluation	I-Test
for	O
known	B-Problem
sigmoid-vesicle	I-Problem
fistula	I-Problem
.	O
	
3.	O
Small	B-Problem
amount	I-Problem
of	I-Problem
ascites	I-Problem
,	O
somewhat	O
increased	O
anterior	O
to	O
the	O
liver	O
.	O
	
4.	O
Bilateral	B-Problem
renal	I-Problem
cysts	I-Problem
.	O
	
5.	O
Heavy	B-Problem
calcification	I-Problem
of	I-Problem
the	I-Problem
aorta	I-Problem
and	I-Problem
SMA	I-Problem
and	I-Problem
its	I-Problem
branches	I-Problem
.	O
	
Due	O
to	O
atherosclerosis	B-Problem
,	O
assessment	B-Test
of	I-Test
the	I-Test
intraluminal	I-Test
process	I-Test
of	O
these	O
branches	O
is	O
limited	O
.	O
	
CTA/CT	B-Test
abd	I-Test
03-07	O
:	O
	
1.	O
No	O
evidence	O
of	O
pulmonary	B-Problem
embolism	I-Problem
.	O
	
Small	B-Problem
bilateral	I-Problem
pleural	I-Problem
effusions	I-Problem
with	O
compressive	B-Problem
atelectasis	I-Problem
.	O
	
2.	O
Left	B-Problem
lower	I-Problem
quadrant	I-Problem
thick-walled	I-Problem
peripherally	I-Problem
enhancing	I-Problem
fluid	I-Problem
collection	I-Problem
,	O
which	O
appears	O
to	O
communicate	O
with	O
the	O
sutured	O
end	O
of	O
the	O
proximal	O
sigmoid	O
colon	O
via	O
a	B-Problem
small	I-Problem
collection	I-Problem
of	I-Problem
extraluminal	I-Problem
gas	I-Problem
.	O
	
In	O
the	O
correct	O
clincial	O
setting	O
,	O
this	O
could	O
be	O
consistent	O
with	O
an	B-Problem
abscess	I-Problem
.	O
	
3.	O
Moderate	B-Problem
intraabdominal	I-Problem
ascites	I-Problem
.	O
	
4.	O
Status	O
post	O
ileostomy	B-Treatment
without	O
evidence	O
of	O
small-bowel	B-Problem
obstruction	I-Problem
.	O
	
5.	O
Distended	B-Problem
gallbladder	I-Problem
.	O
	
6.	O
Diverticulosis	B-Problem
within	I-Problem
the	I-Problem
right	I-Problem
remnant	I-Problem
sigmoid	I-Problem
colon	I-Problem
.	O
	
03-21	O
VCUG	B-Test
-	O
no	O
leak	B-Problem
	
Brief	O
Hospital	O
Course	O
:	O
	
Ms	O
Crossman	O
was	O
admitted	O
on	O
2015-02-21	O
from	O
an	O
outside	O
hospital	O
to	O
the	O
ICU	O
.	O
	
Neuro	O
:	O
Developed	O
confusion	B-Problem
during	O
her	O
first	O
5	O
days	O
in	O
the	O
ICU	O
.	O
	
Post-operatively	O
mental	O
status	O
improved	O
.	O
	
Intermitent	B-Problem
delirium	I-Problem
throughout	O
admission	O
.	O
	
Required	O
restraints	B-Treatment
to	O
prevent	O
DC	O
of	O
pertinent	B-Treatment
therapies	I-Treatment
while	O
in	O
the	O
ICU	O
.	O
	
Currently	O
AAOx3	O
.	O
	
Cardiovascular	O
:	O
Complained	O
of	O
chest	B-Problem
pain	I-Problem
during	O
first	O
few	O
days	O
of	O
admission	O
,	O
a	O
cardiology	O
consult	O
was	O
obtained	O
.	O
	
She	O
recieved	O
serial	B-Test
enzymes	I-Test
and	O
EKGs	B-Test
.	O
	
Troponins	B-Test
remained	O
mildly	B-Problem
elevated	I-Problem
as	O
high	O
as	O
0.6	O
throughout	O
her	O
admission	O
,	O
and	O
most	O
recent	O
result	O
now	O
0.1	O
.	O
	
She	O
was	O
treated	O
in	O
IUC	O
for	O
unstable	B-Problem
angina	I-Problem
with	O
nitroglycerin	B-Treatment
.	O
	
It	O
was	O
recommended	O
to	O
maximize	O
her	B-Treatment
medical	I-Treatment
treatment	I-Treatment
with	O
Beta	B-Treatment
blockers	I-Treatment
,	O
aspirin	B-Treatment
,	O
a	B-Treatment
statin	I-Treatment
and	O
an	B-Treatment
ACE	I-Treatment
Inhibitor	I-Treatment
.	O
	
Required	O
diuresis	B-Treatment
of	O
>	O
9	O
L	O
while	O
in	O
the	O
ICU	O
,	O
after	O
2nd	B-Treatment
surgery	I-Treatment
.	O
	
Continues	O
to	O
have	O
trace	B-Problem
lower	I-Problem
extremity	I-Problem
edema	I-Problem
,	O
and	O
recieves	O
lasix	B-Treatment
po	I-Treatment
.	O
	
Respiratory	O
:	O
She	O
was	O
intubated	B-Treatment
briefly	O
post-op	O
subtotal	B-Treatment
colectomy	I-Treatment
and	O
again	O
for	O
several	O
days	O
after	O
second	B-Treatment
surgery	I-Treatment
.	O
	
Recieved	O
nebulizer	B-Treatment
treatments	I-Treatment
post-op	O
in	O
the	O
ICU	O
,	O
after	O
successfully	O
extubated	O
.	O
	
Gastrointestinal	O
:	O
Her	B-Test
initial	I-Test
CT	I-Test
scan	I-Test
showed	O
dilated	B-Problem
Turner	I-Problem
colon	I-Problem
,	O
wall	B-Problem
thickening	I-Problem
and	O
pneumatosis	B-Problem
see	O
pertinent	O
results	O
.	O
	
She	O
was	O
initially	O
treated	O
nonoperatively	O
with	O
IV	B-Treatment
fluids	I-Treatment
,	O
antibiotics	B-Treatment
,	O
serial	B-Test
exams	I-Test
and	O
NGT	B-Treatment
decompression	I-Treatment
.	O
	
On	O
HD#5	O
flexible	B-Test
sigmoidoscopy	I-Test
was	O
performed	O
for	O
colonic	B-Treatment
decompression	I-Treatment
.	O
	
On	O
HD#6	O
,	O
colonscopy	B-Test
was	O
performed	O
for	O
decompression	B-Treatment
,	O
and	O
revealed	O
pseudomembrane	B-Problem
and	O
friable	B-Problem
colonic	I-Problem
tissue	I-Problem
.	O
	
Her	O
abdomen	O
remained	O
tender	B-Problem
and	O
distended	B-Problem
despite	O
attempted	O
decompression	B-Treatment
.	O
	
She	O
was	O
taken	O
to	O
the	O
OR	O
for	O
Subtotal	B-Treatment
Colectomy	I-Treatment
,	O
G	B-Treatment
tube	I-Treatment
and	O
ileostomy	B-Treatment
due	O
to	O
unresponsiveness	B-Problem
to	O
non-operative	B-Treatment
treatment	I-Treatment
.	O
	
Ileostomy	B-Treatment
remains	O
pink	O
and	O
intact	O
,	O
draining	O
green-brown	O
soft	O
stool	O
.	O
	
Her	O
post-operative	O
course	O
continued	O
uneventfully	O
in	O
the	O
ICU	O
,	O
and	O
she	O
was	O
transferred	O
to	O
the	O
floor	O
POD#6	O
.	O
	
She	O
developed	O
additional	B-Problem
abdominal	I-Problem
tenderness	I-Problem
and	O
distention	B-Problem
.	O
	
Her	B-Test
HCT	I-Test
dropped	O
and	O
she	O
recieved	O
1	B-Treatment
unit	I-Treatment
PRBCs	I-Treatment
.	O
	
Geriatric	O
consult	O
was	O
obtained	O
to	O
assist	O
with	O
management	O
.	O
	
On	O
POD#8	O
a	B-Test
CT	I-Test
scan	I-Test
was	O
obtained	O
which	O
revealed	O
an	B-Problem
abcess	I-Problem
with	O
a	B-Problem
colovesicular	I-Problem
fistula	I-Problem
.	O
	
She	O
was	O
taken	O
to	O
the	O
OR	O
for	O
exploration	B-Test
and	O
drainage	B-Treatment
.	O
	
She	O
recieved	O
further	B-Treatment
resection	I-Treatment
of	I-Treatment
remaining	I-Treatment
colon	I-Treatment
,	O
repair	B-Treatment
of	O
a	B-Problem
leak	I-Problem
from	I-Problem
Relaford	I-Problem
pouch	I-Problem
and	O
repair	B-Treatment
of	O
colovesicular	B-Problem
fistula	I-Problem
.	O
	
After	O
her	B-Treatment
2nd	I-Treatment
surgery	I-Treatment
she	O
returned	O
to	O
the	O
ICU	O
and	O
improved	O
steadily	O
.	O
	
Abdomen	O
remained	O
soft	O
and	O
nontender	B-Problem
.	O
	
She	O
remained	O
on	O
IV	B-Treatment
antibiotics	I-Treatment
x	O
14	O
days	O
and	O
required	O
pressors	B-Treatment
for	O
the	O
first	O
few	O
days	O
post-op	O
.	O
	
Her	B-Problem
incision	I-Problem
has	O
remained	O
clean	O
,	O
dry	O
,	O
intact	O
,	O
with	O
staples	B-Treatment
removed	O
on	O
POD#	O
27/18	O
.	O
	
Genitourinary	O
:	O
She	O
had	O
a	B-Treatment
foley	I-Treatment
catheter	I-Treatment
from	O
the	O
time	O
of	O
admission	O
.	O
	
POD#	O
23/14	O
she	O
recieved	O
a	B-Test
cystoscopy	I-Test
which	O
revealed	O
no	O
leak	B-Problem
.	O
	
Her	B-Treatment
foley	I-Treatment
was	O
subsequently	O
dc	O
'd	O
.	O
	
Musculoskeletal	O
:	O
Has	O
suffered	O
significant	B-Problem
deconditioning	I-Problem
since	O
admission	O
,	O
but	O
has	O
consisitently	O
recieved	O
PT	B-Treatment
.	O
	
See	O
PT	O
note	O
for	O
further	B-Test
assessment	I-Test
and	O
discussion	O
.	O
	
Nutrition	O
:	O
She	O
was	O
held	O
NPO	B-Treatment
at	O
admission	O
,	O
and	O
initiated	O
on	O
TPN	B-Treatment
by	O
HD#3	O
.	O
	
Post-operatively	O
she	O
began	O
on	O
TF	B-Treatment
s,	I-Treatment
and	O
the	B-Treatment
TPN	I-Treatment
was	O
weaned	O
down	O
.	O
	
By	O
POD#	O
05-29	O
she	O
was	O
having	O
high	B-Problem
residuals	I-Problem
on	O
TF	B-Treatment
s,	I-Treatment
so	O
TPN	B-Treatment
was	O
reinitiated	O
.	O
	
Tf	B-Treatment
's	I-Treatment
were	O
dc	O
'ed	O
prior	O
to	O
second	B-Treatment
surgery	I-Treatment
.	O
	
POD#	O
15/6	O
,	O
she	O
resumed	O
TF	B-Treatment
's	I-Treatment
and	O
TPN	B-Treatment
was	O
tapered	O
again	O
.	O
	
TF	O
goals	O
were	O
achieved	O
and	O
TPN	B-Treatment
dc	O
'ed.	O
	
A	O
diet	O
by	O
mouth	O
was	O
initiated	O
.	O
	
At	O
time	O
of	O
discharge	O
she	O
is	O
tolerating	O
a	O
regular	O
diet	O
with	O
TF	B-Treatment
's	I-Treatment
at	O
goal	O
.	O
	
Patient	O
is	O
an	B-Problem
insulin	I-Problem
dependent	I-Problem
diabetic	I-Problem
.	O
	
She	O
was	O
followed	O
by	O
Cape	O
Cod	O
Hospital	O
Clinic	O
for	O
treatment	B-Treatment
of	O
persistent	B-Problem
hyperglycemia	I-Problem
.	O
	
Pain	B-Problem
:	O
Her	B-Problem
pain	I-Problem
was	O
controlled	O
with	O
IV	B-Treatment
pain	I-Treatment
medicines	I-Treatment
while	O
in	O
ICU	O
.	O
	
She	O
has	O
been	O
adequately	O
controlled	O
with	O
Tylenol	B-Treatment
,	O
Motrin	B-Treatment
&	O
Oxycodone	B-Treatment
by	O
mouth	O
,	O
per	O
recommendations	O
by	O
Geriatrics	O
.	O
	
POD#	O
22/15	O
Ms	O
Crossman	O
was	O
transferred	O
to	O
3	O
North	O
where	O
she	O
continued	O
to	O
progress	O
well	O
with	O
PT	B-Treatment
,	O
increasing	O
PO	O
intake	O
,	O
tolerating	O
TF	B-Treatment
s,	I-Treatment
and	O
weaning	O
from	O
nasal	B-Treatment
cannula	I-Treatment
oxygen	I-Treatment
.	O
	
She	O
has	O
remained	O
stable	O
with	O
no	O
acute	B-Problem
events	I-Problem
.	O
	
She	O
is	O
discharged	O
to	O
rehab	O
on	O
POD#	O
27/18	O
.	O
	
Medications	O
on	O
Admission	O
:	O
	
Norvasc	B-Treatment
	
Atenolol	B-Treatment
	
Isosorbide	B-Treatment
	
Lasix	B-Treatment
	
Insulin	B-Treatment
	
Discharge	O
Medications	O
:	O
	
1.	O
Heparin	B-Treatment
(	I-Treatment
Porcine	I-Treatment
)	I-Treatment
5,000	O
unit	O
/	O
mL	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
mL	O
Injection	O
TID	O
(	O
3	O
times	O
a	O
day	O
).	O
	
2.	O
Acetaminophen	B-Treatment
325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O
	
3.	O
Polyvinyl	B-Treatment
Alcohol	I-Treatment
-	O
Povidone	B-Treatment
1.4-0.6	O
%	O
Dropperette	O
Sig	O
:	O
02-25	O
Drops	O
Ophthalmic	O
PRN	O
(	O
as	O
needed	O
).	O
	
4.	O
Metoprolol	B-Treatment
Tartrate	I-Treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
).	O
	
5.	O
Aspirin	B-Treatment
81	O
mg	O
Tablet	O
,	O
Chewable	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Chewable	O
PO	O
DAILY	O
(	O
Daily	O
).	O
	
6.	O
Atorvastatin	B-Treatment
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O
	
7.	O
Lisinopril	B-Treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
0.5	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O
	
8.	O
Furosemide	B-Treatment
40	O
mg	O
Tablet	O
Sig	O
:	O
1.5	O
Tablets	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O
	
9.	O
Ipratropium	B-Treatment
Bromide	I-Treatment
17	O
mcg	O
/	O
Actuation	O
Aerosol	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Puff	O
Inhalation	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O
	
10.	O
Albuterol	B-Treatment
90	O
mcg	O
/	O
Actuation	O
Aerosol	O
Sig	O
:	O
1-2	O
Puffs	O
Inhalation	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
.	O
	
11.	O
Oxycodone	B-Treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
for	O
pain	B-Problem
.	O
	
12.	O
Docusate	B-Treatment
Sodium	I-Treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O
	
13.	O
Potassium	B-Treatment
Chloride	I-Treatment
20	O
mEq	O
Tab	O
Sust	O
.	O
Rel	O
.	O
Particle	O
/	O
Crystal	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tab	O
Sust	O
.	O
Rel	O
.	O
Particle	O
/	O
Crystal	O
PO	O
once	O
a	O
day	O
.	O
	
14.	O
Glargine	B-Treatment
Sig	O
:	O
Twenty	O
Two	O
(	O
22	O
)	O
units	O
at	O
bedtime	O
.	O
	
15.	O
Miconazole	B-Treatment
Nitrate	I-Treatment
2	O
%	O
Powder	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Appl	O
Topical	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O
	
16.	O
Miconazole	B-Treatment
Nitrate	I-Treatment
2	O
%	O
Cream	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Appl	O
Topical	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O
	
17.	O
Ibuprofen	B-Treatment
100	O
mg/5	O
mL	O
Suspension	O
Sig	O
:	O
Twenty	O
(	O
20	O
)	O
mL	O
PO	O
Q8H	O
(	O
every	O
8	O
hours	O
)	O
as	O
needed	O
.	O
	
18.	O
Debrox	B-Treatment
6.5	O
%	O
Drops	O
Sig	O
:	O
Five	O
(	O
5	O
)	O
Drop	O
Otic	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
for	O
5	O
days	O
:	O
both	O
ears	O
.	O
	
19.	O
Trazodone	B-Treatment
50	O
mg	O
Tablet	O
Sig	O
:	O
1	O
/	O
2-1	O
Tablet	O
PO	O
HS	O
(	O
at	O
bedtime	O
).	O
	
Discharge	O
Disposition	O
:	O
	
Extended	O
Care	O
	
Discharge	O
Diagnosis	O
:	O
	
Hurtado	B-Problem
Colon	I-Problem
	
Diverticulitis	B-Problem
	
S/P	O
Subtotal	B-Treatment
Colectomy	I-Treatment
,	O
Ileostomy	B-Treatment
,	O
Gastrostomy	B-Treatment
tube	I-Treatment
	
S/P	O
Exploratory	B-Test
laparotomy	I-Test
,	O
resection	B-Treatment
of	I-Treatment
small	I-Treatment
intestine	I-Treatment
with	O
primary	B-Treatment
anastomosis	I-Treatment
,	O
Sigmoid	B-Treatment
colectomy	I-Treatment
,	O
repair	B-Treatment
of	O
colovesicular	B-Problem
fistula	I-Problem
	
Unstable	B-Problem
Angina	I-Problem
	
Discharge	O
Condition	O
:	O
	
stable	O
	
Discharge	O
Instructions	O
:	O
	
Please	O
call	O
the	O
surgeon	O
or	O
return	O
to	O
the	O
Emergency	O
Department	O
if	O
you	O
develop	O
chest	B-Problem
pain	I-Problem
,	O
shortness	B-Problem
of	I-Problem
breath	I-Problem
,	O
fever	B-Problem
greater	I-Problem
than	I-Problem
101.5	I-Problem
,	O
foul	B-Problem
smelling	I-Problem
or	I-Problem
colorful	I-Problem
drainage	I-Problem
from	O
your	B-Problem
incisions	I-Problem
,	O
redness	B-Problem
or	O
swelling	B-Problem
,	O
severe	B-Problem
abdominal	I-Problem
pain	I-Problem
or	O
distention	B-Problem
,	O
persistent	B-Problem
nausea	I-Problem
or	O
vomiting	B-Problem
,	O
inability	B-Problem
to	I-Problem
eat	I-Problem
or	I-Problem
drink	I-Problem
,	O
or	O
any	O
	
other	B-Problem
symptoms	I-Problem
which	O
are	O
concerning	O
to	O
you	O
.	O
	
No	O
tub	O
baths	O
or	O
swimming	O
.	O
	
You	O
may	O
shower	O
.	O
	
If	O
there	O
is	O
clear	B-Problem
drainage	I-Problem
from	O
your	B-Problem
incisions	I-Problem
,	O
cover	O
with	O
a	B-Treatment
dry	I-Treatment
dressing	I-Treatment
.	O
	
Leave	O
white	B-Treatment
strips	I-Treatment
above	O
your	B-Problem
incisions	I-Problem
in	O
place	O
,	O
allow	O
them	O
to	O
fall	O
off	O
on	O
their	O
own	O
.	O
	
Activity	O
:	O
No	O
heavy	O
lifting	O
of	O
items	O
12-08	O
pounds	O
until	O
the	O
follow	O
up	O
appointment	O
with	O
your	O
doctor	O
.	O
	
Medications	O
:	O
Resume	O
your	O
home	B-Treatment
medications	I-Treatment
.	O
	
You	O
should	O
take	O
a	B-Treatment
stool	I-Treatment
softener	I-Treatment
,	O
Colace	B-Treatment
100	O
mg	O
twice	O
daily	O
as	O
needed	O
for	O
constipation	B-Problem
.	O
	
You	O
will	O
be	O
given	O
pain	B-Treatment
medication	I-Treatment
which	O
may	O
make	O
you	O
drowsy	B-Problem
.	O
	
Followup	O
Instructions	O
:	O
	
Provider	O
:	O
Joe	O
Kari	O
,	O
MD	O
Phone	O
:(	O
625	O
)	O
747-8259	O
	
Date	O
/	O
Time	O
:	O
2014-04-11	O
1:15	O
	
Joe	O
Kari	O
MD	O
09-697	O
	
Completed	O
by	O
:	O
Carol	O
Robert	O
NP	O
80-CIY	O
2014-03-25	O
@	O
0837	O
	
Signed	O
electronically	O
by	O
:	O
DR.	O
Marion	O
SCHNEIDER	O
on	O
:	O
Sandra	O
2014-03-25	O
12:56	O
PM	O
	
(	O
End	O
of	O
Report	O
)	O
	
Admission	O
Date	O
:	O
	
2012-06-07	O
	
Discharge	O
Date	O
:	O
	
2012-06-09	O
	
Date	O
of	O
Birth	O
:	O
	
1963-12-03	O
	
Sex	O
:	O
	
M	O
	
Service	O
:	O
	
MEDICINE	O
	
Allergies	O
:	O
	
Patient	O
recorded	O
as	O
having	O
No	O
Known	B-Problem
Allergies	I-Problem
to	I-Problem
Drugs	I-Problem
	
Attending	O
:	O
Christopher	O
KJ	O
Cater	O
,	O
M.D.	O
	
Chief	O
Complaint	O
:	O
	
Overdose	B-Problem
	
Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O
	
NG	B-Treatment
tube	I-Treatment
	
History	O
of	O
Present	O
Illness	O
:	O
	
Mr.	O
Vazquez	O
is	O
a	O
48	O
year	O
old	O
man	O
with	O
a	O
history	O
of	O
hepatitis	B-Problem
C	I-Problem
,	O
bipolar	B-Problem
disorder	I-Problem
with	O
suicide	O
attempts	O
in	O
the	O
past	O
,	O
recent	O
CMED	O
admit	O
earlier	O
in	O
4/05	O
who	O
was	O
found	O
alert	O
approximately	O
one	O
hour	O
after	O
taking	O
an	O
unspecified	O
number	O
of	O
pills	B-Treatment
.	O
	
Per	O
report	O
,	O
there	O
were	O
empty	O
bottles	O
of	O
Inderal	B-Treatment
and	O
Klonopin	B-Treatment
found	O
at	O
bedside	O
,	O
as	O
well	O
as	O
02-26	O
full	O
bottles	O
of	O
geodon	B-Treatment
,	O
gabapentin	B-Treatment
,	O
Lescol	B-Treatment
and	O
paroxitine	B-Treatment
.	O
	
The	O
patient	O
was	O
reportedly	O
alert	O
at	O
scene	O
,	O
and	O
then	O
became	O
unresponsive	B-Problem
in	O
route	O
to	O
the	O
hospital	O
.	O
	
In	O
the	O
Rita	O
,	O
the	O
patient	O
was	O
intubated	O
and	O
given	O
activated	B-Treatment
charcoal	I-Treatment
.	O
	
His	B-Test
initial	I-Test
BP	I-Test
was	O
60/P	O
with	O
a	B-Test
pulse	I-Test
in	O
the	O
60	O
s.	O
	
He	O
was	O
given	O
4	O
amps	O
of	O
calcium	B-Treatment
gluconate	I-Treatment
,	O
and	O
started	O
on	O
a	B-Treatment
Calcium	I-Treatment
gtt	I-Treatment
.	O
	
He	O
was	O
also	O
given	O
5mg	O
of	O
glucagon	B-Treatment
and	O
started	O
on	O
a	B-Treatment
glucagon	I-Treatment
drip	I-Treatment
with	O
good	O
response	O
.	O
	
His	B-Test
urine	I-Test
and	O
serum	B-Test
tox	I-Test
screens	I-Test
were	O
notable	O
only	O
for	O
benzos	B-Treatment
,	O
otherwise	O
negative	O
.	O
	
He	O
was	O
seen	O
by	O
cardiology	O
,	O
and	O
toxicology	O
was	O
consulted	O
via	O
telephone	O
.	O
	
He	O
was	O
admitted	O
to	O
the	O
CMED	O
,	O
intubated	O
for	O
airway	B-Treatment
protection	I-Treatment
and	O
started	O
on	O
both	O
a	B-Treatment
calcium	I-Treatment
and	I-Treatment
glucagon	I-Treatment
drip	I-Treatment
.	O
	
There	O
was	O
evidence	O
of	O
possible	O
aspiration	B-Problem
pneumonia	I-Problem
on	O
CXR	B-Test
,	O
though	O
he	O
was	O
extubated	O
without	O
incident	O
on	O
the	O
AM	O
of	O
transfer	O
to	O
the	O
medicine	O
floor	O
.	O
	
CMED	O
was	O
made	O
aware	O
,	O
and	O
they	O
are	O
actively	O
involved	O
in	O
his	O
care	O
.	O
	
Past	O
Medical	O
History	O
:	O
	
Hep	B-Problem
C	I-Problem
	
Bipolar	B-Problem
D/O	I-Problem
with	O
one	O
suicide	O
attempt	O
by	O
overdose	B-Problem
several	O
years	O
ago	O
	
Agoraphobia	B-Problem
	
Panic	B-Problem
disorder	I-Problem
	
Narcissism	B-Problem
	
No	O
history	O
of	O
head	B-Problem
trauma	I-Problem
or	O
seizure	B-Problem
disorder	I-Problem
	
Social	O
History	O
:	O
	
Denies	O
alcohol	O
use	O
.	O
	
Has	O
a	O
history	O
of	O
cocaine	O
abuse	O
-	O
in	O
remission	O
for	O
6	O
years	O
,	O
with	O
one	O
relapse	O
2.5	O
years	O
ago	O
.	O
	
Has	O
a	O
history	O
of	O
qualude	O
use	O
since	O
high	O
school	O
,	O
also	O
in	O
remission	O
.	O
	
Denies	O
use	O
of	O
AA/NA	O
.	O
Smokes	O
1ppd	O
.	O
	
Patient	O
lives	O
at	O
home	O
with	O
his	O
mother	O
,	O
father	O
and	O
brother	O
.	O
	
Reports	O
that	O
he	O
has	O
suffered	O
from	O
anxiety	B-Problem
since	O
childhood	O
and	O
needed	O
to	O
drop	O
out	O
of	O
college	O
.	O
	
Unemployed	O
and	O
on	O
disability	O
.	O
	
Waiting	O
for	O
a	O
subsidized	O
apartment	O
.	O
	
No	O
current	O
relationship	O
.	O
	
Family	O
History	O
:	O
	
Denies	O
.	O
	
Physical	O
Exam	O
:	O
	
Vitals	B-Test
:	O
99.3	O
67	O
(	O
60-70	O
)	O
99/53	O
(	O
90-100	O
s)	O
96%	O
on	O
RA	O
3.7L	O
+	O
LOS	O
	
Gen	O
:	O
caucasian	O
man	O
lying	O
in	O
bed	O
,	O
NAD	B-Problem
	
HEENT	O
:	O
NCAT	O
,	O
PERRL	O
,	O
EOMI	O
,	O
no	O
icterus	B-Problem
,	O
OP	O
clear	O
,	O
MMM	O
,	O
no	O
tongue	B-Problem
fasciculations	I-Problem
	
Neck	O
:	O
supple	O
,	O
no	O
LAD	B-Problem
,	O
no	O
JVD	B-Problem
	
CV	O
:	O
RRR	O
,	O
nl	O
s1	O
s2	O
,	O
no	O
m/g/r	B-Problem
	
Lungs	O
:	O
?	O
decreased	B-Problem
BS	I-Problem
over	I-Problem
left	I-Problem
middle	I-Problem
lung	I-Problem
,	O
otherwise	O
CTA	O
	
Abd	O
:	O
normal	O
size	O
,	O
nd	B-Problem
,	O
no	O
scars	B-Problem
,	O
nl	O
bs	O
,	O
soft	O
,	O
nt	B-Problem
,	O
palp	O
liver	O
	
Ext	O
:	O
no	O
c/c/e	B-Problem
,	O
no	O
edema	B-Problem
	
Neuro	O
:	O
no	O
asterixis	B-Problem
,	O
CN	O
II-XII	O
intact	O
,	O
5/5	O
strength	O
throughout	O
,	O
sensation	O
to	O
LT	B-Test
intact	O
throughout	O
,	O
gait	O
deferred	O
	
CMED	O
:	O
A+Ox3	O
,	O
mood	O
"	O
great	O
,"	O
affect	O
approp	O
,	O
speech	B-Problem
stuttering	I-Problem
,	O
linear	O
TP	O
,	O
no	O
SI	B-Problem
or	O
HI	B-Problem
	
Pertinent	O
Results	O
:	O
	
Labs	O
on	O
admit	O
:	O
	
2012-06-07	O
09:55	O
PM	O
BLOOD	B-Test
WBC	B-Test
-	O
8.9	O
RBC	B-Test
-	O
4.94	O
Hgb	B-Test
-	O
15.8	O
Hct	B-Test
-	O
45.3	O
MCV	B-Test
-	O
92	O
MCH	B-Test
-	O
31.9	O
MCHC	B-Test
-	O
34.8	O
RDW	B-Test
-	O
12.4	O
Plt	B-Test
Ct	I-Test
-	O
175	O
	
2012-06-07	O
09:55	O
PM	O
BLOOD	B-Test
Neuts	B-Test
-	O
49.9	O
*	O
Lymphs	B-Test
-	O
42.4	O
*	O
Monos	B-Test
-	O
5.5	O
Eos	B-Test
-	O
1.6	O
Baso	B-Test
-	O
0.6	O
	
2012-06-07	O
09:55	O
PM	O
BLOOD	B-Test
Plt	B-Test
Ct	I-Test
-	O
175	O
	
2012-06-07	O
09:55	O
PM	O
BLOOD	B-Test
PT	B-Test
-	O
12.8	O
PTT	B-Test
-	O
25.7	O
INR(PT)	B-Test
-	O
1.0	O
	
2012-06-07	O
09:55	O
PM	O
BLOOD	B-Test
Glucose	B-Test
-	O
108	O
*	O
UreaN	B-Test
-	O
13	O
Creat	B-Test
-	O
0.7	O
Na	B-Test
-	O
146	O
*	O
K	B-Test
-	O
3.7	O
Cl	B-Test
-	O
109	O
*	O
HCO3	B-Test
-	O
30	O
*	O
AnGap	B-Test
-	O
11	O
	
2012-06-07	O
09:55	O
PM	O
BLOOD	B-Test
Albumin	B-Test
-	O
3.9	O
Calcium	B-Test
-	O
8.5	O
Phos	B-Test
-	O
4.2	O
Mg	B-Test
-	O
2.0	O
	
2012-06-07	O
09:55	O
PM	O
BLOOD	B-Test
ALT	B-Test
-	O
44	O
*	O
AST	B-Test
-	O
31	O
AlkPhos	B-Test
-	O
36	O
*	O
TotBili	B-Test
-	O
0.2	O
	
2012-06-07	O
09:55	O
PM	O
BLOOD	B-Test
ASA	B-Test
-	O
NEG	O
Ethanol	B-Test
-	O
NEG	O
Acetmnp	B-Test
-	O
NEG	O
Bnzodzp	B-Test
-	O
NEG	O
Barbitr	B-Test
-	O
NEG	O
Tricycl	B-Test
-	O
NEG	O
	
Labs	O
today	O
:	O
	
2012-06-08	O
09:30	O
AM	O
BLOOD	B-Test
WBC	B-Test
-	O
10.1	O
RBC	B-Test
-	O
4.35	O
*	O
Hgb	B-Test
-	O
14.2	O
Hct	B-Test
-	O
39.9	O
*	O
MCV	B-Test
-	O
92	O
MCH	B-Test
-	O
32.6	O
*	O
MCHC	B-Test
-	O
35.6	O
*	O
RDW	B-Test
-	O
12.4	O
Plt	B-Test
Ct	I-Test
-	O
151	O
	
2012-06-08	O
09:30	O
AM	O
BLOOD	B-Test
Glucose	B-Test
-	O
115	O
*	O
UreaN	B-Test
-	O
14	O
Creat	B-Test
-	O
0.8	O
Na	B-Test
-	O
142	O
K	B-Test
-	O
4.1	O
Cl	B-Test
-	O
112	O
*	O
HCO3	B-Test
-	O
26	O
AnGap	B-Test
-	O
8	O
	
2012-06-08	O
09:30	O
AM	O
BLOOD	B-Test
Calcium	B-Test
-	O
10.4	O
*	O
Phos	B-Test
-	O
2.8	O
Mg	B-Test
-	O
1.8	O
	
2012-06-08	O
	
CXR	B-Test
:	O
	
An	B-Treatment
endotracheal	I-Treatment
tube	I-Treatment
terminates	O
just	O
above	O
the	O
thoracic	O
inlet	O
approximately	O
6.5	O
cm	O
above	O
the	O
carina	O
.	O
	
The	B-Treatment
nasogastric	I-Treatment
tube	I-Treatment
terminates	O
within	O
the	O
stomach	O
.	O
	
Cardiac	O
and	O
mediastinal	O
contours	O
are	O
within	O
normal	O
limits	O
.	O
	
There	O
is	O
a	B-Problem
patchy	I-Problem
area	I-Problem
of	I-Problem
increased	I-Problem
opacity	I-Problem
in	O
the	O
left	O
retrocardiac	O
region	O
,	O
which	O
was	O
not	O
seen	O
on	O
the	B-Test
earlier	I-Test
study	I-Test
.	O
	
Right	O
lung	O
is	O
clear	O
.	O
	
Left	O
costophrenic	O
angle	O
has	O
been	O
excluded	O
from	O
the	B-Test
study	I-Test
and	O
cannot	O
be	O
assessed	O
.	O
	
There	O
is	O
no	O
evidence	O
of	O
right	B-Problem
pleural	I-Problem
effusion	I-Problem
or	O
right	B-Problem
pneumothorax	I-Problem
.	O
	
IMPRESSION	O
:	O
	
1)	O
Endotracheal	B-Treatment
tube	I-Treatment
is	O
slightly	O
proximal	O
in	O
location	O
,	O
and	O
could	O
be	O
advanced	O
approximately	O
1.5	O
cm	O
for	O
more	O
optimal	O
placement	O
.	O
	
2)	O
Patchy	B-Problem
left	I-Problem
retrocardiac	I-Problem
opacity	I-Problem
which	O
may	O
be	O
due	O
to	O
patchy	B-Problem
atelectasis	I-Problem
,	O
aspiration	B-Problem
,	O
or	O
early	B-Problem
pneumonia	I-Problem
.	O
	
Followup	B-Test
radiograph	I-Test
suggested	O
	
Brief	O
Hospital	O
Course	O
:	O
	
A/P	O
:	O
48yo	O
man	O
with	O
h/o	O
HCV	B-Problem
,	O
bipolar	B-Problem
DO	I-Problem
,	O
h/o	O
suicide	O
attempts	O
,	O
a/w	O
overdose	B-Problem
of	O
Inderal	B-Treatment
,	O
Klonopin	B-Treatment
,	O
Geodon	B-Treatment
,	O
s/T	O
Jackson	O
stay	O
with	O
intubation	B-Treatment
for	O
airway	B-Treatment
protection	I-Treatment
,	O
with	O
question	O
of	O
L	B-Problem
retrocardiac	I-Problem
infiltrate	I-Problem
,	O
now	O
doing	O
well	O
.	O
	
Overdose	O
:	O
	
-	O
monitor	O
on	O
tele	B-Test
overnight	O
	
-	O
if	O
HR	B-Test
drops	O
,	O
restart	O
glucagon	B-Treatment
gtt	I-Treatment
	
-	O
watch	O
for	O
BZD	B-Problem
withdrawal	I-Problem
,	O
agitation	B-Problem
	
Bipolar	B-Problem
disorder	I-Problem
:	O
	
-	O
appreciate	O
CMED	O
consult	O
;	O
patient	O
to	O
be	O
discharged	O
to	O
inpatient	O
CMED	O
facility	O
once	O
stable	O
	
-	O
suicide	B-Treatment
precautions	I-Treatment
	
Activity	O
:	O
OOB	O
with	O
assist	O
	
FEN	O
:	O
house	O
diet	O
	
PPX	O
:	O
SC	B-Treatment
heparin	I-Treatment
,	O
bowel	B-Treatment
regimen	I-Treatment
,	O
nicotine	B-Treatment
patch	I-Treatment
	
CODE	O
:	O
full	O
	
DISPO	O
:	O
transfer	O
to	O
inpatient	O
CMED	O
likely	O
tomorrow	O
	
Medications	O
on	O
Admission	O
:	O
	
Neurontin	B-Treatment
800	O
mg	O
tid	O
	
Ziprasidone	B-Treatment
bid	O
	
Propanolol	B-Treatment
20	O
mg	O
tid	O
	
Klonopin	B-Treatment
2	O
mg	O
tid	O
	
Paxil	B-Treatment
30	O
mg	O
qd	O
	
Protonix	B-Treatment
40	O
mg	O
qd	O
	
Folate	B-Treatment
1	O
mg	O
qd	O
	
Lescol	B-Treatment
40	O
qd	O
	
Discharge	O
Disposition	O
:	O
	
Home	O
	
Discharge	O
Diagnosis	O
:	O
	
Depression	B-Problem
	
Discharge	O
Condition	O
:	O
	
Depressed	B-Problem
	
Discharge	O
Instructions	O
:	O
	
Going	O
to	O
UMass	O
Memorial	O
Medical	O
Center	O
4	O
.	O
	
Followup	O
Instructions	O
:	O
	
Please	O
f	O
/	O
u	O
with	O
PCP	O
D	O
2	O
weeks	O
.	O
	
Joseph	O
Judy	O
MD	O
35-943	O
	
Completed	O
by	O
:	O
John	O
Konderla	O
MD	O
01-196	O
2012-06-09	O
@	O
1707	O
	
Signed	O
electronically	O
by	O
:	O
DR.	O
Felix	O
Garcia	O
on	O
:	O
FRI	O
2012-06-15	O
4:29	O
PM	O
	
(	O
End	O
of	O
Report	O
)	O
	
Admission	O
Date	O
:	O
	
2013-02-12	O
	
Discharge	O
Date	O
:	O
	
2013-02-16	O
	
Date	O
of	O
Birth	O
:	O
	
1937-03-25	O
	
Sex	O
:	O
	
F	O
	
Service	O
:	O
	
CARDIOTHORACIC	O
	
HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O
	
The	O
patient	O
was	O
referred	O
from	O
an	O
outside	O
hospital	O
with	O
a	O
chief	O
complaint	O
of	O
increasing	B-Problem
shortness	I-Problem
of	I-Problem
breath	I-Problem
and	O
tires	B-Problem
easily	I-Problem
with	O
exertion	O
.	O
	
Admitted	O
to	O
Bay	O
State	O
Medical	O
Center	O
Hospital	O
in	O
2012-10-22	O
in	O
congestive	B-Problem
heart	I-Problem
failure	I-Problem
at	O
that	O
time	O
.	O
	
Via	O
echocardiogram	B-Test
,	O
found	O
to	O
have	O
aortic	B-Problem
stenosis	I-Problem
.	O
	
Referred	O
to	O
Memorial	O
Hospital	O
(	O
Worcester	O
)	O
for	O
cardiac	B-Test
catheterization	I-Test
to	O
further	O
evaluate	O
her	B-Problem
aortic	I-Problem
stenosis	I-Problem
.	O
	
Cardiac	B-Test
catheterization	I-Test
done	O
on	O
01-07	O
showed	O
an	B-Test
aortic	I-Test
valve	I-Test
area	I-Test
of	O
.38	O
cm.sq.	O
,	O
with	O
a	B-Test
mean	I-Test
gradient	I-Test
of	O
62	O
,	O
and	O
a	B-Test
peak	I-Test
gradient	I-Test
of	O
85	O
.	O
	
Moderate	B-Problem
pulmonary	I-Problem
hypertension	I-Problem
,	O
PA	B-Test
pressure	I-Test
48/24	O
,	O
1+	B-Problem
mitral	I-Problem
regurgitation	I-Problem
,	O
severe	B-Problem
aortic	I-Problem
stenosis	I-Problem
with	O
an	B-Test
LVEDP	I-Test
of	O
19	O
and	O
an	B-Test
ejection	I-Test
fraction	I-Test
of	O
43%	O
.	O
	
She	O
was	O
then	O
referred	O
to	O
Cardiothoracic	O
Surgery	O
for	O
aortic	B-Treatment
valve	I-Treatment
replacement	I-Treatment
.	O
	
PAST	O
MEDICAL	O
HISTORY	O
:	O
	
1.	O
Aortic	B-Problem
stenosis	I-Problem
	
2.	O
Diabetes	B-Problem
mellitus	I-Problem
Type	I-Problem
2	I-Problem
	
3.	O
Right	B-Treatment
hip	I-Treatment
replacement	I-Treatment
	
4.	O
Noninsulin	B-Problem
dependent	I-Problem
diabetes	I-Problem
mellitus	I-Problem
	
MEDICATIONS	O
ON	O
ADMISSION	O
:	O
	
Include	O
Glucovance	B-Treatment
5/500	O
one	O
tablet	O
twice	O
a	O
day	O
,	O
Univasc	B-Treatment
7.5	O
mg	O
once	O
daily	O
,	O
lasix	B-Treatment
20	O
mg	O
every	O
other	O
day	O
,	O
and	O
aspirin	B-Treatment
325	O
mg	O
once	O
daily	O
.	O
	
ALLERGIES	O
:	O
	
No	O
known	B-Problem
drug	I-Problem
allergies	I-Problem
.	O
	
FAMILY	O
HISTORY	O
:	O
	
Significant	O
for	O
her	O
father	O
,	O
who	O
died	O
at	O
50	O
years	O
from	O
myocarditis	B-Problem
.	O
	
SOCIAL	O
HISTORY	O
:	O
	
She	O
lives	O
alone	O
in	O
Methuen	O
with	O
five	O
stairs	O
.	O
	
She	O
has	O
a	O
remote	O
tobacco	O
history	O
,	O
quit	O
in	O
October	O
,	O
one	O
pack	O
per	O
day	O
for	O
50	O
years	O
.	O
	
No	O
alcohol	O
use	O
.	O
	
PHYSICAL	O
EXAMINATION	O
:	O
	
Vital	O
signs	O
:	O
	
Heart	B-Test
rate	I-Test
108	O
and	O
regular	O
,	O
blood	B-Test
pressure	I-Test
145/76	O
,	O
respiratory	B-Test
rate	I-Test
20	O
,	O
height	B-Test
5'2"	O
,	O
weight	B-Test
141	O
pounds	O
.	O
	
General	O
:	O
	
Healthy-appearing	O
woman	O
,	O
in	O
no	O
acute	B-Problem
distress	I-Problem
.	O
	
Skin	O
:	O
	
No	O
lesions	B-Problem
or	O
rashes	B-Problem
.	O
	
Head	O
,	O
eyes	O
,	O
ears	O
,	O
nose	O
and	O
throat	O
:	O
	
Pupils	O
equal	O
,	O
round	O
and	O
reactive	O
to	O
light	O
,	O
extraocular	O
movements	O
intact	O
,	O
anicteric	B-Problem
,	O
not	O
injected	B-Problem
.	O
	
Oropharynx	O
:	O
	
Mucous	O
membranes	O
moist	O
.	O
	
Neck	O
:	O
	
Supple	O
,	O
no	O
lymphadenopathy	B-Problem
,	O
no	O
jugular	B-Problem
venous	I-Problem
distention	I-Problem
,	O
no	O
thyromegaly	B-Problem
.	O
	
Chest	O
:	O
	
Clear	O
to	O
auscultation	B-Test
bilaterally	O
.	O
	
Heart	O
:	O
	
Regular	O
rate	O
and	O
rhythm	O
,	O
S1	O
,	O
S2	O
,	O
with	O
III/VI	B-Problem
blowing	I-Problem
murmur	I-Problem
.	O
	
Abdomen	O
:	O
	
Soft	O
,	O
nontender	B-Problem
,	O
nondistended	B-Problem
,	O
normal	O
active	O
bowel	O
sounds	O
,	O
no	O
hepatosplenomegaly	B-Problem
.	O
	
Extremities	O
:	O
	
Warm	O
and	O
well	O
perfused	O
,	O
with	O
no	O
cyanosis	B-Problem
,	O
clubbing	B-Problem
or	O
edema	B-Problem
,	O
no	O
varicosities	B-Problem
.	O
	
Neurological	O
:	O
	
Cranial	O
nerves	O
II	O
through	O
XII	O
grossly	O
intact	O
.	O
	
Moves	O
all	O
extremities	O
.	O
	
Strength	B-Test
5/5	O
in	O
upper	O
and	O
lower	O
extremities	O
.	O
	
Sensation	O
intact	O
in	O
all	O
dermatomes	O
.	O
	
Pulses	B-Test
:	O
	
Femoral	B-Test
2	O
+	O
bilaterally	O
,	O
dorsalis	B-Test
pedis	I-Test
1	O
+	O
bilaterally	O
,	O
posterior	B-Test
tibial	I-Test
1	O
+	O
bilaterally	O
,	O
and	O
radial	B-Test
2	O
+	O
bilaterally	O
.	O
	
No	O
carotid	B-Problem
bruits	I-Problem
were	O
noted	O
.	O
	
LABORATORY	O
DATA	O
:	O
	
White	B-Test
count	I-Test
5.3	O
,	O
hematocrit	B-Test
43	O
,	O
platelets	B-Test
200	O
.	O
	
Sodium	B-Test
138	O
,	O
potassium	B-Test
4.9	O
,	O
chloride	B-Test
102	O
,	O
CO2	B-Test
25	O
,	O
BUN	B-Test
24	O
,	O
creatinine	B-Test
0.9	O
,	O
glucose	B-Test
309	O
.	O
	
Electrocardiogram	B-Test
:	O
	
Rate	B-Test
of	O
91	O
,	O
first	B-Problem
degree	I-Problem
AV	I-Problem
block	I-Problem
,	O
intervals	B-Test
.22	O
,	O
.92	O
,	O
.36	O
,	O
with	O
left	B-Problem
ventricular	I-Problem
hypertrophy	I-Problem
.	O
	
Chest	B-Test
x-ray	I-Test
is	O
pending	O
at	O
the	O
time	O
of	O
physical	B-Test
.	O
	
HOSPITAL	O
COURSE	O
:	O
	
The	O
patient	O
was	O
a	O
direct	O
admission	O
to	O
the	O
operating	O
room	O
on	O
02-12	O
,	O
at	O
which	O
time	O
she	O
underwent	O
an	O
	
aortic	B-Treatment
valve	I-Treatment
replacement	I-Treatment
.	O
	
Please	O
see	O
the	O
operative	O
report	O
for	O
full	O
details	O
.	O
	
In	O
summary	O
,	O
she	O
had	O
an	B-Treatment
aortic	I-Treatment
valve	I-Treatment
replacement	I-Treatment
with	O
a	B-Treatment
#21	I-Treatment
mosaic	I-Treatment
porcine	I-Treatment
valve	I-Treatment
.	O
	
She	O
tolerated	O
the	B-Treatment
operation	I-Treatment
well	O
,	O
and	O
was	O
transferred	O
from	O
the	O
operating	O
room	O
to	O
the	O
Cardiothoracic	O
Intensive	O
Care	O
Unit	O
.	O
	
The	O
patient	O
did	O
well	O
in	O
the	O
immediate	O
postoperative	O
period	O
,	O
however	O
,	O
her	B-Test
blood	I-Test
pressure	I-Test
remained	O
somewhat	B-Problem
labile	I-Problem
.	O
	
Therefore	O
,	O
she	O
was	O
continued	O
on	O
a	B-Treatment
Neo-Synephrine	I-Treatment
drip	I-Treatment
to	O
maintain	O
a	B-Test
systolic	I-Test
blood	I-Test
pressure	I-Test
greater	O
than	O
110	O
.	O
	
In	O
addition	O
,	O
she	O
was	O
slow	O
to	O
awaken	O
after	O
her	B-Treatment
anesthesia	I-Treatment
was	O
reversed	O
,	O
and	O
in	O
several	O
attempts	O
to	O
wean	O
from	O
the	B-Treatment
ventilator	I-Treatment
,	O
she	O
developed	O
a	B-Problem
respiratory	I-Problem
acidosis	I-Problem
.	O
	
She	O
therefore	O
remained	O
on	O
the	B-Treatment
ventilator	I-Treatment
throughout	O
the	O
day	O
of	O
postoperative	O
day	O
one	O
.	O
	
On	O
postoperative	O
day	O
two	O
,	O
the	O
patient	O
remained	O
hemodynamically	O
stable	O
.	O
	
Her	B-Treatment
Neo-Synephrine	I-Treatment
drip	I-Treatment
was	O
weaned	O
to	O
off	O
.	O
	
She	O
was	O
again	O
weaned	O
from	O
the	B-Treatment
ventilator	I-Treatment
,	O
and	O
successfully	O
extubated	O
.	O
	
Her	B-Treatment
chest	I-Treatment
tubes	I-Treatment
were	O
discontinued	O
and	O
,	O
at	O
the	O
end	O
of	O
the	O
day	O
,	O
she	O
was	O
transferred	O
from	O
the	O
Cardiothoracic	O
Intensive	O
Care	O
Unit	O
to	O
the	O
floor	O
for	O
continuing	B-Treatment
postoperative	I-Treatment
care	I-Treatment
and	O
cardiac	B-Treatment
rehabilitation	I-Treatment
.	O
	
After	O
being	O
transferred	O
to	O
the	O
floor	O
,	O
the	O
patient	O
did	O
well	O
.	O
	
Over	O
the	O
next	O
several	O
days	O
,	O
her	O
activity	O
level	O
was	O
increased	O
with	O
the	O
assistance	O
of	O
Physical	O
Therapy	O
and	O
the	O
nursing	O
staff	O
.	O
	
She	O
remained	O
hemodynamically	O
stable	O
.	O
	
Her	O
respiratory	O
condition	O
remained	O
stable	O
and	O
,	O
on	O
postoperative	O
day	O
four	O
,	O
she	O
was	O
deemed	O
stable	O
and	O
ready	O
to	O
be	O
transferred	O
to	O
rehabilitation	O
for	O
continuing	B-Treatment
postoperative	I-Treatment
care	I-Treatment
and	O
physical	O
	
therapy	B-Treatment
.	O
	
At	O
the	O
time	O
of	O
transfer	O
,	O
the	B-Test
patient	I-Test
's	I-Test
physical	I-Test
examination	I-Test
is	O
as	O
follows	O
:	O
	
Vital	O
signs	O
:	O
	
Temperature	B-Test
98.4	O
,	O
heart	B-Test
rate	I-Test
78	O
and	O
sinus	B-Test
rhythm	I-Test
,	O
blood	B-Test
pressure	I-Test
106/50	O
,	O
respiratory	B-Test
rate	I-Test
18	O
,	O
oxygen	B-Test
saturation	I-Test
97%	O
on	O
room	O
air	O
.	O
	
Weight	B-Test
preoperatively	O
was	O
67	O
kg	O
,	O
at	O
discharge	O
is	O
70.9	O
kg	O
.	O
	
Laboratory	B-Test
data	I-Test
on	O
02-15	O
:	O
	
White	B-Test
count	I-Test
4.1	O
,	O
hematocrit	B-Test
23	O
,	O
platelets	B-Test
144	O
.	O
	
Sodium	B-Test
141	O
,	O
potassium	B-Test
4.3	O
,	O
chloride	B-Test
108	O
,	O
CO2	B-Test
25	O
,	O
BUN	B-Test
24	O
,	O
creatinine	B-Test
0.8	O
,	O
glucose	B-Test
140	O
.	O
	
Physical	O
examination	O
:	O
	
Alert	O
and	O
oriented	O
x	O
3	O
,	O
moves	O
all	O
extremities	O
,	O
conversant	O
.	O
	
Respiratory	O
:	O
	
Scattered	B-Problem
rhonchi	I-Problem
with	O
diminished	B-Problem
breath	I-Problem
sounds	I-Problem
in	I-Problem
the	I-Problem
bases	I-Problem
.	O
	
Cor	O
:	O
	
Regular	O
rate	O
and	O
rhythm	O
,	O
S1	O
,	O
S2	O
,	O
with	O
soft	B-Problem
systolic	I-Problem
ejection	I-Problem
murmur	I-Problem
.	O
	
Sternum	O
is	O
stable	O
.	O
	
Incision	B-Problem
with	O
staples	B-Treatment
,	O
open	O
to	O
air	O
,	O
clean	O
and	O
dry	O
.	O
	
Abdomen	O
:	O
	
Soft	O
,	O
nontender	B-Problem
,	O
nondistended	B-Problem
,	O
normal	O
active	O
bowel	O
sounds	O
.	O
	
Extremities	O
:	O
	
Warm	O
and	O
well	O
perfused	O
,	O
with	O
no	O
cyanosis	B-Problem
,	O
clubbing	B-Problem
or	O
edema	B-Problem
.	O
	
DISCHARGE	O
MEDICATIONS	O
:	O
	
Ranitidine	B-Treatment
150	O
mg	O
twice	O
a	O
day	O
,	O
enteric-coated	B-Treatment
aspirin	I-Treatment
325	O
mg	O
once	O
daily	O
,	O
Glucovance	B-Treatment
5/500	O
one	O
tablet	O
twice	O
a	O
day	O
,	O
metoprolol	B-Treatment
25	O
mg	O
twice	O
a	O
day	O
,	O
Furosemide	B-Treatment
20	O
mg	O
once	O
daily	O
for	O
14	O
days	O
,	O
potassium	B-Treatment
chloride	I-Treatment
20	O
mEq	O
once	O
daily	O
for	O
14	O
days	O
,	O
Colace	B-Treatment
100	O
mg	O
twice	O
a	O
day	O
,	O
Niferex	B-Treatment
150	O
mg	O
once	O
daily	O
,	O
Percocet	B-Treatment
5/325	O
one	O
to	O
two	O
tablets	O
every	O
four	O
hours	O
as	O
needed	O
,	O
ibuprofen	B-Treatment
400	O
mg	O
every	O
six	O
hours	O
as	O
needed	O
.	O
	
DISCHARGE	O
DIAGNOSIS	O
:	O
	
1.	O
Aortic	B-Problem
stenosis	I-Problem
status	O
post	O
aortic	B-Treatment
valve	I-Treatment
replacement	I-Treatment
with	O
a	B-Treatment
#21	I-Treatment
mosaic	I-Treatment
porcine	I-Treatment
valve	I-Treatment
	
2.	O
Diabetes	B-Problem
mellitus	I-Problem
Type	I-Problem
2	I-Problem
	
3.	O
Right	B-Treatment
hip	I-Treatment
replacement	I-Treatment
	
CONDITION	O
ON	O
TRANSFER	O
:	O
	
Stable	O
.	O
	
DISCHARGE	O
INSTRUCTIONS	O
:	O
	
She	O
is	O
to	O
have	O
follow	O
up	O
with	O
Dr.	O
Bloomfield	O
in	O
one	O
month	O
,	O
and	O
follow	O
up	O
in	O
the	O
Wound	O
Clinic	O
in	O
two	O
	
weeks	O
.	O
	
Alice	O
S.	O
Shadle	O
,	O
M.D.	O
	
37-538	O
	
Dictated	O
By	O
:	O
James	O
F.	O
Buchanan	O
,	O
M.D.	O
	
MEDQUIST36	O
	
D	O
:	O
2013-02-15	O
18:35	O
	
T	O
:	O
2013-02-16	O
01:03	O
	
JOB	O
#:	O
	
59205	O
	
Signed	O
electronically	O
by	O
:	O
DR.	O
Richard	O
Gray	O
on	O
:	O
Tommy	O
2013-02-17	O
12:05	O
AM	O
	
(	O
End	O
of	O
Report	O
)	O
	
Admission	O
Date	O
:	O
	
2015-09-16	O
	
Discharge	O
Date	O
:	O
	
2015-09-21	O
	
Date	O
of	O
Birth	O
:	O
	
1962-09-26	O
	
Sex	O
:	O
	
M	O
	
Service	O
:	O
	
CARDIOTHOR	O
	
REASON	O
FOR	O
ADMISSION	O
:	O
	
Mitral	B-Treatment
valve	I-Treatment
repair	I-Treatment
.	O
	
HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O
	
The	O
patient	O
is	O
a	O
52	O
year	O
old	O
Czech	O
speaking	O
gentleman	O
with	O
a	O
history	O
of	O
severe	B-Problem
mitral	I-Problem
regurgitation	I-Problem
.	O
	
For	O
the	O
past	O
several	O
years	O
,	O
the	O
patient	O
has	O
continued	O
to	O
have	O
significant	B-Problem
exercise	I-Problem
intolerance	I-Problem
which	O
has	O
limited	O
his	O
ability	O
to	O
work	O
.	O
	
He	O
reports	O
severe	B-Problem
dyspnea	I-Problem
on	O
exertion	O
.	O
	
The	O
patient	O
had	O
a	O
recent	O
admission	O
earlier	O
in	O
the	O
month	O
and	O
he	O
was	O
discharged	O
on	O
2015-09-10	O
,	O
after	O
undergoing	O
cardiac	B-Test
catheterization	I-Test
.	O
	
This	O
was	O
significant	O
for	O
demonstrating	O
no	O
flow-limited	B-Problem
disease	I-Problem
in	I-Problem
the	I-Problem
coronaries	I-Problem
but	O
several	B-Problem
fistulae	I-Problem
	
from	O
the	O
left	O
anterior	O
descending	O
to	O
the	O
PA	O
.	O
	
Several	O
of	O
these	O
were	O
coil	B-Treatment
embolized	I-Treatment
during	O
this	O
admission	O
.	O
	
He	O
tolerated	O
this	O
well	O
,	O
was	O
sent	O
home	O
,	O
and	O
now	O
returns	O
for	O
his	B-Treatment
mitral	I-Treatment
valve	I-Treatment
repair	I-Treatment
.	O
	
PAST	O
MEDICAL	O
HISTORY	O
:	O
	
1.	O
Mitral	B-Problem
valve	I-Problem
regurgitation	I-Problem
.	O
	
PAST	O
SURGICAL	O
HISTORY	O
:	O
	
None	O
.	O
	
MEDICATIONS	O
ON	O
ADMISSION	O
:	O
	
1.	O
Atenolol	B-Treatment
25	O
mg	O
p.o.	O
q.	O
day	O
.	O
	
2.	O
Enteric-coated	B-Treatment
aspirin	I-Treatment
325	O
mg	O
p.o.	O
q.	O
day	O
.	O
	
3.	O
Nitroglycerin	B-Treatment
sublingual	I-Treatment
p.r.n.	O
	
ALLERGIES	O
:	O
	
No	O
known	B-Problem
drug	I-Problem
allergies	I-Problem
.	O
	
SOCIAL	O
HISTORY	O
:	O
	
The	O
patient	O
is	O
currently	O
on	O
Disability	O
and	O
lives	O
at	O
home	O
with	O
his	O
wife	O
.	O
	
Kimberly	O
was	O
born	O
in	O
Great	O
Britain	O
.	O
	
He	O
denies	O
any	O
ETOH	O
or	O
tobacco	O
use	O
.	O
	
FAMILY	O
HISTORY	O
:	O
	
Negative	O
.	O
	
PHYSICAL	O
EXAMINATION	O
:	O
	
The	O
patient	O
is	O
in	O
no	O
acute	B-Problem
distress	I-Problem
.	O
	
Temperature	B-Test
is	O
98.3	O
F.	O
;	O
pulse	B-Test
is	O
76	O
;	O
blood	B-Test
pressure	I-Test
113/52	O
;	O
breathing	B-Test
18	O
;	O
98%	O
on	O
room	O
air	O
.	O
	
HEENT	O
:	O
	
The	O
patient	O
is	O
missing	B-Problem
many	I-Problem
teeth	I-Problem
.	O
	
Oropharynx	O
is	O
clear	O
.	O
	
There	O
is	O
no	O
cervical	B-Problem
lymphadenopathy	I-Problem
.	O
	
Supple	O
neck	O
.	O
	
Heart	O
is	O
regular	O
rate	O
and	O
rhythm	O
with	O
a	B-Problem
III/VI	I-Problem
systolic	I-Problem
ejection	I-Problem
murmur	I-Problem
.	O
	
His	O
lungs	O
are	O
clear	O
to	O
auscultation	B-Test
bilaterally	O
.	O
	
Abdomen	O
is	O
soft	O
and	O
nontender	B-Problem
.	O
	
The	O
patient	O
has	O
no	O
cyanosis	B-Problem
,	O
clubbing	B-Problem
or	O
edema	B-Problem
in	I-Problem
extremities	I-Problem
.	O
	
LABORATORY	O
:	O
	
On	O
admission	O
include	O
a	B-Test
white	I-Test
blood	I-Test
cell	I-Test
count	I-Test
of	O
5.6	O
,	O
hematocrit	B-Test
of	O
32.5	O
,	O
platelets	B-Test
of	O
202	O
.	O
	
Sodium	B-Test
of	O
140	O
,	O
potassium	B-Test
of	O
3.5	O
,	O
BUN	B-Test
of	O
4	O
,	O
creatinine	B-Test
of	O
0.6	O
,	O
glucose	B-Test
of	O
137	O
.	O
	
Chest	B-Test
x-ray	I-Test
shows	O
no	O
infiltrate	B-Problem
or	O
pneumothorax	B-Problem
.	O
	
Cardiac	B-Test
catheterization	I-Test
demonstrates	O
no	O
significant	B-Problem
disease	I-Problem
in	I-Problem
the	I-Problem
coronary	I-Problem
arteries	I-Problem
.	O
	
Two	O
branches	O
of	O
an	B-Problem
left	I-Problem
anterior	I-Problem
descending	I-Problem
to	I-Problem
PA	I-Problem
fistula	I-Problem
which	O
was	O
successfully	O
coiled	O
.	O
	
There	O
is	O
a	B-Problem
persistent	I-Problem
flow	I-Problem
through	O
an	O
inferior	O
branch	O
of	O
the	O
left	O
anterior	O
descending	O
to	O
PA	B-Problem
fistula	I-Problem
and	O
a	O
persistent	O
branch	O
of	O
the	B-Problem
circumflex	I-Problem
to	I-Problem
PA	I-Problem
branch	I-Problem
fistula	I-Problem
which	O
anatomically	O
were	O
not	O
suitable	O
for	O
coil	B-Treatment
embolization	I-Treatment
.	O
	
Ejection	B-Test
fraction	I-Test
was	O
60%	O
.	O
	
HOSPITAL	O
COURSE	O
:	O
	
On	O
the	O
day	O
of	O
admission	O
,	O
the	O
patient	O
went	O
to	O
the	O
Operating	O
Room	O
and	O
underwent	O
a	O
minimally	O
invasive	O
	
mitral	B-Treatment
valve	I-Treatment
repair	I-Treatment
.	O
	
He	O
tolerated	O
this	B-Treatment
procedure	I-Treatment
well	O
.	O
	
The	O
patient	O
was	O
brought	O
to	O
the	O
cardiothoracic	O
Intensive	O
Care	O
Unit	O
in	O
stable	O
condition	O
on	O
minimal	B-Treatment
pressor	I-Treatment
support	I-Treatment
.	O
	
He	O
was	O
successfully	O
weaned	O
off	O
this	B-Treatment
support	I-Treatment
.	O
	
The	O
patient	O
was	O
fully	O
weaned	O
from	O
ventilatory	B-Treatment
support	I-Treatment
secondary	O
to	O
a	B-Problem
persistent	I-Problem
acidemia	I-Problem
.	O
	
This	O
was	O
treated	O
with	O
sodium	B-Treatment
bicarbonate	I-Treatment
and	O
a	B-Treatment
Swan-Ganz	I-Treatment
was	O
placed	O
to	O
provide	O
close	B-Test
hemodynamic	I-Test
monitoring	I-Test
.	O
	
The	O
patient	O
was	O
found	O
to	O
have	O
stable	O
hemodynamics	O
with	O
appropriate	O
mixed	O
venous	B-Test
saturations	I-Test
in	O
the	O
70%	O
range	O
.	O
	
The	O
patient	O
was	O
corrected	O
to	O
a	O
normal	O
pH	O
of	O
7.41	O
by	O
the	O
first	O
postoperative	O
night	O
and	O
remained	O
stable	O
.	O
	
He	O
was	O
then	O
weaned	O
off	O
of	O
ventilatory	B-Treatment
support	I-Treatment
and	O
was	O
successfully	O
extubated	O
.	O
	
The	O
patient	O
did	O
have	O
a	B-Problem
slight	I-Problem
bit	I-Problem
of	I-Problem
confusion	I-Problem
early	O
in	O
post-extubation	O
course	O
which	O
cleared	O
.	O
	
This	O
was	O
also	O
compounded	O
by	O
a	O
language	O
barrier	O
since	O
the	O
patient	O
cannot	O
speak	O
English	O
.	O
	
In	O
addition	O
,	O
the	O
patient	O
's	O
early	O
postoperative	O
course	O
had	O
a	O
tremendous	O
urine	B-Test
output	I-Test
.	O
	
It	O
was	O
equally	O
up	O
to	O
700	O
cc.	O
an	O
hour	O
and	O
a	B-Test
renal	I-Test
consultation	I-Test
was	O
obtained	O
.	O
	
He	O
underwent	O
a	B-Test
head	I-Test
CT	I-Test
scan	I-Test
to	O
rule	O
out	O
intracranial	B-Problem
pathology	I-Problem
leading	O
to	O
diabetes	B-Problem
insipidus	I-Problem
.	O
	
This	O
was	O
negative	O
.	O
	
The	B-Test
patient	I-Test
's	I-Test
serum	I-Test
and	O
urine	B-Test
electrolytes	I-Test
indicated	O
that	O
this	B-Treatment
diuresis	I-Treatment
was	O
appropriate	O
.	O
	
The	B-Test
patient	I-Test
's	I-Test
urine	I-Test
output	I-Test
has	O
decreased	O
and	O
his	B-Test
BUN	I-Test
and	O
creatinine	B-Test
remained	O
normal	O
.	O
	
The	B-Treatment
patient	I-Treatment
's	I-Treatment
Foley	I-Treatment
was	O
discontinued	O
.	O
	
He	O
had	O
developed	O
some	B-Problem
hematuria	I-Problem
which	O
has	O
resolved	O
.	O
	
The	O
patient	O
has	O
remained	O
stable	O
and	O
is	O
now	O
ready	O
for	O
discharge	O
to	O
home	O
with	O
follow-up	O
in	O
approximately	O
four	O
weeks	O
.	O
	
DISCHARGE	O
DIAGNOSES	O
:	O
	
1.	O
Mitral	B-Problem
regurgitation	I-Problem
status	O
post	O
minimally	B-Treatment
invasive	I-Treatment
mitral	I-Treatment
valve	I-Treatment
repair	I-Treatment
.	O
	
DISCHARGE	O
MEDICATIONS	O
:	O
	
1.	O
Lopressor	B-Treatment
75	O
mg	O
p.o.	O
twice	O
a	O
day	O
.	O
	
2.	O
Colace	B-Treatment
100	O
mg	O
p.o.	O
twice	O
a	O
day	O
.	O
	
3.	O
Percocet	B-Treatment
one	O
to	O
two	O
p.o.	O
q.	O
four	O
hours	O
p.r.n.	O
	
4.	O
Aspirin	B-Treatment
325	O
mg	O
p.o.	O
q.	O
day	O
.	O
	
CONDITION	O
ON	O
DISCHARGE	O
:	O
	
Stable	O
.	O
	
DIGibsonE	O
INSTRUCTIONS	O
:	O
	
1.	O
The	O
patient	O
will	O
follow-up	O
with	O
Dr.	O
de	O
las	O
Grau	O
in	O
four	O
weeks	O
.	O
	
2.	O
He	O
will	O
follow-up	O
with	O
his	O
primary	O
care	O
physician	O
,	O
Dr.	O
Blake	O
,	O
in	O
two	O
weeks	O
.	O
	
3.	O
The	O
patient	O
will	O
call	O
for	O
any	B-Problem
fevers	I-Problem
or	O
difficulties	B-Problem
with	I-Problem
the	I-Problem
wound	I-Problem
care	I-Problem
,	O
and	O
will	O
be	O
instructed	O
with	O
an	O
interpreter	O
present	O
.	O
	
Bruce	O
lou	O
Murphy	O
,	O
M.D.	O
	
07-760	O
	
Dictated	O
By	O
:	O
Ellen	O
V	O
Wise	O
,	O
M.D.	O
	
MEDQUIST36	O
	
D	O
:	O
2015-09-21	O
08:34	O
	
T	O
:	O
2015-09-26	O
15:44	O
	
JO	O
B#:	O
	
18430	O
	
Signed	O
electronically	O
by	O
:	O
DR.	O
Mary	O
van	O
den	O
Mosley	O
on	O
:	O
WED	O
2015-10-14	O
7:16	O
PM	O
	
(	O
End	O
of	O
Report	O
)	O
	
Admission	O
Date	O
:	O
	
2013-10-29	O
	
Discharge	O
Date	O
:	O
	
2013-11-04	O
	
Date	O
of	O
Birth	O
:	O
	
1943-01-06	O
	
Sex	O
:	O
	
M	O
	
Service	O
:	O
	
CARDIOTHORACIC	O
	
Allergies	O
:	O
	
Patient	O
recorded	O
as	O
having	O
No	O
Known	B-Problem
Allergies	I-Problem
to	I-Problem
Drugs	I-Problem
	
Attending	O
:	O
Angie	O
CM	O
Johnson	O
,	O
M.D.	O
	
Chief	O
Complaint	O
:	O
	
Coronary	B-Problem
artery	I-Problem
disease	I-Problem
requiring	O
surgical	B-Treatment
intervention	I-Treatment
	
Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O
	
CABG	B-Treatment
x	O
5	O
	
History	O
of	O
Present	O
Illness	O
:	O
	
Mr.	O
Andersen	O
is	O
a	O
71-year-old	O
male	O
with	O
worsening	B-Problem
anginal	I-Problem
symptoms	I-Problem
who	O
underwent	O
catheterization	B-Test
that	O
showed	O
severe	B-Problem
three-vessel	I-Problem
disease	I-Problem
.	O
	
He	O
is	O
presenting	O
for	O
revascularization	B-Treatment
.	O
	
Past	O
Medical	O
History	O
:	O
	
DM2	B-Problem
-	O
dx	O
'd	O
at	O
the	O
age	O
of	O
48	O
	
Arthritis	B-Problem
	
HTN	B-Problem
	
Tonsillectomy	B-Treatment
around	O
the	O
age	O
of	O
10	O
	
Social	O
History	O
:	O
	
Quit	O
smoking	O
23	O
years	O
ago	O
,	O
occasional	O
ETOH	O
,	O
denies	O
illicit	O
drug	O
use	O
.	O
	
Lives	O
with	O
wife	O
,	O
retired	O
12	O
years	O
ago	O
after	O
working	O
as	O
electrician	O
for	O
Attleboro	O
Donald	O
	
Family	O
History	O
:	O
	
Father	O
died	O
of	O
colon	B-Problem
cancer	I-Problem
.	O
	
Mother	O
with	O
pacemaker	B-Treatment
,	O
alive	O
at	O
91	O
years	O
old	O
.	O
	
Physical	O
Exam	O
:	O
	
Awake	O
and	O
alert	O
,	O
NAD	B-Problem
	
HEENT	O
:	O
PERRLA	O
,	O
no	O
carotid	B-Problem
bruits	I-Problem
	
CV	O
:	O
RRR	O
,	O
no	O
M/R/G	B-Problem
	
Lungs	O
:	O
CTA	O
b/l	O
	
Abd	O
:	O
Soft	O
,	O
NT/ND	B-Problem
,	O
NABS	O
	
Ext	O
:	O
cool	O
,	O
no	O
varicosities	B-Problem
,	O
1+	O
pedal	B-Test
pulses	I-Test
	
Pertinent	O
Results	O
:	O
	
2013-10-29	O
11:37	O
AM	O
BLOOD	B-Test
WBC	B-Test
-	O
11.4	O
*#	O
RBC	B-Test
-	O
3.09	O
*#	O
Hgb	B-Test
-	O
9.1	O
*#	O
Hct	B-Test
-	O
27.5	O
*#	O
MCV	B-Test
-	O
89	O
MCH	B-Test
-	O
29.5	O
MCHC	B-Test
-	O
33.3	O
RDW	B-Test
-	O
14.6	O
Plt	B-Test
Ct	I-Test
-	O
180	O
	
2013-10-29	O
11:37	O
AM	O
BLOOD	B-Test
PT	B-Test
-	O
16.2	O
*	O
PTT	B-Test
-	O
29.0	O
INR(PT)	B-Test
-	O
1.7	O
	
2013-10-29	O
11:37	O
AM	O
BLOOD	B-Test
Plt	B-Test
Ct	I-Test
-	O
180	O
	
2013-10-29	O
01:09	O
PM	O
BLOOD	B-Test
Glucose	B-Test
-	O
172	O
*	O
UreaN	B-Test
-	O
11	O
Creat	B-Test
-	O
0.9	O
Na	B-Test
-	O
142	O
Cl	B-Test
-	O
111	O
*	O
HCO3	B-Test
-	O
22	O
	
2013-10-29	O
01:09	O
PM	O
BLOOD	B-Test
Mg	B-Test
-	O
2.6	O
	
Brief	O
Hospital	O
Course	O
:	O
	
The	O
patient	O
was	O
taken	O
to	O
the	O
operating	O
room	O
on	O
2013-10-29	O
for	O
a	B-Treatment
CABG	I-Treatment
x5	O
.	O
	
Please	O
see	O
operative	O
note	O
for	O
full	O
details	O
.	O
	
The	O
patient	O
tolerated	O
this	B-Treatment
procedure	I-Treatment
well	O
.	O
	
He	O
was	O
taken	O
immediately	O
post-operatively	O
to	O
the	O
CSRU	O
.	O
	
He	O
was	O
extubated	O
that	O
night	O
.	O
	
The	O
did	O
well	O
in	O
the	O
ICU	O
.	O
	
His	B-Treatment
central	I-Treatment
line	I-Treatment
and	O
chest	B-Treatment
tubes	I-Treatment
were	O
removed	O
on	O
post-op	O
day	O
#2	O
and	O
was	O
transferred	O
to	O
the	O
floor	O
in	O
stable	O
condition	O
.	O
	
On	O
post-op	O
day	O
#3	O
,	O
the	B-Treatment
patient	I-Treatment
's	I-Treatment
pacing	I-Treatment
wires	I-Treatment
were	O
removed	O
,	O
and	O
his	B-Treatment
lopressor	I-Treatment
was	O
started	O
.	O
	
On	O
post-op	O
day	O
#4	O
,	O
the	O
patient	O
failed	O
the	O
first	O
of	O
his	B-Test
void	I-Test
trials	I-Test
.	O
	
He	O
was	O
seen	O
and	O
cleared	O
by	O
physical	O
therapy	O
.	O
	
He	O
was	O
discharged	O
home	O
on	O
post-op	O
day	O
#6	O
in	O
stable	O
condition	O
with	O
a	B-Treatment
foley	I-Treatment
catheter	I-Treatment
and	O
leg	B-Treatment
bag	I-Treatment
.	O
	
Medications	O
on	O
Admission	O
:	O
	
Avandia	B-Treatment
8	O
mg	O
daily	O
	
Glipizide	B-Treatment
10	O
mg	O
bid	O
	
Diovan	B-Treatment
160	O
mg	O
daily	O
	
Metformin	B-Treatment
500	O
mg	O
two	O
tabs	O
bid	O
	
Omeprazole	B-Treatment
20	O
mg	O
q	O
PM	O
	
Discharge	O
Medications	O
:	O
	
1.	O
Docusate	B-Treatment
Sodium	I-Treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
for	O
constipation	B-Problem
.	O
	
Disp	O
:*	O
60	O
Capsule	O
(s)*	O
Refills	O
:*	O
2	O
*	O
	
2.	O
Aspirin	B-Treatment
81	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
).	O
	
Disp	O
:*	O
30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(s)*	O
Refills	O
:*	O
2	O
*	O
	
3.	O
Oxycodone	B-Treatment
-	O
Acetaminophen	B-Treatment
5-325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4H	O
(	O
every	O
4	O
hours	O
)	O
as	O
needed	O
for	O
pain	B-Problem
for	O
30	O
doses	O
.	O
	
Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O
	
4.	O
Atorvastatin	B-Treatment
Calcium	I-Treatment
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O
	
Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O
	
5.	O
Rosiglitazone	B-Treatment
Maleate	I-Treatment
8	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O
	
6.	O
Glipizide	B-Treatment
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O
	
7.	O
Tamsulosin	B-Treatment
0.4	O
mg	O
Capsule	O
,	O
Sust.	O
Release	O
24	O
HR	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
,	O
Sust	O
.	O
Release	O
24	O
HR	O
PO	O
HS	O
(	O
at	O
bedtime	O
).	O
	
Disp	O
:*	O
30	O
Capsule	O
,	O
Sust.	O
Release	O
24	O
HR	O
(s)*	O
Refills	O
:*	O
0	O
*	O
	
8.	O
Metoprolol	B-Treatment
Tartrate	I-Treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
0.5	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O
	
Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O
	
9.	O
Furosemide	B-Treatment
20	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
every	O
twelve	O
(	O
12	O
)	O
hours	O
.	O
	
Disp	O
:*	O
60	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O
	
10.	O
Pantoprazole	B-Treatment
Sodium	I-Treatment
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
).	O
	
Disp	O
:*	O
30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(s)*	O
Refills	O
:*	O
2	O
*	O
	
11.	O
Potassium	B-Treatment
Chloride	I-Treatment
10	O
mEq	O
Capsule	O
,	O
Sustained	O
Release	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Capsule	O
,	O
Sustained	O
Release	O
PO	O
Q12H	O
(	O
every	O
12	O
hours	O
).	O
	
Disp	O
:*	O
120	O
Capsule	O
,	O
Sustained	O
Release	O
(s)*	O
Refills	O
:*	O
2	O
*	O
	
Discharge	O
Disposition	O
:	O
	
Home	O
with	O
Service	O
	
Discharge	O
Diagnosis	O
:	O
	
Coronary	B-Problem
artery	I-Problem
disease	I-Problem
	
Discharge	O
Condition	O
:	O
	
Stable	O
	
Discharge	O
Instructions	O
:	O
	
Please	O
return	O
to	O
the	O
hospital	O
or	O
call	O
Dr.	O
Alvarado	O
's	O
office	O
if	O
you	O
experience	O
chills	B-Problem
or	O
fever	B-Problem
greater	I-Problem
than	I-Problem
101	I-Problem
degrees	I-Problem
F.	I-Problem
	
Please	O
call	O
if	O
you	O
notice	O
redness	B-Problem
,	O
swelling	B-Problem
,	O
or	O
tenderness	B-Problem
of	O
your	B-Problem
chest	I-Problem
wound	I-Problem
,	O
or	O
if	O
it	O
begins	O
to	O
drain	O
pus	B-Problem
.	O
	
No	O
heavy	O
lifting	O
or	O
driving	O
until	O
follow	O
up	O
with	O
Dr.	O
Mullins	O
.	O
	
You	O
may	O
shower	O
.	O
	
Wash	O
incision	B-Problem
with	O
mild	O
soap	O
and	O
water	O
,	O
then	O
pat	O
dry	O
.	O
	
You	O
will	O
need	O
to	O
follow	O
up	O
with	O
your	O
primary	O
care	O
physician	O
/	O
urologist	O
prior	O
to	O
removal	O
of	O
your	B-Treatment
urinary	I-Treatment
catheter	I-Treatment
.	O
	
Followup	O
Instructions	O
:	O
	
Provider	O
:	O
Mary	O
,	O
Francis	O
Z.	O
739-488-1975	O
Call	O
to	O
schedule	O
appointment	O
.	O
	
Please	O
follow	O
up	O
in	O
1	O
month	O
.	O
	
Provider	O
:	O
Laurie	O
,	O
Paul	O
G.	O
(	O
858	O
)	O
481-2816	O
Call	O
to	O
schedule	O
appointment	O
.	O
	
Please	O
follow	O
up	O
in	O
1	O
week	O
.	O
	
Bernice	O
Jessica	O
MD	O
95-512	O
	
Completed	O
by	O
:	O
Carol	O
Lydia	O
MD	O
27-960	O
2013-11-05	O
@	O
0029	O
	
Signed	O
electronically	O
by	O
:	O
DR.	O
Elizabeth	O
GS	O
Vega	O
on	O
:	O
FRI	O
2013-12-06	O
12:28	O
PM	O
	
(	O
End	O
of	O
Report	O
)	O
	
Admission	O
Date	O
:	O
	
2020-03-11	O
	
Discharge	O
Date	O
:	O
	
2020-03-23	O
	
Date	O
of	O
Birth	O
:	O
	
1946-04-03	O
	
Sex	O
:	O
	
M	O
	
Service	O
:	O
	
MEDICINE	O
	
Allergies	O
:	O
	
Penicillins	B-Treatment
	
Attending	O
:	O
Ross	O
Z	O
Kenmore	O
,	O
M.D.	O
	
Chief	O
Complaint	O
:	O
	
Transfer	O
from	O
Newton-Wellesley	O
Hospital	O
hospital	O
for	O
epidural	B-Problem
abscess	I-Problem
	
Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O
	
1.	O
Partial	B-Treatment
vertebrectomy	I-Treatment
of	I-Treatment
L3	I-Treatment
and	I-Treatment
L4	I-Treatment
.	O
	
2.	O
Fusion	B-Treatment
at	I-Treatment
L3-L4	I-Treatment
.	O
	
3.	O
Vertebral	B-Treatment
Spacer	I-Treatment
at	I-Treatment
L3-L4	I-Treatment
.	O
	
4.	O
Anterior	B-Treatment
instrumentation	I-Treatment
L3-L4	I-Treatment
.	O
	
5.	O
Autograft	B-Treatment
,	O
bone	B-Treatment
morphogenic	I-Treatment
protein	I-Treatment
,	O
and	O
allograft	B-Treatment
.	O
	
6.	O
Debridement	B-Treatment
	
7.	O
Incision	B-Treatment
and	O
drainage	B-Treatment
	
8.	O
Echocardiogram	B-Test
	
History	O
of	O
Present	O
Illness	O
:	O
	
73	O
yo	O
M	O
transferred	O
from	O
Newton-Wellesley	O
Hospital	O
hospital	O
for	O
epidural	B-Problem
abscess	I-Problem
.	O
	
Pt	O
has	O
h/o	O
colon	B-Problem
can	I-Problem
to	I-Problem
liver	I-Problem
,	O
s/p	O
resxn	B-Treatment
with	O
serosal	B-Problem
implants	I-Problem
in	O
9/03	O
.	O
	
Pt	O
states	O
he	O
has	O
been	O
receiving	O
chemotherapy	B-Treatment
up	O
until	O
1	O
week	O
ago	O
.	O
	
States	O
he	O
first	O
developed	O
back	B-Problem
pain	I-Problem
5	O
weeks	O
ago	O
but	O
was	O
still	O
able	O
to	O
ambulate	O
with	O
his	B-Treatment
cane	I-Treatment
.	O
	
Last	O
week	O
it	O
was	O
worse	O
and	O
he	O
was	O
seen	O
in	O
clinic	O
.	O
	
An	B-Test
MRI	I-Test
was	O
done	O
and	O
this	O
showed	O
a	B-Problem
signal	I-Problem
abno	I-Problem
in	I-Problem
L3	I-Problem
L4	I-Problem
?	O
disciitis	B-Problem
vs	O
osteo	B-Problem
without	O
a	B-Problem
definitive	I-Problem
epidural	I-Problem
abscess	I-Problem
.	O
	
Initially	O
on	O
Vanc	B-Treatment
and	O
Cipro	B-Treatment
on	O
Friday	O
but	O
then	O
seen	O
by	O
ID	O
who	O
reccommended	O
no	O
abx	B-Treatment
but	O
a	B-Test
bone	I-Test
biopsy	I-Test
,	O
blood	B-Test
cx	I-Test
.	O
	
He	O
was	O
also	O
seen	O
by	O
spine	O
who	O
repeated	O
the	B-Test
MRI	I-Test
and	O
this	O
showed	O
L3-4	B-Problem
osteomyelitis	I-Problem
and	O
discitis	B-Problem
and	O
an	B-Problem
epidural	I-Problem
abscess	I-Problem
,	O
5cm	O
.	O
	
He	O
was	O
subsequently	O
restared	O
on	O
Vancomycin	B-Treatment
for	O
Corynebacterium	B-Problem
in	O
blood	B-Test
cx	I-Test
from	O
Fri	O
;	O
Followup	B-Test
cx	I-Test
has	O
been	O
NGTD	O
.	O
	
CXR	B-Test
also	O
showed	O
small	B-Problem
pleural	I-Problem
effusion	I-Problem
and	O
attempt	O
was	O
made	O
to	O
tap	B-Treatment
it	O
,	O
but	O
pt	O
did	O
not	O
tolerate	O
the	B-Treatment
procedure	I-Treatment
and	O
asked	O
that	O
it	O
be	O
deferred	O
.	O
	
He	O
did	O
undergo	O
a	B-Test
CT-guided	I-Test
aspiration	I-Test
/	I-Test
biopsy	I-Test
at	I-Test
the	I-Test
L3-4	I-Test
disc	I-Test
space	I-Test
on	O
2020-03-11	O
and	O
the	O
pt	O
was	O
transferred	O
to	O
Mediplex	O
Rehab	O
Hospital	O
immediately	O
following	O
this	O
.	O
	
No	O
results	O
from	O
this	O
were	O
sent	O
.	O
	
Currently	O
pt	O
denies	O
sensory	B-Problem
deficits	I-Problem
or	O
weakness	B-Problem
.	O
	
States	O
he	O
is	O
not	O
able	O
to	O
walk	O
because	O
of	O
severe	B-Problem
pain	I-Problem
.	O
	
States	O
pain	B-Problem
is	O
worst	O
when	O
he	O
sits	O
up	O
or	O
twists	O
his	O
back	O
.	O
	
No	O
bowel	B-Problem
or	I-Problem
bladder	I-Problem
incontinence	I-Problem
.	O
	
Past	O
Medical	O
History	O
:	O
	
-	O
epidural	B-Problem
abscess	I-Problem
	
-	O
colon	B-Problem
cancer	I-Problem
with	O
mets	B-Problem
to	I-Problem
liver	I-Problem
s/p	O
resection	B-Treatment
09-07	O
.	O
	
Oncologist	O
is	O
Dr.	O
Rowles	O
.	O
	
-	O
CAD	B-Problem
s/p	O
CABG	B-Treatment
x4	O
in	O
'	O
03	O
.	O
	
-	O
hypercholesterolemia	B-Problem
	
-	O
DM	B-Problem
with	O
neuropathy	B-Problem
.	O
	
-	O
persistent	B-Problem
R	I-Problem
foot	I-Problem
ulcer	I-Problem
	
Social	O
History	O
:	O
	
Lives	O
alone	O
in	O
apartment	O
in	O
Boston	O
.	O
	
Is	O
married	O
but	O
"	O
separated	O
"	O
from	O
his	O
wife	O
,	O
although	O
they	O
still	O
help	O
each	O
other	O
-	O
	
he	O
states	O
he	O
gives	O
her	O
one	O
of	O
his	O
pensions	O
and	O
she	O
helps	O
him	O
with	O
medicines	B-Treatment
etc	O
.	O
	
Quit	O
tobacco	O
in	O
2003	O
after	O
smoking	O
1	O
ppd	O
for	O
"	O
a	O
very	O
long	O
time	O
".	O
	
Drank	O
ETOH	O
heavily	O
until	O
8	O
years	O
ago	O
when	O
he	O
quit	O
.	O
	
Denies	O
IVDU	O
.	O
	
Has	O
children	O
but	O
they	O
are	O
not	O
nearby	O
.	O
	
Family	O
History	O
:	O
	
NC	O
	
Physical	O
Exam	O
:	O
	
98.6	O
,	O
104/50	O
,	O
96	O
,	O
20	O
,	O
96%	O
RA	O
	
Gen	O
:	O
in	O
NAD	B-Problem
,	O
but	O
winces	O
in	O
pain	B-Problem
with	O
movements	O
of	O
his	O
back	O
.	O
	
HEENT	O
:	O
Clear	O
OP	O
,	O
MM	B-Problem
very	I-Problem
dry	I-Problem
.	O
	
NECK	O
:	O
Supple	O
,	O
No	O
LAD	B-Problem
,	O
No	O
JVD	B-Problem
	
CHEST	O
:	O
Port	B-Treatment
a	I-Treatment
cath	I-Treatment
in	I-Treatment
R	I-Treatment
chest	I-Treatment
,	O
no	O
erythema	B-Problem
or	O
tenderness	B-Problem
.	O
	
CV	O
:	O
RR	O
,	O
NL	O
rate	O
.	O
	
NL	O
S1	O
,	O
S2	O
.	O
	
II/VI	B-Problem
SEM	I-Problem
at	I-Problem
LSB	I-Problem
with	O
radiation	B-Problem
to	I-Problem
apex	I-Problem
.	O
	
LUNGS	O
:	O
+	O
crackles	B-Problem
at	I-Problem
L	I-Problem
base	I-Problem
>	O
R	O
base	O
.	O
	
ABD	O
:	O
Pt	O
very	B-Problem
tense	I-Problem
in	I-Problem
abdomen	I-Problem
(	O
states	O
belly	O
is	O
fine	O
,	O
but	O
he	O
is	O
weary	O
of	O
his	O
back	O
).	O
	
Well	B-Problem
healed	I-Problem
midline	I-Problem
scar	I-Problem
from	O
chest	O
down	O
to	O
pubis	O
.	O
	
No	O
HSM	B-Problem
.	O
	
EXT	O
:	O
No	O
edema	B-Problem
.	O
	
Dressing	B-Treatment
c/d/i	O
over	O
R	B-Problem
LE	I-Problem
ulcer	I-Problem
.	O
	
1	O
+	O
DP	B-Test
pulses	I-Test
BL	O
	
NEURO	O
:	O
A&Ox3	O
.	O
	
Appropriate	O
.	O
	
CN	O
02-17	O
grossly	O
intact	O
.	O
	
Preserved	O
sensation	O
throughout	O
.	O
	
5/5	O
strength	O
throughout	O
,	O
though	O
weary	O
of	O
moving	O
back	O
.	O
	
Back	O
:	O
+	O
ttp	B-Problem
of	I-Problem
lumbar	I-Problem
spine	I-Problem
and	I-Problem
paraspinal	I-Problem
muscles	I-Problem
,	O
R	O
>	O
L	O
.	O
	
No	O
erythema	B-Problem
or	O
swelling	B-Problem
noted	O
.	O
	
CMED	O
CSRU	O
:	O
Listens	O
and	O
responds	O
to	O
questions	O
appropriately	O
,	O
pleasant	O
	
Pertinent	O
Results	O
:	O
	
Na	B-Test
:	O
135	O
,	O
K	B-Test
4.5	O
,	O
Cl	B-Test
96	O
,	O
CO2	B-Test
27	O
,	O
BUN	B-Test
12	O
,	O
Cr	B-Test
0.7	O
,	O
Glu	B-Test
167	O
,	O
Ca	B-Test
8.4	O
,	O
Vanco	B-Test
trough	I-Test
13	O
,	O
WBC	B-Test
5.3	O
,	O
Hct	B-Test
32.0	O
,	O
plt	B-Test
330	O
,	O
INR	B-Test
1.0	O
.	O
	
No	O
culture	B-Test
data	I-Test
was	O
sent	O
.	O
	
STUDIES	O
:	O
	
MRI	B-Test
lumbar	I-Test
spine	I-Test
(	O
Youville	O
Hospital	O
2020-03-10	O
):	O
L3-4	B-Problem
osteomyelitis	I-Problem
,	O
discitis	B-Problem
,	O
and	O
epidural	B-Problem
abscess	I-Problem
.	O
	
Degenerative	B-Problem
changes	I-Problem
including	O
multilevel	B-Problem
central	I-Problem
spinal	I-Problem
stenosis	I-Problem
.	O
	
Impression	B-Problem
on	I-Problem
the	I-Problem
anterior	I-Problem
aspect	I-Problem
of	I-Problem
the	I-Problem
lower	I-Problem
spinal	I-Problem
cord	I-Problem
at	I-Problem
T11-12	I-Problem
by	O
disc	B-Problem
bulge	I-Problem
.	O
	
Addendum	O
:	O
Findings	O
are	O
c/w	O
paraspinous	B-Problem
extension	I-Problem
of	I-Problem
infection	I-Problem
anteriorly	O
and	O
laterally	O
into	O
the	O
medial	O
aspects	O
of	O
the	O
psoas	O
muscles	O
bilaterally	O
at	O
the	O
L3	O
and	O
L4	O
levels	O
.	O
	
CXR	B-Test
(	O
Youville	O
Hospital	O
2020-03-09	O
):	O
Persistent	B-Problem
unchanged	I-Problem
L	I-Problem
mid	I-Problem
and	I-Problem
lower	I-Problem
lung	I-Problem
field	I-Problem
airspace	I-Problem
disease	I-Problem
with	O
moderate	B-Problem
L	I-Problem
pleural	I-Problem
effusion	I-Problem
.	O
	
Brief	O
Hospital	O
Course	O
:	O
	
73	O
yo	O
M	O
transferred	O
from	O
Youville	O
Hospital	O
with	O
h/o	O
colon	B-Problem
cancer	I-Problem
with	O
known	B-Problem
liver	I-Problem
mets	I-Problem
now	O
with	O
epidural	B-Problem
abscess	I-Problem
and	O
corynebacterium	B-Problem
bacteremia	I-Problem
:	O
	
#	O
Epidural	B-Problem
abscess	I-Problem
:	O
The	O
patient	O
was	O
evaluated	O
by	O
orthopedic	O
spine	O
consult	O
service	O
and	O
ID	O
.	O
	
He	O
was	O
continued	O
on	O
IV	B-Treatment
vancomycin	I-Treatment
throughout	O
his	O
course	O
and	O
had	O
therapeutic	O
troughs	B-Test
.	O
	
The	O
patient	O
was	O
taken	O
to	O
the	O
OR	O
twice	O
with	O
orthopaedics	O
.	O
	
Please	O
see	O
the	O
operation	O
notes	O
for	O
details	O
about	O
the	B-Treatment
surgeries	I-Treatment
.	O
	
The	O
patient	O
was	O
briefly	O
admitted	O
to	O
the	O
ICU	O
for	O
low	B-Problem
hematocrit	I-Problem
and	O
hyponatremia	B-Problem
immediately	O
following	O
the	B-Treatment
surgery	I-Treatment
but	O
was	O
then	O
transferred	O
back	O
to	O
the	O
floor	O
in	O
stable	O
condition	O
.	O
	
The	O
patient	O
had	O
a	B-Treatment
PICC	I-Treatment
line	I-Treatment
placed	O
and	O
will	O
continue	O
a	B-Treatment
8	I-Treatment
week	I-Treatment
course	I-Treatment
of	I-Treatment
antibiotics	I-Treatment
.	O
	
The	O
patient	O
will	O
also	O
wear	O
a	B-Treatment
back	I-Treatment
brace	I-Treatment
at	O
all	O
times	O
while	O
out	O
of	O
bed	O
.	O
	
#	O
Candidemia	B-Problem
:	O
The	O
patient	O
was	O
noted	O
to	O
have	O
a	O
positive	B-Test
blood	I-Test
culture	O
from	O
03-12	O
.	O
	
The	O
patient	O
was	O
started	O
on	O
Diflucan	B-Treatment
.	O
	
Ophthalmology	O
was	O
consulted	O
and	O
ruled	O
out	O
ocular	B-Problem
spread	I-Problem
.	O
	
The	B-Treatment
patient	I-Treatment
's	I-Treatment
portocath	I-Treatment
was	O
removed	O
.	O
	
The	O
tip	O
was	O
culture	B-Test
negative	O
.	O
	
The	O
patient	O
will	O
get	O
a	O
total	O
of	O
a	B-Treatment
two	I-Treatment
week	I-Treatment
course	I-Treatment
of	I-Treatment
Diflucan	I-Treatment
.	O
	
#	O
Corynebacterium	B-Problem
bacteremia	I-Problem
:	O
presumably	O
Corynebacterium	B-Problem
in	O
epidural	B-Problem
abscess	I-Problem
as	O
well	O
.	O
	
The	O
patient	O
had	O
no	O
blood	B-Test
cultures	I-Test
to	O
grow	O
corynebacterium	B-Problem
while	O
hospitalized	O
.	O
	
#	O
Pleural	B-Problem
effusion	I-Problem
:	O
The	O
patient	O
was	O
noted	O
have	O
an	B-Problem
effusion	I-Problem
on	O
CXR	B-Test
.	O
	
IP	O
was	O
consulted	O
and	O
did	O
a	B-Test
thoracentesis	I-Test
.	O
	
The	B-Test
tap	I-Test
was	O
negative	O
for	O
malignant	B-Problem
cells	I-Problem
.	O
	
A	B-Test
repeat	I-Test
CT	I-Test
was	O
done	O
showing	O
nodular	B-Problem
thickening	I-Problem
along	O
the	O
right	O
major	O
and	O
minor	O
fissure	O
,	O
concerning	O
for	O
intrapleural	B-Problem
tumor	I-Problem
implants	I-Problem
.	O
	
IP	O
reviewed	O
the	B-Test
films	I-Test
and	O
recommended	O
continue	O
oncologic	B-Treatment
care	I-Treatment
according	O
to	O
	
outpatient	O
course	O
and	O
pleurodesis	B-Treatment
if	O
the	O
pt	O
becomes	O
symptomatic	B-Problem
02-07	O
fluid	B-Problem
accumulation	I-Problem
.	O
	
The	O
patient	O
will	O
follow	O
up	O
with	O
his	O
oncologist	O
.	O
	
#	O
Foot	B-Problem
ulcer	I-Problem
:	O
diabetic	B-Problem
ulcer	I-Problem
s/p	O
surgery	B-Treatment
but	O
never	O
healed	O
.	O
	
Wound	O
care	O
was	O
consulted	O
and	O
made	O
recommendations	O
for	O
ulcer	B-Treatment
care	I-Treatment
.	O
	
His	B-Treatment
dressings	I-Treatment
were	O
changed	O
by	O
the	O
nursing	O
staff	O
accordingly	O
.	O
	
#	O
Anemia	B-Problem
:	O
His	B-Test
HCT	I-Test
remained	O
stable	O
post-surgery	O
.	O
	
The	O
patient	O
was	O
continued	O
on	O
his	B-Treatment
iron	I-Treatment
supplements	I-Treatment
.	O
	
Medications	O
on	O
Admission	O
:	O
	
-	O
Iron	B-Treatment
Sulfate	I-Treatment
300	O
mg	O
po	O
tid	O
	
-	O
Procrit	B-Treatment
40,000	O
units	O
SC	O
q	O
Friday	O
	
-	O
Lovenox	B-Treatment
40	O
mg	O
SC	O
q24	O
for	O
DVT	O
ppx	O
	
-	O
Albuterol	B-Treatment
/	O
Atrovent	B-Treatment
nebs	O
q4	O
	
-	O
Morphine	B-Treatment
2-4	O
mg	O
IV	O
q3-4	O
prn	O
	
-	O
Mylanta	B-Treatment
30	O
cc	O
po	O
q6	O
prn	O
	
-	O
Pepcid	B-Treatment
20	O
mg	O
po	O
daily	O
	
-	O
insulin	B-Treatment
sliding	I-Treatment
scale	I-Treatment
	
-	O
glipizide	B-Treatment
5	O
mg	O
po	O
bid	O
	
-	O
metformin	B-Treatment
500	O
mg	O
po	O
bid	O
	
-	O
metoprolol	B-Treatment
50	O
mg	O
po	O
daily	O
	
-	O
Vancomycin	B-Treatment
1.5	O
gm	O
q	O
12	O
hours	O
	
Discharge	O
Medications	O
:	O
	
1.	O
Albuterol	B-Treatment
Sulfate	I-Treatment
0.083	O
%	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Inhalation	O
Q4H	O
(	O
every	O
4	O
hours	O
)	O
as	O
needed	O
.	O
	
2.	O
Ipratropium	B-Treatment
Bromide	I-Treatment
0.02	O
%	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Inhalation	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
.	O
	
3.	O
Aluminum-Magnesium	B-Treatment
Hydroxide	I-Treatment
225-200	O
mg	O
/	O
5	O
mL	O
Suspension	O
Sig	O
:	O
15-30	O
MLs	O
PO	O
QID	O
(	O
4	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O
	
4.	O
Glipizide	B-Treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O
	
5.	O
Miconazole	B-Treatment
Nitrate	I-Treatment
2	O
%	O
Powder	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Appl	O
Topical	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O
	
6.	O
Acetaminophen	B-Treatment
325	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
for	O
fever	B-Problem
or	O
pain	B-Problem
.	O
	
7.	O
Metoprolol	B-Treatment
Tartrate	I-Treatment
25	O
mg	O
Tablet	O
Sig	O
:	O
1.5	O
Tablets	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O
	
8.	O
Cepacol	B-Treatment
2	O
mg	O
Lozenge	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Lozenge	O
Mucous	O
membrane	O
PRN	O
(	O
as	O
needed	O
).	O
	
9.	O
Docusate	B-Treatment
Sodium	I-Treatment
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O
	
10.	O
Senna	B-Treatment
8.6	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O
	
11.	O
Oxycodone	B-Treatment
5	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
every	O
4-6	O
hours	O
as	O
needed	O
for	O
pain	B-Problem
for	O
14	O
days	O
.	O
	
12.	O
Fluconazole	B-Treatment
200	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
)	O
for	O
7	O
days	O
.	O
	
13.	O
Oxycodone	B-Treatment
10	O
mg	O
Tablet	O
Sustained	O
Release	O
12	O
HR	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
Sustained	O
Release	O
12HR	O
PO	O
Q12H	O
(	O
every	O
12	O
hours	O
).	O
	
14.	O
Bisacodyl	B-Treatment
5	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O
	
15.	O
Aspirin	B-Treatment
81	O
mg	O
Tablet	O
,	O
Chewable	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Chewable	O
PO	O
DAILY	O
(	O
Daily	O
).	O
	
16.	O
Vancomycin	B-Treatment
in	I-Treatment
Dextrose	I-Treatment
1	O
g	O
/	O
200	O
mL	O
Piggyback	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Intravenous	O
Q	O
12H	O
(	O
Every	O
12	O
Hours	O
):	O
To	O
finish	O
on	O
2020-05-12	O
.	O
	
17.	O
Pepcid	B-Treatment
20	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
.	O
	
18.	O
Heparin	B-Treatment
Lock	I-Treatment
Flush	I-Treatment
(	I-Treatment
Porcine	I-Treatment
)	I-Treatment
100	O
unit	O
/	O
mL	O
Syringe	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
ML	O
Intravenous	O
DAILY	O
(	O
Daily	O
)	O
as	O
needed	O
:	O
10	O
ml	O
NS	B-Treatment
followed	O
by	O
2	O
ml	O
of	O
100	O
Units	O
/	O
ml	O
heparin	B-Treatment
(	O
200	O
units	O
heparin	B-Treatment
)	O
each	O
lumen	O
Daily	O
and	O
PRN	O
.	O
	
Inspect	O
site	O
every	O
shift	O
.	O
	
19.	O
Insulin	B-Treatment
Glargine	I-Treatment
100	O
unit	O
/	O
mL	O
Solution	O
Sig	O
:	O
Four	O
(	O
4	O
)	O
units	O
Subcutaneous	O
at	O
dinner	O
time	O
.	O
	
20.	O
Insulin	B-Treatment
Lispro	I-Treatment
(	I-Treatment
Human	I-Treatment
)	I-Treatment
100	O
unit	O
/	O
mL	O
Cartridge	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Subcutaneous	O
four	O
times	O
a	O
day	O
:	O
As	O
directed	O
by	O
sliding	B-Treatment
scale-please	I-Treatment
see	O
attached	O
scale	O
.	O
	
Discharge	O
Disposition	O
:	O
	
Home	O
	
Discharge	O
Diagnosis	O
:	O
	
Primary	O
diagnosis	O
:	O
Epidural	B-Problem
abscess	I-Problem
	
Secondary	O
diagnosis	O
:	O
	
-	O
colon	B-Problem
cancer	I-Problem
with	O
mets	B-Problem
to	I-Problem
liver	I-Problem
s/p	O
resection	B-Treatment
09-07	O
.	O
	
-	O
CAD	B-Problem
s/p	O
CABG	B-Treatment
x4	O
in	O
'	O
03	O
.	O
	
-	O
hypercholesterolemia	B-Problem
	
-	O
DM	B-Problem
with	O
neuropathy	B-Problem
.	O
	
-	O
persistent	B-Problem
R	I-Problem
foot	I-Problem
ulcer	I-Problem
	
Discharge	O
Condition	O
:	O
	
Stable	O
,	O
afebrile	B-Problem
	
Discharge	O
Instructions	O
:	O
	
You	O
were	O
diagnosed	O
with	O
an	B-Problem
epidural	I-Problem
abscess	I-Problem
.	O
	
Continue	O
to	O
take	O
the	B-Treatment
antibiotics	I-Treatment
as	O
directed	O
.	O
	
Take	O
the	B-Treatment
pain	I-Treatment
medication	I-Treatment
as	O
directed	O
and	O
do	O
not	O
drive	O
while	O
taking	O
this	B-Treatment
medication	I-Treatment
.	O
	
Call	O
the	O
doctor	O
or	O
return	O
to	O
the	O
Thomas	O
for	O
:	O
	
-	O
fever	B-Problem
>	O
102	O
	
-	O
chest	B-Problem
pain	I-Problem
or	O
shortness	B-Problem
of	I-Problem
breath	I-Problem
	
-	O
worsening	B-Problem
pain	I-Problem
or	O
weakness	B-Problem
in	I-Problem
your	I-Problem
legs	I-Problem
,	O
loss	B-Problem
of	I-Problem
bowel	I-Problem
or	I-Problem
bladder	I-Problem
function	I-Problem
or	O
any	B-Problem
other	I-Problem
concerning	I-Problem
symptoms	I-Problem
.	O
	
Followup	O
Instructions	O
:	O
	
Please	O
follow	O
up	O
with	O
Dr.	O
Scott	O
Ann	O
,	O
MD	O
Phone	O
:(	O
921	O
)	O
538	O
8079	O
on	O
2020-04-30	O
at	O
11:00am	O
.	O
	
Please	O
follow	O
up	O
with	O
Dr	O
Erb	O
-	O
3/30/07	O
at	O
10:00am	O
.	O
	
Please	O
follow	O
up	O
with	O
Dr.	O
Rowles	O
,	O
your	O
oncologist	O
,	O
in	O
2-3	O
weeks	O
	
Brooke	O
Donna	O
MD	O
37-421	O
	
Completed	O
by	O
:	O
Jessica	O
POPE	O
MD	O
58-704	O
2020-03-23	O
@	O
1515	O
	
Signed	O
electronically	O
by	O
:	O
DR.	O
Maryjane	O
WS	O
Hammond	O
on	O
:	O
FRI	O
2020-05-01	O
12:36	O
AM	O
	
(	O
End	O
of	O
Report	O
)	O
	
